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Abstract 
Workplace health promotion (WHP) describes any initiative carried out in the workplace to 
support and ultimately improve the health and wellbeing of people at work. 
Implementation of WHP is often unique to the organisation, and can include individual, 
social, cultural, environmental and political processes. Funding of WHP may necessitate an 
economic evaluation. The ideal evaluative method, however, is unclear. This thesis 
investigated the application of health economics in WHP by considering established 
guidelines and business needs to conduct an economic evaluation of an organisational 
approach to WHP in state government, Tasmania, Australia; Healthy@Work (2009-2012).  
The first chapter is a review of the global WHP evidence. A quality-based systematic 
literature review identified currently used components of economic evaluations. It found 
that methodological quality of economic evaluations was generally low to moderate and 
that benefits were measured predominately by changes in absenteeism and healthcare 
costs. The review also provided a robust synthesis of return on investment, accounting for 
quality along with offering recommendations for improving the state of evidence in WHP.  
From insights gained, a resource was then developed on behalf of a research-policy 
partnership. The second chapter describes the development of a workplace health savings 
calculator that is currently a national resource to assist employers at a business case level 
and is available in a WHP toolkit on the Australian federal government website.  
Data sourced locally (Healthy@Work) and nationally (Household Income and Labour 
Dynamics of Australia; HILDA) were used in a further analysis to investigate the validity of 
health utility in the employee population. It demonstrated construct validity of a measure of 
health status (SF-6D) derived from health-related quality of life (SF-12v2), and 
recommended its use in economic evaluations. This finding closes the gap between 
evaluations in WHP and health economic guidelines. 
Collectively these works helped identify measure and value what costs and benefits are 
involved in WHP. The final chapter applied this knowledge. An economic evaluation of 
Healthy@Work was conducted. Overall costs and impacts from health status, total lost 
productive time and healthcare utilisation were presented in a cost consequence analysis. 
There was no health status change found and inherent challenges for WHP when positioned 
within a public health paradigm were discussed.  
This thesis presents a range of studies that add to the body of knowledge for conducting 
economic evaluations in workplace health promotion. It discusses economic forms and 
analytic methods in the pursuit of best fit for WHP.   
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Healthy worker effect An epidemiological term referring to selection bias in worker 
health outcomes compared to normative populations. Workers 
are more likely to be healthier and less susceptible to morbidity 
and premature mortality due to the very nature of being well 
enough to work compared to the general population that 
includes people unable to work due to health problems  
  
HERO Health Enhancement Research Organization, an American 
national non-profit organisation identifying and sharing best 
practices in employee health management through research, 
education, policy, strategy, leadership and infrastructure 
  
HILDA Household Income and Labour Dynamics of Australia survey; a 
clustered stratified panel survey of persons residing in private 
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dwellings in Australia. Data collection commenced in 2001. The 
data set is maintained by the Faculty of Business and 
Economics, The University of Melbourne, Victoria Australia  
  
HRQOL Health-related quality of life; a multi-item measurement of the 
domains of health. Instruments can be generic, disease or 
population specific 
  
HWA WHO’s global Healthy Work Approach, an initiative based on 
principles of health promotion, occupational health and safety, 
human resource management and sustainable development to 
strengthen stakeholders partnerships 
  
iHEA International Health Economics Association 
  
Instrument A questionnaire, scale or survey with an associated method for 
attaching a numerical value to the answers  
  
K10 Kessler 10 Psychological Distress Scale; ten non-specific 
psychological distress questions that sum to give a total score 
between 10 (low) and 50 (high) psychological distress 
  
MD23 Ministerial Direction 23 – Workplace Health and Wellbeing. A 
policy guideline drafted by the H@W central coordinators and 
passed in parliament on 7 June 2010. 
  
MAUI Multi-attribute utility instrument is a preference-based 
instrument to assess health status amenable to economic 
evaluations 
  
Model A conceptual or mathematical framework which defines how 
values will be combined (for example, simple or weighted 
averaging of the level of the item responses)  
  
NICE National Institute for Health and Care Excellence 
NPAPH National Partnership Agreement on Preventive Health, an 
Australian Government commitment of funds to assist national 
health promotion, prevention and care co-ordination bodies 
tackle the rising prevalence of lifestyle-related chronic disease 
  
Occupational type Employment types, categorised as blue collar, white collar, 
service, professional and manager as per ANZSCO classification 
  
OECD Organization for Economic Cooperation and Development, an 
international economic organisation of 34 countries to 
stimulate economic progress and world trade. 
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PAHSMA Port Arthur Historic Site Management Authority 
pH@W partneringHealthy@Work; a collaborating team of researchers 
(from Menzies Institute for Medical Research and other schools 
within the University of Tasmania) and policy makers within 
TSS. This partnership had the specific task over five years 
(2009-2014) to evaluate both health and economic benefits of 
H@W alongside the project life. 
  
PT Public Trustee 
QALY Quality Adjusted Life Year, a single index measurement that 
combines length of life (life expectancy) adjusting for quality of 
life, commonly used in cost-utility analysis and seen as a gold 
standard measure in evidence-based decision making 
guidelines 
  
RCT Randomised Controlled Trial 
  
Reliability A measure of consistency. It is the proportion of the total 
variability in scores which is accounted for by the differences in 
the average values across observations. It applies to the 
interval consistency of the items of an instrument and to the 
test re-test consistency of the instrument over time.  
  
ROI Return on investment. An outcome from cost-benefit analysis 
that is expressed as a ratio formula, represented as  
(cost-benefit)/cost 
  
SD Standard Deviation 
  
SE Standard Error 
  
SF-6D Short form 6D (SF-6D (12) and SF-6D (36)) bracketed numbers 
represent the form from where the SF-6D is derived, origin: 
UK/USA. Preference-based measure of health status, known as 
a multi-attribute utility instrument (MAUI) 
  
SF-12 Short form 12 (version 1 and version 2), origin: USA. A health-
related quality of life measure of health status 
  
SF-36 Short form 36. An original version of health-related quality of 
life measure of health status 
  
Sensitivity The extent to which the instrument content allows the 
detection of changes in a health state  
SME Small to medium enterprise 
SNAPS Smoking, Nutrition, Alcohol, Physical activity and Stress; 
workplace health intervention categories 
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TAFE Tasmanian Skills Institute 
TAO Tasmanian Audit Office 
TAS Tasmania, the island State of Australia 
  
TFS Tasmania Fire Service 
TSS Tasmanian State Service, the Tasmanian Government 
comprising of the public sector state service workforce 
delivering public service to the State 
  
UK United Kingdom of Great Britain  
  
USA United States of America 
  
Validity Measurement of what is intended 
  
WHO World Health Organization 
WHO-WPRO World Health Organization – Western Pacific Regional Office 
  
WHP Workplace health promotion, a strategy, intervention or 
initiative aimed at improving the health and wellbeing of 
people at work 
  
WTP Willingness to Pay 
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1 Chapter one: Workplace health promotion: history, complexity, 
the role of health economics and introducing Healthy@Work  
1.1 Introduction 
This thesis investigated the application of health economics in workplace health promotion. 
It considered established guidelines and business needs to inform an economic evaluation 
of an organisational workplace health promotion project implemented in the Tasmanian 
Government, Australia; Healthy@Work (2009-2012). This introductory chapter described 
the history and economics of workplace health promotion, its complexity due to the multi-
determinants of workers’ health, its evolution across the decades, and the role of health 
economics in program evaluation. It also introduces the workplace health promotion 
project, Healthy@Work, and describes relevant information that was necessary for 
conducting its economic evaluation. 
Throughout history optimising health and minimising threats to health have been a 
fundamental human endeavour. Today there is an increasing focus on preventive health 
(actions to reduce or eliminate disease) and health promotion “the process of enabling 
people to increase control over, and to improve their health” p1.1 A major influence for this 
focus is the increased burden of disease due to preventable chronic conditions, and that in 
addition to an aging population and escalating health care costs, the public health system is 
struggling.2 Explanatory models of health promotion are based on our understanding of the 
determinants of health, those primary conditions for health, such as education, housing, 
and employment. The analytical approach in health promotion incorporates legacies from 
the eras of public health (health protection, behavioural change), the ‘new public health’ 
(change facilitation, multi-sectorial partnerships)3 and its latest extension, ecological public 
health (interdependence of sustainability, equity).4,5 Subsequently, health promotion within 
an ecological framework recognises the influences of educational, economic, social, cultural, 
environmental, spiritual and political actions on individuals and communities and is 
committed to a multi-sectorial and collaborative strategy that will empower people and 
populations.6 
Key elements of health promotion were formalised by the 1986 Ottawa Charter: 1) create 
supportive environments, 2) build healthy public policy, 3) strengthen community action, 4) 
improve personal skills and 5) re-orient health services.1 These led to an organised public 
health ‘settings approach’ to strengthen structures and processes that act effectively on the 
determinants of health in all sectors, including workplaces.7,8 By 2008 the World Health 
Organization’s (WHO) Commission on the Social Determinants of Health9 presented a clear 
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message that investment within settings was necessary to improve the health and health 
equity of all. The challenge is how to evaluate health gains in sectors that traditionally 
measure success in terms of economic activity.10 
1.2 Workplace health promotion 
Workplace health promotion (WHP) has been defined in most recent years as “the 
combined efforts of employers, employees and society to improve the health and wellbeing 
of people at work” p 2.11 This definition takes on a societal context, acknowledging that 
WHP relies on the involvement of all stakeholders, including government, insurers and trade 
unions. Implicitly it represents the multiple groups within society that can potentially 
experience gains through WHP. The fundamental principle underlying WHP is that through 
development of planned strategies to address identified employee health and wellbeing 
needs (these may include diseases, hazards, behavioural/environmental risks within the 
ecological framework), the health and wellbeing of employees will improve. 
1.2.1 History of WHP, the link to economies and the business case 
Traditionally WHP strategies had an ‘individualistic’ educational focus,12 and predominantly 
targeted an individual employee’s modifiable lifestyle risks for chronic disease such as 
smoking, nutrition, alcohol consumption, physical activity, and stress.13  
The prominence of workplaces as a public health ‘setting’ within the global health 
promotion movement was elevated in 1997 by the 4th International Health Promotion 
Conference in Jakarta, the Jakarta Statement14 and the Jakarta Declaration.15 Together they 
identified that workplaces had the ability to reach large populations of workers, their 
families, communities and societies as a whole, and that a healthy workforce was vital for 
sustainable social and economic development (Figure 1.1).  
Work, Health and Development 
Healthy workers 

Productive workers 

Successful businesses 

Healthy economy 

Sustainable development 
Figure 1.1 Concept of healthy workplaces, linking healthy workers to sustainable development; 
WHO-WPRO (1999) Regional guidelines for the development of healthy workplaces16 
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In addition, a new initiative called the WHO global Healthy Work Approach (HWA) was 
established to serve as a catalyst to strengthen stakeholder partnerships and corporate 
sector investment. It was based on principles of health promotion, occupational health and 
safety, human resource management and sustainable development.17 It acknowledged the 
economic value in optimising human resources through health promotion and aimed to 
inspire organisations to participate in WHP. For business, this value proposition holds true 
today and is reflected in current main drivers for the WHP business case: “Corporate values 
which recognize the social and economic relevance of a participatory workplace culture” 
p55. 18 Recognition of economic advantage and business success ensured WHP was seen as 
mutually beneficial for both employees and the organisations adopting it. Although the 
HWA initiative helped motivate the business case for WHP, fundamentally the ideology 
originated from a social responsibility to improve employee welfare and conditions,19 not an 
organisation’s bottom line. However in the mid-1980s and preceding the HWA initiative, 
companies in the United States indeed recognised preventive health care at the workplace 
as a fiscally responsible approach to cost containment, especially for health-care related 
costs. This helped prioritise the development of criteria to justify a workplace health 
program,20 which has become  known as the business case for WHP. 
Definition of a business case 
A ‘business case’ provides information for business justification. It represents a financial 
evaluation to assist in company efficiencies and objectives. Ultimately it demonstrates the 
business need for a given action by providing reasoning to initiate, continue or cease a 
project. There are three important components of a business case; 
 1. expected business benefits,  
 2. expected costs of the project,  
 3. expected risks.  
Consideration should also be given to the option of doing nothing (the inclusion of costs and 
risks of inactivity). Deciding if a project is worthwhile in order to allocate company funds 
requires putting a price on these components. Inherently what the costs benefits and risks 
are ‘expected’ to be requires decisions around potential performance. 
    Source: Messner (2013) making the Compelling Business Case21 
Evaluating the business case of WHP is complex as it involves measuring the potential 
performance on outcomes of health. Complex because health by definition is a ‘state of 
being’ that requires action and is affected by behaviour which can be difficult to change. 
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Also, health is affected by processes outside an individual employee’s control. Ill-health can 
be created within the organisation itself. The evolution of WHP is nuanced by our 
understanding around the multi-determinants of workers’ health. 
1.2.2 The evolution of WHP through the multi-determinants of workers’ health 
Global recognition for the multi-determinants of workers’ health identified a new set of 
leading indicators that helped target and reorientate WHP efforts.7 Factors affecting worker 
health and wellbeing were not only related to individual lifestyle and living conditions (the 
early single target ‘individualistic’ WHP focus) they were now seen to also include a number 
of workplace determinants (work styles and practices, work groups, organisation and 
culture, environment and working conditions).16,22 Greater understanding of the role 
workplaces play in the health of workers illustrated that the workplace has the potential to 
heal or harm, and that health was not the sole responsibility of the worker.23 For example, 
enabling factors in workplace culture (sense of community, positive culture, shared vision) 
were identified as relevant for improving worker health practices.24 Acknowledgement of 
the multi-determinants of worker health ultimately shaped WHP in the 1990s to what is 
now seen as the latest generation in the evolution of WHP strategies.8,25 Ideally, WHP 
should be: 
 Multi/interdisciplinary and integrative in approach and including environmental, 
social and organisational measures, 
 Strategic in managing health, with strategies incorporating all activities, policies, and 
decisions,  
 Targeting the health of employees, their families, and their communities, and  
 Linked to market success through consumer purchasing decisions. 
 
Subsequent research has demonstrated that multiple interacting work-related factors both 
directly and indirectly impact workers’ health.26,27 Moreover, the processes and impacts on 
workers through this broader concept of WHP have been inextricably linked to both 
employee health and company performance. These have been showcased in a conceptual 
model.28 Within the model (Figure 1.2) are both the individual health and organisational 
outcomes of specific interest for the work within this thesis. The complexities inherent in 
the multi-determinants of health remain one of the biggest challenges in developing 
methodology, economic models and resources to assist the business case in WHP.  
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Figure 1.2 Conceptual model of WHP, with permission from the authors and the American Journal 
of Health Promotion28 
 
1.2.3 WHP is a complex concept with global participation  
Not only is WHP complex, the settings in which WHP is implemented are vastly variable. 
Today, businesses offering a WHP initiative are multifarious, and spread worldwide 
throughout many jurisdictions and political contexts. Without confirmatory academic 
publications to this effect, a recent global workplace health promotion study within a grey 
literature report29 charted 1,041 businesses active in delivering WHP by region. Figure 1.3 
shows the spread. 
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1.3 The role of health economics in WHP evaluation 
Health economics is a discipline considered by most to have been formalised in an article 
published in 1963 in the American Economic Review. Written by Kenneth Arrow it was titled 
“Uncertainty and the welfare economics of medical care,”30 although earlier contributions 
to health economics have been noted (one dating back to the 17th Century)31,32 and the 
earliest definition was published in 1958 by Selma Mushkin.33 The history of health 
economics is not pivotal to this dissertation, except to state its relative youth and 
consequential developing methodologies in comparison to other scientific disciplines.  
1.3.1 Definition of health economics  
Health economics is a subdivision of economics, and is  
“the study of how scarce resources are allocated among alternative uses for the care 
of sickness and the promotion, maintenance and improvement of health, including 
the study of how healthcare and health-related services, their costs and benefits, and 
health itself are distributed among individuals and groups in society.” World Bank 
Health Economics Glossary 34 
Thus, health economics is a science of choice in an environment of scarcity. It is used to 
inform decision makers on how best to allocate their resources, most often with the aim to 
measure and optimise health benefits for a population.35 The first ever recorded health 
economic evaluation (well before the discipline formally emerged) quantified costs and 
benefits of measures to reduce the effects of the plague in 17th Century England (Appendix 
1A). Important categorisations in economic thought are microeconomics and 
macroeconomics. Microeconomics refers to decisions of individual consumers and firms and 
is distinct from the broader ‘macro’ scale economic aggregates such as gross domestic 
product.36  
Figure 1.3 
 Indication by region of where 
companies are offering WHP.  
Source: “Working Well: A 
Global Survey of Health 
Promotion, Workplace 
Wellness and Productivity 
Strategies” Buck Consultants 
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The focus for this thesis is on the application of health economic evaluations to inform the 
business case for WHP. This thesis draws from microeconomic theory of health economics. 
This is an important distinction as it relates to scope and one that determines what tools 
and methods of health economics are available for use, for there are numerous elements 
within the discipline itself (Figure 1.4). This thesis is delineated by the multi-determinants of 
workers’ health (Figure 1.4, Box A), how health is defined and valued by decision makers 
implementing WHP (Figure 1.4, Box B) and the microeconomic application of economic 
evaluations (Figure 1.4, Box E). It should be noted that this thesis offers no evaluative focus 
on interactions between different sectors of the economy to address the global public 
health’s ‘settings approach’ – the social reforms where WHP has gained its universal 
adoption (Figure 1.4, Box G).  
 
Figure 1.4 The plumbing diagram (Williams, 1987): a schematic presentation of the main health 
economics elements.37 Available and reproduced from the public domain 
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1.3.2 Economic evaluations  
Considering the business case inputs of cost, benefit and risk to evaluate feasibility of a 
project from the company perspective, the application of health economics to conduct 
health economic evaluations of WHP appears to be a good fit.  
An economic evaluation is "the comparative analysis of alternative courses of action in 
terms of both their costs and consequences” p9 35 They are carried out so that resources 
(costs) are allocated efficiently, considering the consequences (benefits or adverse effects) 
that arise. The decision makers (i.e. government or business) then use the information 
provided in the evaluation to decide whether to fund an action (intervention, program). 
When faced with resource scarcity, decision makers usually have a limited or fixed budget 
and many possible alternative actions where resources could be utilised. Therefore it is an 
inherent task for economic evaluations to deliver a comparative analysis to provide 
information on actions that may or may not be beneficial enough in respect to the best 
alternative use of funds.35 Ultimately an economic evaluation should answer the question: 
“Is the action good value for money?” 
1.3.3 Types of analysis in economic evaluations 
The type of analysis needed to answer this question depends on how the benefits are 
expressed. There are several types relevant to this work. When benefits are expressed in 
terms of a single unit of effect, such as function, risk severity or other units (i.e. blood 
pressure or number of days absent) the analysis is known as a cost-effectiveness analysis 
(CEA). If this effect is measured by healthy years (i.e. using a preference-based health 
measure such as health utility) the analysis is referred to as a cost-utility analysis (CUA). In a 
cost-benefit analysis (CBA) all consequences, (i.e. benefits due to improved health, future 
healthcare costs avoided or increased productive output due to improved health status, or 
adverse consequences like side effects) are translated into a monetary value. All three 
analytical types can offer a value for money answer as they value effectiveness measure(s) 
relative to its costs.38,39 In contrast, a form of evaluation that does not provide an estimate 
of value for money, but that is still of interest is the cost-consequence analysis (CCA). This 
type is appropriate when there are multiple benefit measures making value for money 
difficult to precisely quantify. A CCA presents data on all costs and benefits, measured in the 
most appropriate units. For the decision maker this form of economic evaluation displays an 
array of benefits alongside costs so they can decide on relative importance.40 From this the 
analyst can value specific outcomes of interest as needed.35 In 2000 a review of abstracts 
within the UK NHS Economic Evaluation Database (NHS EED), evaluations were most likely 
CEA (85%) rather than CUA (9.3%) or CBA (1.4%).41 There was no analytical breakdown for 
CCA, although a more recent 2009 review of public health interventions found 78% of 
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economic evaluations conducted either a cost-effectiveness or cost-consequence analysis.42 
This indicates the common types of economic evaluations used in public health and reflects 
the National Institute for Health and Care Excellence (NICE) in the UK’s support for 
conducting CCA’s when it is not appropriate to conduct CEA or CUAs.43 In both reviews, 
studies conducted in workplace health promotion were not specified. A summary of analysis 
types, what costs and benefits are assessed, characteristics, strengths and challenges when 
applied to WHP are presented in Appendix 1B. 
1.3.4 Components of an economic evaluation 
There are three components of an economic evaluation36 
1. Framing the evaluation. 
2. Identifying, measuring, valuing costs. 
3. Identifying, measuring, valuing consequences (outcomes, benefits, adverse events). 
Framing involves a clear statement of whose costs are considered (the perspective), the 
purpose for conducting the evaluation and the time frame (as costs and benefits change). 
When identifying, measuring and valuing costs and benefits a number of influences need to 
be considered. These are displayed in Figure 1.5.  
 
Figure 1.5 Components of an economic evaluation as applied to a WHP action: identify, measure 
and value costs and benefits. Adapted from Drummond et al. (2005)35 
In summary, the application of health economics theory advises that financial analysis of 
WHP should fundamentally analyse health and its impacts on health benefits, first by 
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defining health and placing value on it, and second by conducting an evaluation that 
responds to the existence of competing priorities, limited resources, and unlimited 
demands. When economic evaluations fail to follow these principles the information 
provided may contribute to inefficient policy and practice, and could be considered of low 
methodological quality.44 
1.3.5 Quality of economic evaluations 
There have been longstanding discussions concerning the quality of economic evaluations in 
WHP.45-48 The earliest dates back to a 1988 review. It concluded “the claims of profitability 
are based on analyses seriously flawed, in terms of assumptions, data, or methodology” 
p106. 45 The trepidation surrounding economic evaluation results is not specific to WHP, and 
as health economic theories started entering the medical research literature in the 1990s, 
guidelines, recommendations and checklists were produced to strengthen the methodology 
of the discipline as a whole.44,49-52 Critical assessment of economic evaluations are 
paramount to minimise risk of bias53 and checklists have been developed that separate the 
various elements of methodology within an economic evaluation so that closer scrutiny can 
take place.35,54-60 Although to date only one checklist has been formally validated,58 two 
have received more scrutiny than most and are recommended by economic guidelines.52 
They are: British Medical Journal Checklist for authors and peer reviewers of economic 
submissions;54 and Consensus on Health Economic Criteria (CHEC) list for assessment of 
methodological quality of economic evaluations.55 Most recently a consolidated reporting 
standard has been endorsed and co-published in the attempt to meet consensus among 
academia, clinicians, industry, government and editorial boards, and to guide authors in 
reporting economic methodology.61 It is known as the Consolidated Health Economic 
Evaluation Reporting Standards (CHEERS). 
It is important to highlight that no checklist specific to workplace health promotion exists. In 
addition, the WHO European Working Group on Health Promotion Evaluation in their 
examination of evaluation methods noted that the criteria to judge quality of evidence are 
not altogether optimal for decision making in health promotion.62 This sentiment can be 
extended to workplace health promotion, and as such, currently available economic quality 
checklists may not produce the most precise information appraisal for WHP initiatives. 
Nonetheless all available checklists address similar economic elements and seek to improve 
the credibility of the research endeavour, that is, to determine if the study is appropriate 
and results are valid, transferable and generalisable to other settings. Checklist items 
include: perspective, type of comparator, economic form, costs and benefits (identified, 
measured, valued), incremental analysis, dealing with uncertainty, discount rate, time 
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horizon, and funding source. 
In the Campbell and Cochrane Economics Methods Group handbook it states: “there has 
been relatively little empirical research to investigate the impact upon the results of a 
critical review of health economics studies, of decisions to include economics studies that 
meet some but not all standards of methodological quality” Section 15.5.2.53 Chapter 2 of 
this thesis is one such example. It contains research that investigates the relationship of 
methodological quality on financial outcomes in WHP. 
1.3.6 Employer costs and benefits in workplace health promotion 
In order to consider health economic methodology in WHP, the component costs and 
benefits of a health program in the workplace must be identified. These can be many and 
varied and there is no set standard. Identified costs and benefits in WHP are specific to the 
type of WHP, whose resources are being used, and what processes, impacts and outcomes 
are of importance to the decision maker. A non-exhaustive list represented across the 
literature is provided below. 
Costs: program start up and operation, educational materials, personnel, facilities, 
infrastructure, overhead, supplies to run program (i.e. posters, newsletters), IT support, 
training, administration, marketing, lost productivity, accident and injury, overtime and 
temporary staffing, overall cost to society: due to increased pain,suffering, and  illness. 
Benefits: improved company brand, higher productivity (reduced absence/presenteeism), 
higher commitment, improved employee resilience, reduced claims (medical, legal, worker 
compensation, pharmaceutical, therapy), improved staff turnover/retention/attrition, 
decreased replacement training, better employee job satisfaction/motivation, improved 
company profile/competitiveness, potentially higher profitability, minimal customer 
dissatisfaction, improved service and quality, better working conditions, climate, culture, 
organisation and overall benefit to society: due to decreased pain and suffering, and 
increased quality of life. 
An illustration of the economic benefits of WHP at a company level was adapted from the 
European Network for Workplace Health Promotion ‘Healthy Employees in Healthy 
Organisations’ Report (Figure 1.6): 
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Figure 1.6 Economic benefits of WHP at the company level, adapted from Mossink (2002)63 and de 
Greef (2004)18 
Given such breadth of component costs and benefits in WHP assures not only a high level of 
complexity when conducting financial analysis,28 but also the need for continual monitoring 
and reassessment of their appropriateness64 and the fundamental importance of high 
quality economic reporting standards to overcome inherent difficulties in translation across 
settings.61 Ultimately the decision to invest will lie with the decision maker.  
In countries with national health coverage, such as Australia, companies need not invest in 
WHP to lower medical care costs. Although there is limited empirical investigation within 
this context on what categorises decision makers’ intentions to invest in WHP, one study 
identified four main reasons;65  
1. Moral responsibility - doing social ‘good’ not ‘harm’ to your employees,  
2. Subjective norms - ‘because others do it’ and there’s a perceived social pressure,  
3. Volitional control – use of free will being in a position to do something, and 
4. Attitude – there is value that is seen in the expected outcomes. 
Component costs and benefits that make up the business case for WHP influence only one 
of these four; the attitude of decision makers. There are numerous other reasons to embark 
on providing WHP and although adoption and sustainability is part-assisted by robust 
economic evaluations, it should be contextually noted that WHP is more than just 
economics to many.  
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1.4 WHP in Australia 
Workplace health promotion in Australia has followed overseas trends and the evolutionary 
phases of health promotion which has led to its current integrated organisational 
development approach.7 In 2010-11 Australia was ranked 21st out of the 24 OECD countries 
for its prevention and public health spending (1.7% of total health expenditure, 0.16% of 
gross domestic product), equivalent to $85 per person that year.10 In 2008 the Australian 
Government committed $932.7 million over nine years (2009-2018) in a National 
Partnership Agreement on Preventive Health (NPAPH). This was to assist national health 
promotion, prevention and care co-ordination bodies tackle the rising prevalence of 
lifestyle-related chronic disease. Primarily NPAPH was facilitated from a state and territory 
level, of which in Australia there are seven. ‘Healthy Workplaces’ was one of three funded 
settings under the NPAPH and WHP received its largest ever funding commitment of $294 
million Australian dollars.66,67 
1.5 WHP in Tasmania 
Tasmania is the island state of Australia. Before the NPAPH incentive funding Tasmanian 
workplace health and wellbeing initiatives gained most prominence when the Tasmanian 
State Government via the Premier’s Physical Activity Council outlined a model for WHP in a 
toolkit; ‘Get Moving at Work:  A resource kit for workplace health and wellbeing 
programs.’68 It was based on existing national and international best practice. Other key 
State policy documents that set the direction for promoting health in the workplace were 
“Connecting care:  Chronic Disease Action Framework for Tasmania 2009–2013,”69 “Working 
in Health Promoting Ways: a Strategic Framework,”70 the “Tasmanian Physical Activity Plan 
2005-2010,” its updated version “Tasmania’s Plan for Physical Activity 2011-2021,”71 and 
“Building the Foundations for Mental Health and Wellbeing: A Strategic Framework and 
Action Plan for Implementing Promotion, Prevention and Early Intervention (PPEI) 
Approaches in Tasmania, 2009.”72 Workplace health and safety legislation and regulation for 
businesses in the state are governed by WorkSafe Tasmania, a division of the Tasmanian 
Department of Justice.  
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1.6 Healthy@Work (H@W), a Tasmanian State Government WHP project 
The ultimate aim of this thesis was to conduct an economic evaluation of H@W. H@W was 
a Tasmanian Government project, developed independently of the research-policy 
evaluation team (see 1.8 partneringHealthy@Work) and implemented across the Tasmanian 
State Service (TSS).  
1.6.1 Study setting 
The TSS is the public sector state service of Tasmania located within fourteen Agencies and 
Authorities (agencies) throughout the island state (68,401 square kilometres73). It delivers 
public service to the state’s 510,600 inhabitants.74 Employees within the TSS are diverse and 
include senior executives, front line workers, clerical workers, administrators, lawyers, 
teachers, police, health and emergency personnel, technicians, service providers, labourers, 
junior graduates and cadets. They are either full-time, part-time or casual in employment, 
hold permanent, fixed-term or casual contracts, and are within occupations that fall under 
the following departments: Department of Treasury and Finance (DTaF); Department of 
Health and Human Services (DHHS); Department of Police and Emergency Management 
(DPEM); Department of Education (DoE); Department of Economic Development, Tourism 
and the Arts (DEDTA); Department of Infrastructure, Energy and Resources (DIER); 
Department of Justice (DoJ); Department of Premier and Cabinet (DPaC); Department of 
Primary Industries, Parks, Water and Environment (DPIPWE); Tasmanian Audit Office (TAO); 
Tasmania Fire Service (TFS); Public Trustee (PT); Tasmanian Skills Institute (TAFE); and Port 
Arthur Historic Site Management Authority (PAHSMA). 
Implementation of H@W was one way the TSS is responding to increasing uncertainty, 
including fiscal constraints, demographic change and an aging population. TSS employees 
number close to 30,000 and are pivotal to the success of the state for their provision of 
Government services, policies and programs to the whole community. However, the 
employees are aging and the future composition of the TSS is facing great challenge.  
“In the next five to ten years, more than 50 per cent of the State Service workforce 
will be at the minimum retirement age. In excess of 15,000 people may exit the 
workforce” p4 75 
1.6.2 The Healthy@Work (H@W) Project  
The 2008-2009 Tasmanian State budget included funding for H@W, a four-year workplace 
health and wellbeing project (2008-2012). The government’s vision for this project was ‘well 
developed and effective workplace health and wellbeing initiatives integrated within each 
Tasmanian Government Agency.’ The H@W model was developed within the Public Sector 
Management Office, an office of the Tasmanian DPaC. To develop health promoting 
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initiatives the H@W model required the organisation to: 
1. Establish organisational commitment 
- Identify key champions 
- Ensure a commitment from management 
- Encourage staff commitment 
2. Construct the program 
- Identify staff issues 
- Identify workplace environment and policy issues 
- Implement suitable initiatives based on the issues identified 
3. Manage and evaluate  
- Implement specific initiatives 
- Evaluate the program and it’s initiatives 
- Refine the program and it’s initiatives 
As outlined by the H@W Communications Strategy (Feb 2010-11), project principles were: 
Equity of access, Leadership, Targeting of key priorities, Organisation based strategies, 
Flexible model and Evidence of the impact. Key principles for implementing H@W programs 
are outlined in Table 1.1. The management team within the TSS developed these principles 
from evidence13,16,76-78 and documented them in the H@W policy guidelines.79  
Table 1.1 Key principles for H@W workplace health and wellbeing programs, developed from 
evidence 
1. Is cost-effective and may not be expensive. 
2. Acknowledges and supports Occupational Health and Safety. 
3. Is managed within the workplace.   
4. Includes an assessment of needs to identify health issues in the workplace. 
5. Involves voluntary employee participation and attains high participation. 
6. Includes training in health promotion/workplace health promotion principles and 
access to appropriate information and resources for staff responsible for 
coordinating the program. 
7. Is sustainable and involves a long-term commitment. 
8. Involves equitable access for staff irrespective of their current health status or role 
within the organisation. 
9. Includes an evaluation process. 
10. Recognises that an individual’s health is determined by a set of interdependent 
factors.   
11. Uses a mix of strategies that simultaneously identify or address individual, 
environmental and organisational issues. 
12. Considers the workplace structures, cultures and policies. 
13. Involves senior management and senior management owns the program. 
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14. Is integrated into the organisations’ operations through program governance, 
administration and staffing. 
15. Promotes programs and outcomes internally and externally. 
 
From the onset, H@W embedded best practice by integrating within an existing process 
within the TSS known as People Directions, a comprehensive workforce management 
strategy targeting important issues such as leadership, capability development, planning, 
attraction and retention, and included projects such as “Who We Are” (identity attributes 
and attitude) and “Talking With Our People” (communications strategy).75  
1.6.3 Healthy@Work (H@W) the intervention 
$2.04 million Australian dollars were budgeted for H@W over the 4 year implementation 
period. For this, the TSS sought to establish a culture that values, supports and improves the 
health and wellbeing of employees. H@W was centrally coordinated by the Public Sector 
Management Office. This included developing and resourcing interventions across all 
agencies and incorporated: a coordinated education and communication strategy, mental 
health and wellbeing training, consultancy service, a project website, agency grants and 
subsidies.80 Further details of the interventions can be found in Chapter 5. In brief, each 
Agency (n=14) within the TSS was required to develop a workplace health program plan for 
preventive strategies based on the H@W implementation cycle (Figure 1.7) and key 
principles (Table 1.1). Identification of employee needs and preferences were conducted in 
2009 using an online employee assessment tool, including automated user-feedback for 
employees and Agency summary data generation for managers. This identified any number 
of key health risk factors for appropriate program targeting. Programs included activities 
and health-promoting interventions for smoking, nutrition, physical activity, breaking-up 
sedentary time, alcohol consumption and psycho-social health. Examples included stress 
management, pedometer challenges, influenza vaccination, sedentary break time, healthy 
catering (cafeteria or vending machines), Employee Assistance Programs (EAP), smoke free 
policies and other activities encouraging an organisational change approach to improve 
culture, policies and resources in relation to employee health and wellbeing. 
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Figure 1.7 Healthy@Work implementation cycle 
1.7 partneringHealthy@Work (pH@W) the evaluation of H@W   
The year following commencement of H@W, a partnership was formed between policy 
makers within TSS and researchers at Menzies Institute for Medical Research as well as 
other schools within the University of Tasmania. This partnership known as 
partneringHealthy@Work (pH@W) had the specific task over five years (2009-2014) to 
evaluate both health and economic benefits of H@W alongside the project life. The 
partnership offered researchers a unique opportunity to prospectively investigate a 
population-wide dissemination of WHP in a real world setting with the aim to address the 
feasibility, effectiveness and sustainability of workplace health promotion. It also provided 
the TSS with evidence during the implementation years that could inform and assist 
individual agencies to tailor programs to meet changing needs. Ultimately pH@W afforded 
the pH@W team a collaborative milieu to bring evidence-based research to policy decisions, 
in relation to action, translation and sustainability efforts of H@W.  
No opportunity for research input on the implementation phase of H@W had been 
available, indeed there was a short lag time to form and formalise the partnership. Thus the 
researcher contribution was solely within an evaluative scope. Subsequently, no H@W 
control population was established, and researchers attempted to address the complexity of 
these types of interventions when rolled out to entire populations and within designs 
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contrary to gold standard research criteria. For instance, and in respect to this thesis,  health 
economic guidelines recommend randomised controlled trial as the suggested experimental 
design due to a common economic focus on clinical medicine.53,81  
From the onset, pH@W collaborated to provide evidence of effectiveness that had greatest 
utility for the TSS and that would assist the H@W project. pH@W investigators consisted of 
nine senior researchers, six senior policy makers and three PhD students. Works arising from 
the other students include theses titled “Promoting mental health in a large and diverse 
public sector workforce” (Lisa Jarman) that focussed on mental health and job stress, and 
“Healthy@Work? Lifestyle factors and workplace health promotion” (Michelle Kilpatrick) 
focussed on health-related behaviours and overweight and obesity, and employee 
engagement.  
1.7.1 Funding  
pH@W was funded by a research grant from the National Health and Medical Research 
Council Partnership Projects (Australia), grant no. 544954. Study results and publications 
arising out of the partnership were not contingent on funder approval. The TSS senior policy 
makers within pH@W were considered partners in the research and as such they helped set 
the research priorities and contribute to what was measured. Partner approval was sought 
for works within Chapters 2, 3, 4, and 5 of this thesis and their role as co-author in works 
within Chapters 3 and 5 has been noted within the Statement of Co-authorship. 
1.7.2 Public sector internship 
Due to the unique nature of the research-policy collaboration within the pH@W 
investigative team, a three month (100 hour) practical student placement for each of the 
three PhD students involved in the project was agreed upon. It aimed to provide a working 
model of a public service orientated research-policy alliance and demonstrate a positive 
example of the value of partnership in translational research. As one of the three students 
my internship was to offer additional research resources to the DHHS, Healthy Workers 
Initiative team, to assist in the development of the Healthy Workplace Resource Toolkit. 
Outcomes from my internship were presented in Chapter 3.  
1.7.3 Ethics 
pH@W was conducted in accordance with relevant privacy legislation and with approval 
from the Tasmanian Health and Medical Human Research Ethics Committee; No. H0010501. 
Ethics approval for the public sector internship was granted by the Social Science Human 
Research Ethics Committee (Tasmania) Network; No. H0012482. 
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1.7.4 pH@W design and data sources  
1.7.4.1 Design 
Selected variables from a centralised TSS administrative database of employees was 
provided to researchers by policy partners. This database was password protected and 
stored on a secure digital medium that only the pH@W statistician accessed. After 
extraction, identified information was removed from electronic access. The database 
allowed for linking of pH@W survey responses (see 1.7.4.3 Data sources) to employee 
specifics (i.e. salary, tenure, employment category), for cross-referencing self-reported 
responses such as age. It also allowed for unique IDs to be assigned to each employee for 
matching purposes (see 1.7.4.2 Sampling frame). A unique ID was defined as a unique 
employee number within a single agency and not necessarily an individual person. There 
were 46,411 database records and 27,659 unique IDs in the pH@W sampling frame. 
1.7.4.2 Sampling frame 
46,411 records from a centralised TSS administrative database 
 Exclusions:  
 5 records without agency information (coded “None”)  
 144 records from one agency used in initial survey pilot (not re-sampled)  
 8613 records without matching name and address agency data.  
 8850 records with zero full time equivalent hours employed (i.e. recorded as unpaid) 
In total, 28,799 records were available for sampling (27,659 unique IDs). 
   Acknowledgement: Thanks to Petr Otahal, Statistician, pH@W  
Survey participants were selected by stratified random sampling of unique IDs. Stratification 
was by agency and four types of employment categories and tenure (full-time, part-time, 
fixed term/casual and permanent). A flow chart of the sampling procedure is provided in 
Figure 1.8. This sampling procedure allowed for weighting in analyses. 
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Figure 1.8  Flowchart of pH@W sampling procedure. Acknowledgement: Thanks to Kate Chappell, 
Data Manager, pH@W 
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1.7.4.3 Data sources 
The sources of information on the TSS employee population that were primarily used in this 
thesis were:  
 pH@W survey 2010 (Appendix 1C) 
 pH@W survey 2013 (Appendix 1D) 
These surveys were developed by collaboration within pH@W to include measures relevant 
to both researchers and decision makers. Validated measures were used where available. 
Surveys were administered to employees at two time points (2010 and 2013) using a 
repeated cross-sectional design. Refer to Chapter 4 and 5. 
The sources of information used to investigate H@W at the organisational level are: 
 TSS health and wellbeing agency audit 2010 
 TSS health and wellbeing agency audit 2011 
 TSS health and wellbeing agency audit 2012 
 TSS agency health and wellbeing plans 
Audits were completed yearly by all agencies in the organisation by a senior member of 
staff, usually the H@W co-ordinators or heads of agency. Audits were developed by the 
Government and were conducted as part of the TSS internal policy evaluation of the H@W 
project. They provided a report on the status of each agency health and wellbeing program 
in accordance with policy guidelines. These guidelines were outlined in Ministerial Direction 
23 – Workplace Health and Wellbeing that were drafted by the H@W central coordinators 
and passed in parliament on 7 June 2010.79 Both quantitative and qualitative data in the 
audit were used in this thesis to measure organisational capacity. Refer to Chapter 5.  
1.7.5 Additional data source: Household Income and Labour Dynamics of Australia 
Survey (HILDA) 
Outside the H@W project and pH@W partnership, a final data source was used herein. The 
HILDA survey provided Australian normative data. The data set is maintained by the Faculty 
of Business and Economics, The University of Melbourne, Victoria Australia and an 
Individual Deed of Licence for HILDA general release 11 data was executed on 26 August 
2013.  
HILDA is a clustered stratified panel survey (commencing 2001) of persons residing in 
private dwellings in Australia. The analysis in Chapter 4 used SF-36 (version 1) data from 
employed individuals within Wave 11 obtained from a self-completion questionnaire. SF-36 
is used to derive a preference-based measure of health status.82 Further details regarding 
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HILDA are available83,84 including the criterion validity of SF-36 in HILDA for use in Australian 
research.85 
1.8 Structure of this thesis 
The research presented within this thesis consists of four separate studies as planned 
publications. The context of the work was to inform the pH@W partners of the Tasmanian 
Government on whether H@W provided value for money. To do this my overarching aim 
was to investigate the application of health economics to evaluate workplace health 
promotion. 
Chapter 2 is a systematic review that investigated the methodological quality of economic 
evaluations to see what the expected return on investment was likely to be and determine 
what significant correlates of this economic outcome were. 
Chapter 3 is the outcome from my public sector internship, a resource development project. 
This chapter describes the development of a Workplace Health Savings Calculator that has 
subsequently become publicly available as an Australian federal government WHP business 
case tool. 
Chapter 4 is a construct validation study of a health utility measure (SF-6D) to meet the 
economic evaluative need for improved health measures, and 
Chapter 5 is the economic evaluation of Healthy@Work. 
Chapter 6 provides an overarching discussion of the work presented, including the issues, 
limitations and recommendations related to the application of health economics in the 
evaluation of workplace health promotion. 
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Appendix 1A: First recorded health economic evaluation 
“Of Lessening ye Plagues of London”     
A plan presented October 7, 1667, by Sir William Petty   
1.  London with ye bills hath 696 th(ousand) in 108th(ousand) houses. 
2.  In pestilentiall yeares, (which are one in 20) there dye 1/6th of ye people of plague and 1/5th of all diseases. 
3.  The remedies against spreading of ye plague are shutting up suspected houses and pest-houses within 1/2 mile of 
ye citty. 
4.  In a circle about ye center of London of 35 miles semi-diameter, or a dayes journey, there live as many people and 
are as many houses as in London. 
5.  Six heads may be bee caryd a days journey for 20 sh(illings). 
6.  A family may bee lodged 3 months in ye country for 4sh(illings), so as ye charge of carying out and lodging a 
family at a medium will be 5 sh(illings). 
7.  In ye greatest plague we feare, scarce 20th(ousand) families will bee infected; and in this new method but 
10th(ousand), ye charge whereof will be 50th(ousand) pounds. 
8.  The Pople which ye next plague of London will sweep away will be proably 120th(ousand), which at 7 pounds per 
head is a losse of 8,400 th(ousands), the half whereof is 4,200th(ousands). 
9.  So as 50 is ventured to save 4,200, or about one for 84. 
10.  There never was a Plague in ye campagne of England by which 1/6th of ye people dyed. 
11.  Poore people who live close dye most of ye plague. 
12.  The Plague is about 3 monthes rising and as much falling, which colc weather hastens. 
13.  Killing dogs, making great fires in yet street, nor the use of midicaments are considered sure, for which everyone 
by common directions may bee theire owne Physicians. 
14.  In ye circle of 70 miles diameter, choose 10 large wide roomey disjoyned houses with water and garden to each, 
the Inhabitants to remove at 7 days notice.  
15.  Convenient wagons of coaches to bee prepared to carry away ye suspected. 
16.  A method to furnish ye pesthouses with medicines for their mony. 
17.  Books of devotion for every house. 
Proposalls---when 100 per week dy, the Plague is begun.  If there dye fewer than 120th(ousands), out of ye bills, of all 
diseases within a yeare after, then W(illiam) P(etty) is to have 20sh(illings) per head for all lesse, and to pay 
10sh(illings) per head for all above it.  Every family removed being to provide 10 pounds for ye charge of going and 
coming and for 4 monthes rent. Or a gratuity of   with W(illiam) P(etty) his insurance. 
 
From Lord Edmond Fitzmaurice’s The Life of Sir William Petty, 1895  pp. 121-122, reprinted 
as a footnote to page 109 in The Economic Writings of Sir William Petty by Charles Henry 
Hull Cornell University Press(?) 1899, reprinted by A.M. Kelley, New York, 1963. Kindly 
provided by Professor Thomas E. Getzen; Executive Director, International Health Economics 
Association (iHEA). 
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Appendix 1B: Summary of the types of economic evaluations 
relevant for work presented in this thesis 
Types of 
analysis 
Assessment of 
Costs (C) and 
Benefits (B) 
Characteristics 
Types of 
questions it 
can address 
Strengths Challenges 
Cost Benefit 
Analysis (CBA) 
(C) Monetary 
Units 
(B) 
Monetary 
Units 
A method 
designed to 
value and 
compare all of 
the costs (C) and 
benefits 
(B) of 
interventions in 
equivalent 
monetary terms. 
It provides an 
absolute 
indicator of the 
‘worth’ 
of the 
intervention. 
An intervention 
should 
be implemented 
only if B-C>0 or if 
B/C>1. 
Allocation 
efficiency 
Is the goal 
worth 
achieving? 
Which was 
worthwhile? 
Makes it 
possible to 
compare 
programs that 
generate 
different 
types of 
outcomes— 
within the 
health sector 
and outside of 
it 
Difficult to assign 
a monetary value 
to the outcomes 
of the 
intervention 
 
Ethical issues 
about 
assigning a 
monetary 
value to 
improvements 
in well-being of 
individuals 
 
Cost 
Effectiveness 
Analysis (CEA) 
(C) Monetary 
Units 
(B) Natural 
Health Units or 
outcome of 
effectiveness 
(E), including 
Disability 
Adjusted Life 
Years (DALY) 
This method 
traditionally 
considers a 
single measure 
of output. It 
allows 
comparisons 
among options 
with the 
same indicator 
of effect 
An intervention 
with a lower 
C/E ratio is 
usually 
preferable to 
one with higher 
C/E ratio 
Production 
efficiency 
 
How effective 
was X at 
producing 
health change 
for a 
reasonable 
cost (relative 
to Y)? 
 
 
Comparison of 
health 
outcomes are 
helpful for 
health 
decision-
makers. 
Interventions 
of same 
type competing 
for same 
resources can 
be compared. 
 
Only 
interventions 
that have 
outcomes in the 
same measuring 
units can be 
compared. 
Limited to single 
dimension of 
effectiveness so 
it cannot capture 
the 
multidimensional 
outcomes of 
most workplace 
health 
promotion 
programs 
Cost Utility (C) Monetary This is a variant 
of CEA. 
Production 
efficiency 
Provides a 
common 
No validated 
measure of 
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Analysis (CUA) Units 
(B) Healthy 
Years; Quality 
Adjusted Life 
Years (QALY)  
Benefits 
incorporate 
length of 
life and quality 
of life. The 
analysis requires 
a preference 
based health-
related measure 
known as a 
multi-attribute 
health utility 
instrument 
(MAUI). 
 
How effective 
was X at 
producing life 
year change for 
a reasonable 
cost (relative 
to Y)? 
 
 
outcome 
measure so 
evaluators can 
compare 
interventions 
with broad 
ranges of 
outcomes and 
from 
different 
sectors 
 
health-related 
utility in 
workplace health 
promotion (Refer 
to Chapter 4). 
Often workplace 
health 
promotion 
interventions 
have additional 
benefits beyond 
health gain. 
A measure of 
health utility 
may be 
insensitive to 
changes in 
relatively 
‘healthy’ 
populations. 
Effects may not 
be captured due 
to health benefit 
latency in 
workplace health 
promotion 
Cost 
Consequence 
Analysis (CCA) 
(C) Monetary 
Units 
(B) Natural 
Units (as in 
CEA), not 
restricted to a 
single outcome 
This is a variant 
of CEA. 
It sets out a 
profile of all 
important 
changes so 
that none may 
be overlooked 
Pragmatic 
efficiency 
 
How effective 
was X 
(intervention) 
relative to the 
importance of 
Y (the 
outcomes of 
interest)? 
 
 
It ensures that 
all outcomes of 
importance are 
acknowledged 
It can be difficult 
to determine 
whether an 
intervention 
provides value 
for money, as 
value is implicit, 
priorities and 
preferences 
differ and some 
outcomes 
improve while 
others worsen 
Adapted from de Salazar et.al (2007)86 
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2.1 Preface 
The preceding Introduction Chapter identified a role for economic evaluations in workplace 
health promotion (WHP). Economic evaluations can be conducted in order to measure the 
financial impact of health-promoting initiatives in the workplace to provide information for 
evidence-based decisions. For example, cost benefit analysis can assess allocation efficiency 
and determine whether or not the intervention is worthwhile.1 The importance of 
methodological quality and current critical appraisal methods of economic evaluations were 
also introduced in Chapter 1. Economic analytical techniques in WHP research are variable 
in methodological quality.2-4 As a result, decision makers must use caution in the 
interpretation of published WHP economic outcomes. 
This chapter provides a definitive systematic review of the economic evidence in WHP under 
methodological scrutiny. This chapter has been published in the American Journal of Health 
Promotion (Appendix 2A).  
Impact factor: 2.37 (as of June 2015).  
Baxter S, Sanderson K, Venn AJ, Blizzard CL, Palmer AJ. “The Relationship between 
Return on Investment and Quality of Study Methodology in Workplace Health 
Promotion Programs” American Journal of Health Promotion July 2014; 28(6): 347-
363. 
Additional notes (grey boxes) were added for this thesis and were not part of the original 
publication.   
2 Chapter two: The relationship between return on investment 
and quality of study methodology in workplace health 
promotion programs: a systematic review 
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2.2  Introduction   
Workplace health promotion (WHP) encompasses health promoting and illness prevention 
activities that are available in the workplace. Activities can range from single, one-off 
interventions (e.g. influenza vaccination), to multi-component, multi-level health 
interventions. Economic evaluations of WHP are undertaken to assess outcomes (benefits), 
either potential or realised, for a given cost of program implementation (costs). Rigorous 
estimates of financial impact serve to better engage stakeholders and encourage 
sustainability of investment in workplace health initiatives. Despite this need, economic 
evaluations of WHP are often of poor methodological quality. This was highlighted in a most 
recent review4 which concluded no positive, negative or neutral return on investment (ROI) 
could be estimated due to a lack of high methodological quality economic evaluations 
found. This finding echoes a cautionary past from arguably the earliest review in the field2 
which exposed economic evaluations as subject to both study design and methodological 
quality inconsistencies. Recent evidence identified that study design can impact reported 
financial outcomes,5 concluding randomised control trials (RCTs) were more likely to 
indicate a negative return.  
Our study investigated methodological quality. We defined quality as the quality of 
economic evidence of studies (methodological quality), and examined the impact such 
quality has on ROI. This was accomplished through a systematic review of comparative 
health economic evaluations in WHP (single-target or multicomponent interventions), the 
assessment of methodological quality of the evidence and examination of the relationship 
between quality, key study characteristics and ROI. 
Well-cited systematic reviews have established a strong positive message with consistent 
evidence of a favourable ROI from workplace health interventions.6-10 This consistency could 
be partly due to the duplication of empirical studies seen within them. For example, four of 
these reviews6,7,9,10 span a 13 year period (1999-2012) and represent 89 evaluation studies, 
of which 75 (84%) were reviewed more than once, 36 (40%) reviewed in three or more and 
19 (21%) in all four. In addition, the included studies predominantly predated year 2000. 
Two recent reviews4,11 excluded studies pre-dating year 2000, and both adopted a more 
careful consideration of economic impact in light of methodological flaws. These reviews 
also excluded studies conducted outside the United States (US) which may lack applicability 
for stakeholders in countries like Australia and the United Kingdom (UK) where small to 
medium enterprises (SMEs) predominate, and employee healthcare provisions are not 
incumbent on employers due to a national healthcare system. Thus, US-reviews include 
costs borne outside an employer perspective in such nations. Furthermore, these reviews 
did not investigate the effect poor economic quality may have on financial outcome. 
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Contemporary health economic theory offers better standardised methods for evaluating 
resource use and costs, with guidelines, recommendations and methodological quality 
checklists to improve standards.12-22 Weaknesses in methodology and reporting of economic 
evaluations of WHP undermine their plausibility. Our aim was to examine the ROI of WHP 
through a methodological quality lens. The main hypothesis was that higher methodological 
quality economic evaluations demonstrate smaller financial returns. 
2.3 Methods 
We performed a review following Campbell and Cochrane Economics Methods Group 
(CCEMG) guidelines to incorporating economic evidence in reviews,17,18 the National 
Institute of Health and Clinical Excellence (NICE) guidelines manual,19,20 and the Centre for 
Reviews and Dissemination (CRD) guidance for undertaking reviews in healthcare.15 The 
guidance from these sources formed the basis of our search strategy (the use of economic 
search filters) (Table 2.1), our process of incorporating economic evidence through 
extended economic database searches (in addition to biomedical databases), our use of 
specific health economic evaluation inclusion criteria (only accepting studies that reported 
both costs and cost offsets against a comparison), our choice of methodological quality 
checklist and the structure of this report. 
Table 2.1 Search strategy for National Health Service Economic Evaluation Database (NHS EED), 
Health Technology Assessment (HTA) Database and the Database of Abstracts of Reviews of 
Effects (DARE) 
Long Searcha #1 AND #2 AND #3 NOT #4 
#1 Economic filters 
(outcome) 
"economic evaluation" OR cost OR effectiveness OR “return on 
investment” OR ROI OR "cost effectiveness" OR "cost benefit” OR “cost 
analysis” OR "cost utility" OR CUA OR CBA OR CEA OR "health economic*" 
OR economic* OR “direct cost” OR “indirect cost” OR “intangible cost” OR 
“health care cost” OR productivity OR claim OR turnover OR recruitment 
OR “sick leave” OR “illness days” OR absenteeism OR presenteeism in Title, 
Abstract or Keywords 
#2 Participant workplace OR worksite OR worker* OR employee* OR “work place” OR 
employer OR organisat* OR organizat* OR employer OR business OR staff 
OR occupation* in Title, Abstract or Keywords 
#3 Intervention “health promotion” OR “prevention” OR health OR wellbeing OR wellness 
OR smoking OR nutrition* OR alcohol OR “psychological distress” OR 
physical activity OR exercise OR stress OR dental OR “health screening” OR 
BMI OR BP OR lipids OR flu vaccination OR counselling OR substance abuse 
OR HRA OR “weight management” OR obesity OR Cholesterol OR sleep OR 
“disease management” OR “disease risk” OR prevent* OR promot* OR 
“chronic disease” in Title, Abstract or Keywords 
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#4 Excluding NOT “back pain” OR injur* in Title, Abstract or Keywords  
MESH Searchb  
 
(("Costs and Cost Analysis" explode all trees [Mesh] OR "Cost-Benefit 
Analysis" explode all trees [Mesh] OR "Cost of Illness" explode all trees 
[Mesh] OR "Cost Savings" explode all trees [Mesh] OR "Employer Health 
Costs" explode all trees [Mesh]) AND "Health Promotion" explode all trees 
[Mesh]) 
NHS EED indicates National Health Service Economic Evaluation Database; HTA: Health Technology 
Assessment Database; DARE: Database of Abstracts of Reviews of Effects. 
aLong search performed on 15 November, 2011, yielded NHS EED (504), HTA (26), and DARE (107) 
studies 
bMESH search performed on 7 December, 2011, yielded NHS EED (116), HTA (7), and DARE (13) 
studies 
 
2.3.1 Data sources 
A comprehensive systematic search of the literature was performed. Five economic 
databases — NHS Economic Evaluation Database (NHS EED), Database of Abstracts of 
Reviews of Effects (DARE), Health Technology Database (HTA), Cost Effectiveness Analysis 
Registry (CEA Registry), and American Economic Association EconLit (EconLit) — were 
searched along with major health databases PubMed, Embase, Wiley Online Library and 
Scopus. In addition, a keyword search using Google Scholar, and hand searching of citations 
from relevant papers, previous reviews and health promotion journals were undertaken. 
Economic search filters alongside the biomedical PICO standard (which references the 
Participants, Interventions, Comparisons and Outcomes) and medical subject headings 
(MeSH) terms were used. An example of the search strategy can be seen in Table 2.1. 
2.3.2 Study inclusion and exclusion criteria 
Studies that conducted a full health economic evaluation of a workplace health intervention 
were included. The evaluation by definition required a “comparative analysis of alternative 
courses of action in terms of both their costs and consequences” p 9 1 meaning both costs 
and benefits were reported against a comparator. We defined the target population of each 
intervention as consisting of all adult employees currently working for an organisation that 
had facilitated a workplace health program, irrespective of their health status. The 
interventions ranged from those with a single-target focus (e.g. smoking cessation) or 
multicomponent focus (programs offering 2 or more behaviour targets). The scope of 
interventions included smoking, nutrition, alcohol, depression, anxiety, physical activity, 
stress, dental health, health screening, health risk assessment (HRA), cardio-metabolic risk 
(body mass index, blood pressure, blood, lipids), influenza ‘flu’-vaccination, counselling, and 
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substance abuse. Interventions that focused on organisational changes or a change in 
workplace culture were included provided that the primary outcome was improvement in 
employee health. Our aim was to include a broad range of interventions, and both single 
and multicomponent workplace health programs to provide a comprehensive picture of the 
economic outcomes associated with the diversity of WHP programs on offer. No exclusions 
were made based on location, number of components or delivery mode provided they were 
offered by an employer to benefit the health of current staff. No restriction on year of 
publication was imposed up to and including publications before May 2012, when study 
selection was complete. Studies written in English or German were considered as authors SB 
and AP are bilingual in these languages. 
Return to work studies, studies of workplace safety (ie: injury and rehabilitation programs, 
which were viewed as occupational health-related prevention not disease prevention) and 
studies of retiree populations were excluded.  
2.3.2.1 Study selection 
From the initial yield, studies were selected after review of title and abstract. Final decision 
of inclusion was made after review of the entire manuscript by authors SB and AP. 
2.3.3 Data extraction methods 
Data were extracted on study design (RCT, quasi-experimental [ie: a non-randomised 
comparison group], non-experimental [ie: pre-post only, a before/after comparison group] 
and modelled), sample size and program length, authorship (private company, research 
institutions or government), country of origin, publication year, study characteristics 
(organisation size, industry type, employee target group [healthy, at risk or disease 
management]), and program design (single or multicomponent). Intervention focus was 
grouped into 3 categories: SNAPS (smoking, nutrition, alcohol, physical activity and stress), 
vaccination and other (dental, cancer screening). When studies reported more than one 
intervention arm alongside a comparator, the economic evaluation for each was considered 
a separate study, effectively increasing the number of studies. 
Economic study metrics such as perspective, design (retrospective, prospective), time 
horizon (currency, time value), discount rate, comparator type (control group design, pre-
post, modelled), effect measure (incremental or cost comparison), costs reported (direct, 
indirect), the economic form (cost benefit analysis [CBA],cost effectiveness analysis [CEA], 
cost utility analysis [CUA]), the calculation method, and how outcomes were measured and 
valued were also recorded along with economic results (reported costs, benefits and ROI). 
Data extraction and quality assessment (see below) were performed by one author (SB) and 
a 20% sample was independently coded by another (AP). Any disagreements were resolved 
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through discussion. 
2.3.3.1 Methodological quality assessment 
Studies were scored against the 36-item British Medical Journal Economic Evaluation 
Working Party (BMJ checklist),15,23 a guideline of methodological and essential elements to 
improve clarity of economic evaluations. Items referred to the study question, selection of 
alternatives, form of evaluation, effectiveness data, measurement and valuation of benefit, 
costing, modelling, adjustments for timing of costs and benefits, uncertainty and 
presentation of results and were all considered within three headings: study design, data 
collection and analysis and interpretation (Table 2.2). Each of the 36 items were given equal 
weighting and the items performed or reported were summed and expressed as a 
percentage of the total number of items applicable to each study.15 Studies were then 
placed into categories of methodological quality; high quality (>75%), moderate quality (50-
75%) and low quality (<50%). 
Table 2.2 36-item British Medical Journal Economic Evaluation Working Party (BMJ checklist)* 
Study design 
1. Was the research question stated? 
2. Was the economic importance of the research question stated? 
3. Was/were the viewpoint(s) of the analysis clearly stated and justified? 
4. Was a rationale reported for the choice of the alternative programmes or interventions 
compared? 
5. Were the alternatives being compared clearly described? 
6. Was the form of economic evaluation stated? 
7. Was the choice of form of economic evaluation justified in relation to the questions 
addressed? 
Data collection  
8. Was/were the source(s) of effectiveness estimates used stated? 
9. Were details of the design and results of the effectiveness study given (if based on a single 
study)? 
10. Were details of the methods of synthesis or meta-analysis of estimates given (if based on 
an overview of a number of effectiveness studies)? 
11. Were the primary outcome measure(s) for the economic evaluation clearly stated? 
12. Were the methods used to value health states and other benefits stated? 
13. Were the details of the subjects from whom valuations were obtained given? 
14. Were productivity changes (if included) reported separately? 
15. Was the relevance of productivity changes to the study question discussed? 
16. Were quantities of resources reported separately from their unit cost? 
17. Were the methods for the estimation of quantities and unit costs described? 
18. Were currency and price data recorded? 
19. Were details of price adjustments for inflation or currency conversion given? 
20. Were details of any model used given? 
21. Was there a justification for the choice of model used and the key parameters on which it 
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was based? 
Analysis and interpretation of results 
22. Was time horizon of cost and benefits stated? 
23. Was the discount rate stated? 
24. Was the choice of rate justified? 
25. Was an explanation given if cost or benefits were not discounted? 
26. Were the details of statistical test(s) and confidence intervals given for stochastic data? 
27. Was the approach to sensitivity analysis described? 
28. Was the choice of variables for sensitivity analysis justified? 
29. Were the ranges over which the parameters were varied stated? 
30. Were relevant alternatives compared? (i.e. Were appropriate comparisons made when 
conducting the incremental analysis?) 
31. Was an incremental analysis reported? 
32. Were major outcomes presented in a disaggregated as well as aggregated form? 
33. Was the answer to the study question given? 
34. Did conclusions follow from the data reported? 
35. Were conclusions accompanied by the appropriate caveats? 
36. Were generalisability issues addressed? 
*From Systematic Reviews: CRD's guidance for undertaking reviews in health care, 3rd ed. York, 
UK: Centre for Reviews and Dissemination; 2009:210-211. Available at: 
http://www.york.ac.uk/inst/crd/index_guidance.htm. Reproduced with permission from CRD; 
York, UK. 
 
2.3.3.2 Economic outcomes  
The financial outcomes within each study were represented as an ROI ratio and were either 
extracted if an ROI was provided, or (re)calculated from reported costs and benefits of a 
program against a comparator. When an ROI was not reported, the costs and benefits, as 
measured and specific to the individual study findings for monetary value (currency), price 
year and discounting (if applied) were extracted and the ROI formula applied. 
The formula used was ROI = (Net Benefits – Net Costs of program)/Costs of program.24 
When ROI was reported, the method of ROI calculation was examined and the accepted 
formula was applied to the reported costs and benefits if the calculation method differed. 
Our chosen methodology provided a consistent comparison of financial return between 
studies, in addition to the ratio alleviating any costing differences arising from currency and 
time variances across studies. It should be noted that many employers use 
ROI=Benefits/Costs as the formula for Return on Investment. We compared our ROI findings 
against its comparative ROI (calculated from this commonly used alternative) to examine 
whether our ROI formula accounted for any major difference in the ROI’s we report.  
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The effect measure was categorised as either incremental (the calculated difference in 
program costs and benefits between the intervention and the comparator groups) or cost 
comparison (when benefits were defined as cost savings1 when pre-post analysis). Benefits 
included change in worker productivity, and employer health care costs.  
Costs were extracted as reported, irrespective of discounting. Whether or not discounting 
was performed was addressed by the BMJ methodological checklist (item #23/24/25) and 
accounted for in the quality scoring. Studies that did not report discounting beyond a one 
year time horizon were penalised in score (studies ≤ 1 year time horizon received a NA [not 
applicable] for these items). Additionally, we did not attempt to discount long term costs; a) 
to avoid possible “double discounting” in cases where authors may have discounted but 
failed to report it; b) as often costs were not itemised over time; and c) applying a discount 
rate to both costs and benefits (i.e. both denominator and numerator) would not affect the 
ROI ratio.  
2.3.3.3 Data analysis 
Summary data on ROI are presented as weighted mean and standard deviation (SD) with 
95% confidence intervals (CI). Because the interventions reviewed differed markedly in 
scope and reach, the ROI for each study was weighted by the number of employees 
targeted directly or indirectly by the intervention program. Mean ROIs were stratified by 
study characteristics (refer to 2.3.3 Data extraction methods). Results of unweighted 
analyses are reported for comparison. To determine if certain study characteristics predict 
higher ROI, linear regression methods were used against the ROI weighted by relative 
number of participants. All weighted data were transformed prior to analysis to remove 
skewness. Being represented as a ratio, the dollar value of the numerator and denominator 
of each ROI estimate did not require conversion to units of common purchasing power. 
All statistical analyses were conducted using STATA© version 12 software package 
(Statacorp LP, Texas, USA). 
2.3.3.4 Sensitivity analysis  
Sensitivity analysis of quality scoring was performed using two additional methodological 
quality checklists, the Consensus Health Economic Criteria list (CHEC-List),14 and the NICE 
study limitations checklist: economic evaluations (NICE checklist).20 Comparisons of quality 
scores made by the three checklists were undertaken by assessment of differences in mean 
scores and by using correlation coefficients to summarise stability of ranking.  
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Appendix 2B  Tables 2B.1 and 2B.2. In this Appendix you can find the CHEC-List and the 
NICE study limitations checklist. Tables can be found on pages 135 and  136. 
2.4  Results  
2.4.1 Study selection 
The search concluded in May 2012 following an electronic search (conducted between 24 
October and 8 December 2011) and hand-searching. The electronic search yielded 3,906 
studies. Economic databases generated 1,295 studies (NHSEED (n=620), EconLit (n=518), 
DARE (n=120), HTA (n=33), and CEA Registry (n=4)), and health databases produced 2,611 
studies (MEDLINE (n=79), Wiley (n=33), Scopus (n=1,338) and EMBASE (n=1,161)).  
Appendix 2C  Supplemental Table 2C.1. This table offers a breakdown of the long and MESH 
search for the studies yielded in the electronic search. This table is found on page 137.  
After removal of duplicates (n=400), 2,695 papers were excluded following abstract and title 
screening. The majority (n=1,962) of excluded studies were not workplace health 
intervention studies. Ultimately 42 studies met the inclusion criteria. A further nine were 
excluded by authors SB and AP by consensus due to inadequate economic cost data, 
including lack of comparative analysis or reported program costs or cost offsets,25-33 
reducing the total to 33 studies. Additionally, 18 studies were sourced by hand-searching 
reference lists, for a total of 51 included studies (61 intervention arms) (Figure 2.1).  
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Figure 2.1 Flow diagram of study selection 
NWI = Not a workplace health intervention; NHE = Not a single, empirical primary study reporting 
a health economic evaluation by offering a health economic component, showing evidence of cost 
analysis where cost of program and cost offsets are reported against a comparison; MRE = Papers 
that are meta-analyses, reviews, editorials, letters, or policy papers; OHS = Occupational health 
related injuries, accidents and prevention studies; RTW = Chronic and long term sick leave, return 
to work, injury and rehabilitation studies; Ret’ d = Studies of non-employees, simulated 
participants or retirees; NFE = Not facilitated by the employer; DUP = Duplicate or previously 
accepted study; SIM = Studies solely modelled on simulated participants 
2.4.2 Study characteristics  
Characteristics of included studies are displayed in Table 2.3, listed by their methodological 
quality and categorised by intervention focus ie: traditional health promotion programs 
(SNAPS) and medical/dental programs (vaccination, dental, screening). A subset of studies 
(n=20) that reported direct measurement of claims and records are shown in Table 2.4.  
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Table 2.3 Study characteristics 
Studies (N=51) Year 
Study 
Design 
Origin Duration (years) Organisation Size Industry  Participant n Control n Intervention  Currency Time Value ROI BCR 
  
CATEGORISED HIGH QUALITY (N=15); QUALITY SCORE >75%               
 Traditional health promotion programs           
Groeneveld et al.66 2011 RCT Netherlands 0.5 NS Construction 293 280 Wt,Ind EUR 2008 -0.24~ 0.76 
Proper et al.68 2004 RCT Netherlands 0.75 PS Local Gov 97 167 N,PA,Ind EUR NS -0.71ᵠ 0.29 
Meenan et al.67 2010 RCT USA 2 Large Hospitality 3346 3612 HRA,N,Wt,Ind USD 2008 -0.74~ 0.26 
McEachan et al.39* 2011 RCT UK 0.25 NS Various 662 598 PA GBP NS -4.30ᵠ -3.30 
Greene et al.65* 2009 Model USA 0.5 Large El-Gas-Oil-W 499 499ᶲ CM,Dx USD 2007 3.42ᵠ 4.42 
Naydeck et al.78 2008 Model USA 4 Large+ Insurance 1892 1892ᶲ 
HRA,Sm,N,Wt,PA,MH, 
CM,Dx 
USD 2005 0.27° 1.27 
Taimela et al.69* 2008 RCT Finland 1 Large Construction 134 138 HRA,Ind EUR 2004 3.47ᵠ 4.47 
Shi et al.35 1993 
Non-
exp 
USA 1.5 Large+ El-Gas-Oil-W 412 412ǂ HRA USD 1988 1.49~ 2.49 
 
  
    
301 301ǂ + SH 
  
1.37~ 2.37 
 
  
    
295 295ǂ + Sm,N,Wt,R,PA,MH, CM 3.07~ 4.07 
 
  
    
180 180ǂ + Dx, Ind 
  
1.43~ 2.43 
 Medical/Dental programs           
At'kov et al.42* 2011 Quasi Russia 0.67 Large+ Transport 701 630 Vacc EUR 2006 0.40ᵠ 1.40 
Bridges et al.51* 2001 RCT USA 0.42 NS Manufacturing 587 604 Vacc USD 1999 -0.45~ 0.55 
Cohen et al.41* 2003 RCT Australia 0.12 Large+ Manufacturing 280 270 Vacc AUD NS   0.92ᵠ 1.92 
Colombo et al.52* 2006 Quasi Italy 0.4 Large Health 107 107 Vacc EUR NS 3.16ᵠ 4.16 
Samad et al.54* 2006 Quasi Malaysia 0.08 Large El-Gas-Oil-W 504 518 Vacc USD 2001 3.02ᵠ 4.02 
Morales et al.55* 2004 Quasi Columbia 0.02 Large Finance 423 335 Vacc USD NS 2.60ᵠ 3.60 
Campbell et al.50* 1997 Quasi USA 0.46 NS Manufacturing 131 131 Vacc USD NS -3.80~ -2.80 
  CATEGORISED MODERATE QUALITY (N=14); QUALITY SCORE 50-75%             
 Traditional health promotion programs           
Goetzel et al.63 * 2005 Model USA 10 Large+ El-Gas-Oil-W 25828 25828ᶲ HRA,CM USD 2001 0.76° 1.76 
Baker et al.38 2008 Model USA 1 Various Various 890 890ᶲ HRA,N,Wt,PA,Ind USD 2007 0.17~ 1.17 
Ozminkowski et al.36 1999 Quasi USA 0.97 Large+ Finance 11194 11644 HRA,Dx,Ind USD 1996 3.56° 4.56 
Mills et al.61 2007 Quasi UK 1 NS Manufacturing 618 2500 HRA,N,PA,MH,SF,Ind GBP NS 27.71ᵠ 28.71 
Bertera et al.49 1990 Quasi USA 2 Large+ Manufacturing 29315 14573 
HRA,Sm,N,Wt,PA,MH, 
Psych,CM,Dental 
USD 1986 0.22ᵠ 1.22 
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Nyman et al.34* 2012 Quasi USA 3 Large+ Education 6413ǁ 6413ǁ HRA,PA,Dx USD 2008 0.46~ 1.46 
Aldana et al.76 1993 Quasi USA 2 PS Local Gov 340 340 HRA,CM,Screen,Ind USD 1990 2.60° 3.60 
Schwartz et al.33* 2010 Model USA 1 Large+ Insurance 413 360ᶲ Dx USD 2008 3.20° 4.20 
Golaszewski et al.64 1992 Model USA 14 Large+ Insurance NS NSᶲ HRA,Wt,PA,MH,CM,Dx USD 1986 2.10~ 3.10 
 Medical/Dental programs           
Ichihashi et al.48* 2007 Quasi Japan 7 Small Manufacturing 103 35 Dental (light) USD 1992 -3.45~ -2.45 
 
  
    
160 
 
Dental (medium) 
 
0.46~ 1.46 
 
  
    
59 
 
Dental (heavy) 
 
-0.27~ 0.73 
Schneider et al.57* 2011 Model Germany 0.25 Large Retail 3958 3958 HRA,Screen EUR 2009 1.15ᵠ 2.15 
Dille et al.53* 1999 RCT USA 0.25 Large+ El-Gas-Oil-W 789 931 Vacc USD 1994 4.00~ 5.00 
Schrammel et al.58* 1998 Model USA 6 Large Sci&Tech 1416 1416ᶲ Screen USD 1996 1.95~ 2.95 
Kumpulainen et al.57* 1997 Quasi Finland 0 PS Health 165 186 Vacc FIM 1991 -0.90~ 0.10 
  CATEGORISED LOW QUALITY (N=22); QUALITY SCORE <50%               
 Traditional health promotion programs           
Foote et al.84 1991 Quasi USA 3 NS Manufacturing 337 169 CM USD 1982 1.50° 2.50 
 
  
    
367 
 
+ followup 
  
0.89° 1.89 
 
  
    
183 
 
+tmt 
  
1.72° 2.72 
Wood et al.44 1989 Quasi USA 2 NS Retail 688 387 
HRA,Sm,N,Wt,PA,MH, 
Screen,Cog 
USD NS 3.00ᵠ 4.00 
Aldana et al.47 2005 Quasi USA 2 PS Education 1264 3575 N,Wt,PA,SF,Cog,Dental USD 2002 14.6ᵠ 15.6 
Henke et al.37 2011 Model USA 6 Large+ Manufacturing 31823 31823ᶲ HRA,Sm,N,Wt,PA,MH,CM,Screen,Dx,Ind USD 2009 2.92° 3.92 
Yen et al.75* 2010 Quasi USA 7 NS El-Gas-Oil-W 2036 717 HRA,CM,Dx USD 2007 0.05~ 1.05 
Gibbs et al.43 1985 Quasi USA 5 NS Insurance 667 892 HRA,Sm,N,Wt,R,PA,CM USD 1978 0.45° 1.45 
Merrill et al.80 2011 RCT USA 5 Large Local Gov NS NS HRA,Sm,Wt,CM,Ind USD NS 2.84° 3.84 
Bowne et al.70 1984 
Non-
exp 
USA 5 Large Insurance 184 184ǂ HRA,PA,Ind USD 1980 0.43° 1.43 
Bertera et al.81* 1990 
Non-
exp 
USA 0.12 NS NS 27 27ǂ Sm SH USD NS 3.01~ 4.01 
 
  
    
43 43ǂ Sm tmt 
  
2.30~ 3.30 
Milani et al.45 2009 RCT USA 0.5 Small/NS NS 185 154 HRA,Sm,N,Wt,R,PA,MHDx USD NS 5.00° 6.00 
AHA et al.62* 1987 Quasi USA 0.5 NS Education 82 70 HRA, Ind USD 1985 -0.67~ 0.33 
 
  
    
145 
 
+ N,Wt,PA,CM 
 
0.24~ 1.24 
Gettman et al.77 1986 Quasi USA 2 NS El-Gas-Oil-W 453 325 PA USD NS 0.07~ 1.07 
Leutzinger et al.72 1995 Quasi USA 2 Large+ Transport 1148 1148 HRA,Sm,Wt,MH,CM,Ind USD NS 2.24~ 3.24 
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Windsor et al.74* 1989 RCT USA 3 Large+ Education 190 190ǂ Sm SH USD NS -0.05~ 0.95 
 
  
    
190 190ǂ +Ind 
  
1.84~ 2.84 
Shore et al.59 1989 Quasi Canada 0.5 NS NS 134 NS HRA USD NS 0.41ᵠ 1.41 
Shephard et al.60 1992 Quasi Canada 1 Large Finance 400 800 HRA,N,PA,MH CAD 1990 3.85~ 4.85 
Schultz et al.73 2002 Quasi USA 4 Large Manufacturing 2596 1593 HRA,Screen USD NS 1.65ᵠ 2.65 
Tao et al.46* 2009 Quasi USA 2 Large+ Manufacturing NS NS 
HRA,R,Psych,Screen, 
Vacc,Dx 
NS NS 1.60° 2.60 
Harris et al.79 1986 
Non-
exp 
USA 1 Large Sci&Tech NS NSǂ Sm,MH,CM USD 1985 1.54° 2.54 
Harvey et al.83 1993 Quasi USA 5 Large+/PS Local Gov 4000 NS HRA,Sm,Wt,MH,CM,Ind USD NS 0.23° 1.23 
Serxner et al.82* 1993 
Non-
exp 
USA 1 NS Retail 12 12ǂ Sm USD NS 0.00° 1.00 
Davis et al.71* 2009 
Non-
exp 
USA 4 Large Transport NS NSǂ 
HRA,Sm,N,Wt,PA,CM, 
Screen,Ind 
USD NS 1.43~ 2.43 
ROI: Return on Investment (calculated); BCR: Benefit cost ratio (calculated); RCT: Randomised control trial; Model: Modelled; Non-exp: Non-experimental (ie pre-post only, a 
before/after comparison group); Quasi: Quasi-experimental (ie a non-randomised comparison group); PS: Public service; Organisation size categories: Small (≤250 employees), Large 
(>250), Large+ (5000+ employees); HRA: Health Risk Assessment; Sm: Smoking; PA: Physical activity; MH: Stress, resilience, life management, employee assistance program (EAP); 
Psych: Psych distress, crisis management, anxiety, depression; Ind: Individualised, personalised care; Vacc: Vaccination; Screen: Screening, Health Screening (ie: cancer, mamogram, 
glucose, etc); Dx: Disease management, case management; Cog: Cognitive; CM: Cardiometabolic (changes in BP, Lipids, and Cholesterol); N: Nutrition; Wt: Weight management; Dental: 
Dental (light = 1 visit/7yr, medium = 2-4 visits/7yr, heavy = 5-6 visits/7yr); R: Risky behaviour, substance abuse; SF: Sleep and Fatigue; Tmt: treatment either in a clinic or centre utilising 
health professionals (Drs or nurses); SH: Self-help resources; NS: not stated; USD: US Dollar; EUR: Euro; GBP: British Pound; AUD: Australian Dollar; FIM: Finnish Markka; CAD: Canadian 
Dollar. 
* Studies not previously seen in reviews  
ǂ Pre-post design, controls are the participants at baseline 
ᶲ Modelling studies 
ǁ Total participant years (study counted employees who participated during an entire year and subsequent years from 2006-2008 program) 
~ Both direct and indirect costs measured (refers to the cost offsets or benefits measured, not program costs) 
ᵠ Only indirect costs measured (refers to the cost offsets or benefits measured, not program costs) 
° Only direct costs measured (refers to the cost offsets or benefits measured, not program costs) 
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Table 2.4 Characteristics of studies that included only direct measurement of claims and records 
Studies (N=20) Year 
Study 
Design 
Origin 
Duration 
(years) 
Organisation 
Size 
Industry  Participant n 
Control 
n 
Intervention  Currency 
Time 
Value 
ROI BCR 
  CATEGORISED HIGH QUALITY (N=15); QUALITY SCORE >75%             
 
 Traditional health promotion 
programs 
          
Meenan et al.
67
 2010 RCT USA 2 Medium Hospitality 3346 3612 HRA,N,Wt,Ind USD 2008 -0.74 0.26 
Naydeck et al.
78
 2008 Model USA 4 Large Insurance 1892 1892ᶲ 
HRA,Sm,N,Wt,PA,MH,CM,
Dx 
USD 2005 0.27 1.27 
  CATEGORISED MODERATE QUALITY (N=14); QUALITY SCORE 50-75%        
 
   
 
Traditional health promotion 
programs 
          
Ozminkowski et al.
36
 1999 Quasi USA 0.97 Large Finance 11194 11644 HRA,Dx,Ind USD 1996 3.56 4.56 
Nyman et al.
34
* 2012 Quasi USA 3 Large Education 6413 6413 HRA,PA,Dx USD 2008 0.46 1.46 
Aldana et al.
76
 1993 Quasi USA 2 PS Local Gov 340 340 HRA,CM,Screen,Ind USD 1990 2.60 3.60 
Schwartz et al.
33
* 2010 Model USA 1 Large Insurance 413 360ᶲ Dx USD 2008 3.20 4.20 
 Medical/Dental programs           
Ichihashi et al.
48
* 2007 Quasi Japan 7 Small Manufacturing 103 35 Dental (light) USD 1992 -3.45 -2.45 
 
  
    
160 
 
Dental (medium) 
 
0.46 1.46 
 
  
    
59 
 
Dental (heavy) 
 
-0.27 0.73 
Dille et al.
53
* 1999 RCT USA 0.25 Large El-Gas-Oil-W 789 931 Vacc USD 1994 4.00 5.00 
  CATEGORISED LOW QUALITY (N=22); QUALITY SCORE <50%          
 
   
 
Traditional health promotion 
programs 
          
Foote et al.
84
 1991 Quasi USA 3 NS Manufacturing 337 169 CM 
  
1.50 2.50 
 
  
    
367 
 
 + follow up USD 1982 0.89 1.89 
 
  
    
183 
 
 +tmt 
  
1.72 2.72 
Henke et al.
37
 2011 Model USA 6 Large+ Manufacturing 31823 31823ᶲ 
HRA,Sm,N,Wt,PA,MH,CM,
Screen,Dx,Ind 
USD 2009 2.92 3.92 
Yen et al.
75
* 2010 Quasi USA 7 NS El-Gas-Oil-W 2036 717 HRA,CM,Dx USD 2007 0.05 1.05 
Gibbs et al.
43
 1985 Quasi USA 5 NS Insurance 667 892 HRA,Sm,N,Wt,R,PA,CM USD 1978 0.45 1.45 
Merrill et al.
80
 2011 RCT USA 5 Medium Local Gov NS NS HRA,Sm,Wt,CM,Ind USD NS 2.84 3.84 
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Milani et al.
45
 2009 RCT USA 0.5 Small/NS NS 185 154 
HRA,Sm,N,Wt,R,PA,MH,D
x 
USD NS 5.00 6.00 
Bowne et al.
70
 1984 Non-exp USA 5 Large Insurance 184 184ǂ HRA,PA,Ind USD 1980 0.43 1.43 
AHA et al.
62
* 1987 Quasi USA 0.5 NS Education 82 70 HRA, Ind USD 1985 -0.67 0.33 
 
  
    
145 
 
 + N,Wt,PA,CM 
 
0.24 1.24 
Gettman et al.
77
 1986 Quasi USA 2 NS El-Gas-Oil-W 453 325 PA USD NS 0.07 1.07 
              
Shephard et al.
60
 1992 Quasi Canada 1 Medium Finance 400 800 HRA,N,PA,MH CAD 1990 3.85 4.85 
Harris et al.
79
 1986 Non-exp USA 1 Medium Sci&Tech NS NSǂ Sm,MH,CM USD 1985 1.54 2.54 
Davis et al.
71
* 2009 Non-exp USA 4 Medium Transport NS NSǂ 
HRA,Sm,N,Wt,PA,CM, 
Screen,Ind 
USD NS 1.43 2.43 
ROI: Return on Investment (calculated); BCR: Benefit cost ratio (calculated); RCT: Randomised control trial; Model: Modelled; Non-exp: Non-experimental (ie pre-post only, 
a before/after comparison group); Quasi: Quasi-experimental (ie a non-randomised comparison group); PS: Public service; Organisation size categories: Small (≤250 
employees), Large (>250), Large+ (5000+ employees); HRA: Health Risk Assessment; Sm: Smoking; PA: Physical activity; MH: Stress, resilience, life management, employee 
assistance program (EAP); Ind: Individualised, personalised care; Vacc: Vaccination; Screen: Screening, Health Screening (ie: cancer, mamogram, glucose, etc); Dx: Disease 
management, case management; CM: Cardiometabolic (changes in BP, Lipids, and Cholesterol); N: Nutrition; Wt: Weight management; Dental: Dental (light = 1 visit/7yr, 
medium = 2-4 visits/7yr, heavy = 5-6 visits/7yr); R: Risky behaviour, substance abuse; Tmt: treatment either in a clinic or centre utilising health professionals (Drs or nurses); 
NS: not stated; USD: US Dollar; CAD: Canadian Dollar. 
* Studies not previously seen in reviews  
ǂ Pre-post design, controls are the participants at baseline 
ᶲ Modelling studies 
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A review of authors’ affiliations revealed the majority of papers had authors from private 
companies (67%), research institutions (63%), or both. A smaller percentage included co-
authors from government (12%), healthcare institutions (10%) and not-for-profit 
organisations (8%). 
The majority of studies were quasi-experimental (n=25). There were six non-experimental, 
and on nine occasions a modelled economic evaluation was performed. There were eleven 
randomised controlled trials. 
The studies included 261,901 active participants and 122,242 controls. Overwhelmingly the 
target population for interventions was healthy workers (75%). There were seven studies 
focussed solely on at-risk workers (14%), one study targeting workers who reported one or 
more chronic disease condition(s)34 and one which targeted both at risk and known sufferers 
of chronic disease.35 There were three studies whose target population included all three 
health states.36-38 Workplace health programs were offered predominantly in private 
companies (n=33), with other organisations within the educational (schools, colleges and 
universities), government and healthcare settings represented. Two studies evaluated 
programs that were offered across multiple organisational types.39,40 
Company size was categorized either large (> 250 employees) or small to medium (≤ 250 
employees) as per Australian usage.41 Large companies accounted for 59% (n=30) of 
included studies, of which all but two42,43 originated from the US and sixteen exceeded 5,000 
employees. There were two studies of SMEs, five of a mixture of sizes and 14 studies did not 
state organisational size. 
Sixteen health interventions were represented. Most common was HRA (59%) and programs 
targeting physical activity (37%), weight management (35%), smoking (29%) and nutrition 
(29%). Twelve studies evaluated mental health interventions, five of those additionally 
targeted alcohol consumption36,44-46 or drug use.47 There were three dental interventions.48-
50 Ten studies evaluated flu vaccination, of which nine were single interventions42,43,51-57 and 
the other offered flu vaccination as part of a myriad of initiatives.47 Cancer screening 
programs,58,59 and HRA as a stand-alone intervention,36,60 were each evaluated twice. 
Multicomponent programs (n=23) were almost exclusively adopted by US-based companies. 
A Canadian study incorporated HRA, nutrition, physical activity and mental health 
initiatives61 and a UK study additionally offered sleep and fatigue education.62 All other non-
US studies were single interventions (n=13).  
2.4.3 Characteristics of the economic analysis 
The economic perspective was reported as employer,37,38,42,43,49,51,53,55,56,58,59,61,63-69 
societal40,52 or healthcare.70 Twenty nine studies did not report an economic perspective. 
 
Chapter two: The relationship between return on investment and quality of study 
methodology in workplace health promotion programs: a systematic review 
  
92 | P a g e  
Program costs were valued from company data in 28 studies,35,36,40,42-45,48-51,53-56,61,65-76 either 
alongside or separate to market price,42,43,50,51,53,57,59,67,69,73,74 budget 
expenditure,44,56,58,64,65,68,71,75,77-81 regional cost norms,40,47,52,57,59,63,67 assigned 
pricing,67,74,82,83 or from the literature.38 Six studies34,37,39,46,60,84 reported costs without 
disclosing a valuation method.  
Cost offsets were valued mostly from measured changes in productivity (indirect costs) 
and/or health care (direct costs). Productivity-related benefits were predominantly 
measured by absenteeism,35,36,40,42,43,45,48,50-57,59,60,62,63,65-70,72-74,76,78 sometimes in conjunction 
with presenteeism (on the job productivity gains).43,56,62,66,68 One study looked at 
presenteeism in isolation.39 Reporting of wage costs was variable. Studies reporting 
productivity loss costs valued a work day using either wage norms,39,40,58,67,68 an assigned 
price,51,52,55,59,63,73,74,78,82 from an average36,45,49,53,54,56,57,62,65,66,69,76 or from actual individual 
wage costs,42,43,48,50 using varied methods of calculation. Five studies did not report a 
valuation method.35,60,61,72,75 Direct costs focused on changes in direct medical care,34-
39,44,46,49,51,52,54,57,61,63-65,67,68,71,72,76-81,84,85 health care utilization,34,47,54,59,65 compensation,47,73 
and life insurance claims.65 One third of studies assigned direct costs to changes in risk factor 
prevalence or health status. Direct non-health care costs, such as out-of-pocket expenses for 
purchases associated with improving health was rarely reported.67 Health care cost offsets 
were valued five different ways, on twenty occasions through claims or medical 
records34,35,37,38,44,46,49,54,61,63,68,71,72,76-81,85 (Table 2.4), from the literature,36,52,59,64,65,67,70,75 
databases,39,47,58,73,76,83 health department norms,54,57,67 and participant self-reporting.51,67 
Two studies did not report any valuation method.82,84 
The economic design was retrospective (n=23), prospective (n=11), modelled (n=5) or not 
stated (n=12). Fourteen studies appraised benefits based on resource cost savings without 
assigning monetary values to health outcomes. In these instances the effect measure was 
classified as cost comparisons.35,36,38,47,61,63-65,71,73,75,77,80,82,83 Twenty nine studies had a 
follow-up evaluation greater than 1 year for which 10 studies (34%) discounted 
costs.35,37,44,49,58,64-66,68,79 A reported ROI was published in 23 studies for which 83% required 
recalculation to ensure consistency of ROI metric. The use of a benefit cost ratio (benefits 
divided by costs) defined as the ROI was the most common cause for recalculation. 
2.4.4 Methodological quality assessment 
Overall mean ±SD BMJ checklist score was 57±23% further classified into study design 
(67±24%), data collection, (64±24%) and analysis and interpretation (48±26%). Despite wide 
variability in scores, studies published after year 2000 consistently performed better on all 
methodological quality criteria. With one exception51 studies published pre-2000 did not 
score highly (>75% as described in methods section). 
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Although quality scores using all three checklists were similar, the average score on the BMJ 
checklist was around seven percentage points higher than either the mean CHEC-List score 
(50±27%) or the mean NICE checklist score (50±25%). The close linear relationship between 
the CHEC-List score and the BMJ checklist score (correlation r = 0.93) is depicted in Figure 
2.2. The correlation between the CHEC-List score and the NICE checklist score was r = 0.92, 
and between the BMJ checklist score and the NICE score was r = 0.84. Bland-Altman plots86 
did not reveal systematic patterns in the differences other than the consistently higher 
scoring with the BMJ checklist. Refer Appendix 2C Supplemental Table 2C.2 and 2C.3. 
There was a positive correlation between quality score and year with methodological quality 
improving by 1.15% each year across all studies. Mean score was 38±7% for 1984–1989 
(n=8), 51±18% for 1990- 1999 (n=15), 66±25% for 2000-2009 (n=18), and 67±22% for 2010- 
2012 (n=10). 
 
Figure 2.2 Linear relationship between scores on BMJ and CHEC-List quality checklist 
CHEC-List: Consensus Health Economic Criteria list14 BMJ: British Medical Journal Economic 
Evaluation Working Party checklist23 
 
 
Chapter two: The relationship between return on investment and quality of study 
methodology in workplace health promotion programs: a systematic review 
  
94 | P a g e  
 
Appendix 2C Supplemental Table 2C.4. This table provides an overview of the scoring marks 
from the 36-item BMJ checklist. If a question was able to be answered, ie: criteria was 
reported within the study, the study would receive a ‘yes’ response for that question. Table 
2C.2 provides the mean number of ‘yes’ ‘no’ and ‘not applicable’ scores for all studies, 
presented firstly as summed then as a percentage of ‘yes’ per individual question (overall 
and for studies published pre year 2000 and post 2000).  
Table 2C.4 is found on page 139. 
2.4.5 Synthesis of results 
Mean and weighted mean ROI results are found in Table 2.5. Six studies reported 
subsequent intervention arm(s) alongside a control49,63,85 or pre-post design36,75,82 which 
produced an additional ten outcome measures for an effective sample of 61 comparisons.  
Cost benefit analysis was adopted in 58 comparisons with 45 reporting an ROI. Four 
comparisons applied cost-effectiveness analyses additional to a CBA.51,57,67,69 The ROI metric 
could be calculated during data extraction in all instances where the ROI was not reported.  
Although three studies, each a single comparative analysis, did not conduct a CBA40,43,70 the 
ROI could be calculated. For example, the authors who performed a cost utility analysis40 
reported an incremental net benefit alongside program cost data.  
Overall weighted mean ROI was 1.38 ± 1.97(1.37-1.39). Financial return increased under 
worsening methodological quality. For high quality studies the ROI was 0.26 ± 1.74 (0.23 - 
0.3) (min: -4.3 max: 3.47), which increased in moderate quality to 0.9 ± 1.25 (0.9 – 0.91) 
(min: 3.45 max: 7.97) and was highest in low quality studies, 2.32 ± 2.14 (2.30 - 2.33) (min: 0 
max: 14.60). The same inverse relationship was demonstrated for study design. The ROI was 
negative for RCTs -0.22 ± 2.41 (-0.27 to -0.16) (min: -4.3 max: 5) and increasingly positive 
across quasi-experimental, non-experimental and modelled studies (1.12 ± 2.16 (1.11 - 1.14) 
(min: -3.90 max: 14.60), 1.61 ± 0.91 (1.56 - 1.65) (min: 0.00 max: 3.07), and 2.05 ± 0.88 (2.04 
– 2.06) (min: 0.17 max: 3.42) respectively). These findings attest to the impact rigor (both of 
economic quality and study design) has on reported financial outcome. There was a negative 
return of investment in 7 studies40,49,51,52,67-69 all but one68 were single component programs. 
The sample size (number of participated employees) indicated that higher participation 
numbers resulted in higher ROI however this relationship was not supported in the weighted 
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analysis. By origin, US studies demonstrated a mean weighted ROI 1.37 ± 1.8 (1.36 - 1.38) 
(min: -3.90 max: 14.60) which was marginally higher than the non-US studies ROI of 1.23 ± 
2.72 (1.18 - 1.29) (min: -4.30 max: 7.97). We compared the ROI imputed in this synthesis 
against the ROI reported in the original analysis (19 of 23 studies reporting an ROI required 
recalculation to ensure consistency of metric). The original reported ROI was approximately 
$1 higher, 3.41 ± 3.23 (2.15 - 4.67), and would report an additional $1 return, than our 
imputed ROI 2.21 ± 3.23 (0.96 - 3.46). This is explained by the fact that many of these studies 
define return on investment as ROI = Benefits/Costs instead of the ROI = (Benefits-
Costs)/Costs formula used in this analysis. The weighted analysis minimised this effect. Mean 
weighted ROI as reported was 1.67 ± 2.15 (1.67 - 1.68)( min: 0.32 max: 15.6) only slightly 
higher than our imputed mean weighted ROI 1.5 ± 1.88 (1.49 - 1.51) (min:-3.9 max:14.6) 
after recalculation. Studies that measured both direct (ie: medical) and indirect (ie: 
productivity loss) costs showed a smaller ROI than studies that measured only a single cost 
category. This was true for both weighted and unweighted analyses. Further analysis of 
studies incorporating indirect costs, either alone or alongside direct costs, showed that the 
method used to value a lost workday impacted the ROI result. The largest ROI occurred 
when actual individual wage costs were measured however this was not seen after 
weighting (Table 2.5). 
Table 2.5 Financial return (mean ROI) 
    ROI ± SD (Lower and Upper 95% Confidence Interval) 
    
Studies 
(N) 
 
Weighted* 
Overall 
 
61 1.51 ± 2.6 (0.84 - 2.18) 1.38 ± 1.97 (1.38 - 1.39) 
Quality  High 18 0.79 ± 2.3 (-0.35 - 1.94) 0.26 ± 1.74 (0.23 - 0.3) 
 
Moderate 16 1.5 ± 2.54 (0.15 - 2.85) 0.9 ± 1.25 (0.9 - 0.91) 
 
Low 27 2 ± 2.86 (0.87 - 3.13) 2.32 ± 2.14 (2.3 - 2.33) 
Origin US 44 1.7 ± 2.54 (0.93 - 2.47) 1.37 ± 1.8 (1.36 - 1.38) 
 
Non-US 17 1.03 ± 2.88 (-0.45 - 2.51) 1.23 ± 2.72 (1.18 - 1.29) 
Year Post 2000 30 1.71 ± 3.39 (0.45 - 2.98) 1.58 ± 2.19 (1.57 - 1.59) 
 
Pre 2000 31 1.32 ± 1.63 (0.72 - 1.91) 1.05 ± 1.55 (1.03 - 1.06) 
Study design RCT 12 0.97 ± 2.59 (-0.68 - 2.61) -0.22 ± 2.41 (-0.27 - -0.16) 
 Quasi-experimental 30 1.62 ± 3.3 (0.39 - 2.85) 1.12 ± 2.16 (1.11 - 1.14) 
 Non-experimental 10 1.61 ± 0.98 (0.9 - 2.31) 1.61 ± 0.91 (1.56 - 1.65) 
 Modelled 9 1.77 ± 1.25 (0.81 - 2.73) 2.05 ± 0.88 (2.04 - 2.06) 
Sample sizeᶲ <500 33 1.18 ± 1.96 (0.49 - 1.88) 1.72 ± 1.49 (1.69 - 1.76) 
 500-999 9 1.58 ± 3.43 (-1.05 - 4.22) 1.42 ± 3.3 (1.34 - 1.5) 
 1000-4999 9 2.38 ± 4.69 (-1.23 - 5.98) 0.58 ± 1.72 (0.56 - 0.59) 
 ≥5000 10 1.74 ± 1.11 (0.95 - 2.54) 1.55 ± 1.31 (1.54 - 1.56) 
Intervention focus Vaccination  9 0.98 ± 2.51 (-0.95 - 2.91) 1.8 ± 1.67 (1.74 - 1.86) 
 
SNAPS 46 1.81 ± 2.7 (1.01 - 2.61) 1.39 ± 2 (1.38 - 1.4) 
 
Other 6 0.04 ± 1.87 (-1.92 - 2) 1.31 ± 0.43 (1.3 - 1.32) 
Multi-component 
 
27 2.31 ± 3.09 (1.08 - 3.53) 1.08 ± 2.25 (1.07 - 1.09) 
Single intervention  
 
34 0.88 ± 2.02 (0.17 - 1.59) 1.5 ± 1.38 (1.49 - 1.52) 
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Effect measure Incremental 39 1.47 ± 3.19 (0.44 - 2.51) 1.02 ± 2.46 (1 - 1.04) 
 
Cost comparison 22 1.58 ± 1.16 (1.07 - 2.1) 1.89 ± 1.04 (1.88 - 1.89) 
Studies previously not seen 30 0.88 ± 2.13 (0.08 - 1.67) 0.83 ± 0.94 (0.82 - 0.84) 
°ROI imputed  28 2.21 ± 3.23 (0.96 - 3.46) 1.5 ± 1.88 (1.49 - 1.51) 
~
ROI reported  28 3.41 ± 3.23 (2.15 - 4.67) 1.67 ± 2.15 (1.67 - 1.68) 
Measured costs Directᵠ 17 1.74 ± 1.42 (1.01 - 2.46) 2.29 ± 0.95 (2.28 - 2.3) 
 
Indirect 16 2.56 ± 4.12 (0.37 - 4.76) 0.68 ± 2.17 (0.66 - 0.7) 
 
Both 28 0.77 ± 1.87 (0.05 - 1.5) 0.55 ± 1.38 (0.54 - 0.57) 
Valuation of direct costs Claims and Records 
ǂ
 25
Ʊ
 1.33 ± 1.88 (0.55 - 2.1) 2.74 ± 0.7 (2.74 - 2.75) 
Valuation of indirect costs Wage norms
a
 5 -0.79 ± 2.08 (-3.38 - 1.79) 0.31 ± 0.78 (0.29 - 0.33) 
 Assigned price
b
 11 0.94 ± 2.08 (-0.46 - 2.33) 1.74 ± 0.66 (1.72 - 1.75) 
 Means
c
 17 1.69 ± 2.52 (0.4 - 2.99) 1.96 ± 2.65 (1.9 - 2.02) 
 Individual
d
 4 4.04 ± 7.05 (-7.18 - 15.25) 0.22 ± 0.01 (0.22 - 0.22) 
ROI: return on investment. SD: standard deviation. RCT: randomised control trial. SNAPS: programs 
targeting smoking, nutrition, alcohol, physical activity and/or stress 
* weighted by those exposed to the program and transformed to account for skew 
ᶲ sample size is the number of participants in the treatment arm(s) 
° ROI recalculated to ensure consistency of ROI metric 
~ ROI as it was presented in original analysis 
ᵠ direct costs were valued five ways; claims and medical records, from the literature, databases, 
health department norms, and participant self-reporting  
ǂ those studies reporting direct costs with the source of valuation from employee claims or 
medical records  
Ʊ Large participant number in Henke moved the ROI considerably upon weighting. Weighted 
analysis (excluding Henke) for claims and records was 1.75±0.01(1.72-1.76) 
a studies reporting indirect costs sourced through wage norms such as population norms for 
specific job categories, country norms 
b studies reporting indirect costs where a price was assigned for all 
c studies reporting indirect costs where an average derived cost was used for all 
d studies reporting indirect costs where actual individual cost data was used 
 
 
Regression analysis was undertaken to see which of the study characteristics had a greater 
effect on ROI (Table 2.6). We found methodological quality and measured costs to be 
significant (p<0.01) with low quality studies purporting financial returns several times those 
of high quality studies, and evaluations measuring only direct costs significantly more likely 
to show higher returns than evaluations which included both direct and indirect costs. 
Table 2.6 Univariable and multivariable regression analysis of ROI 
Study Characteristics  Unadjusted 
 
Adjustedǂ 
   β CI β CI 
Quality  High Ref 
   
 
Moderate 1.30  (-0.35 – 2.96) 0.97 (-0.73 – 2.67) 
 
Low 2.94  (1.03 - 4.85) 2.38 (0.38 – 4.37) 
 
p value p<0.01 
 
p<0.01 
 Origin Non-US Ref 
 
Ref 
 
 
US 0.70  (-1.22 – 2.62) -0.33  (-2.25 – 1.58) 
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p value p=0.467 
 
p=0.729 
 Year Pre 2000 Ref 
 
Ref 
 
 
Post 2000 0.48  (-0.52 – 1.48) 0.09  (-0.83 – 1.02) 
 
p value p=0.343 
 
p=0.837 
 Study design RCT Ref 
 
Ref 
 
 
Quasi-experimental 2.08  (-0.24 – 4.41) 0.50  (-1.83 – 2.82) 
 
Non-experimental 2.81  (-3.54 – 9.16) 2.66  (-3.13 – 8.46) 
 
Modelled 2.69  (0.37 – 5.00) 0.38  (-2.22 – 2.99) 
 
p value p=0.057 
 
p=0.971  
Intervention focus Vaccination  Ref 
 
Ref  
 
SNAPS 0.09  (-3.02 – 3.20) -1.98  (-5.23 – 1.28) 
 
Other -0.14  (-4.04 – 3.75) -1.20  (-4.30 – 1.90) 
 
p value p=0.912 
 
p=0.664 
 Program Multi-component Ref 
 
Ref 
 
 
Single intervention  -0.11  (-1.13 – 0.91) 0.34  (-0.72 – 1.39) 
 
p value p=0.837 
 
p=0.525 
 Effect measure Incremental Ref 
 
Ref 
 
 
Cost comparison 0.72  (-0.25 – 1.70) -0.14  (-1.13 – 0.85) 
 
p value p=0.143 
 
p=0.775 
 Measured costs Direct Ref 
 
Ref 
 
 
Indirect -1.19  (-2.21 - -0.18) -0.69  (-1.71 – 0.33) 
 
Both -1.42  (-2.67 - -0.17) -0.86  (-2.13 – 0.41) 
 
p value p<0.01 p=0.117 
 Valuation of indirect 
costs Wage norms Ref 
 
Ref 
 
Assigned price 2.18  (-1.03 – 5.39) 1.11  (-1.83 – 4.05) 
 
Means 2.81  (-0.56 – 6.17) 2.23  (-0.87 – 5.33) 
 
Individual 1.24  (-0.96 – 3.43) 0.42  (-1.64 – 2.49) 
  p value p=0.058   p=0.781   
ǂ Adjusted for methodological quality and measured costs. 
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2.5  Discussion 
This review critically appraised full economic evaluations of both single and multicomponent 
workplace health programs and summarised the reported evidence using mean ROI 
weighted by participant numbers. The main finding (Table 2.5) revealed workplace health 
programs generated a positive return-on-investment, evidenced in all instances except 
randomised control trials. This study also yielded a methodological quality finding in which 
the ROI had a propensity to change in relation to methodological quality, whereby the 
highest quality studies demonstrated smaller returns.  
Pooling of results demonstrated a weighted mean ROI 1.38 ± 1.80 (1.38 - 1.39) [unweighted 
ROI 1.51 ± 2.60 (0.84 - 2.18)]. When subjected to sensitivity analyses, a smaller return was 
seen in studies of high economic quality, when both direct and indirect costs were 
measured, and in studies with a control. This trend was seen in both weighted and 
unweighted results, although the differences were insignificant outside quality. Highest ROI 
figures were reported in low methodological quality studies, in those that reported only 
direct costs (to a greater extent when the valuation method for direct costs came from 
claims or medical records), in cost comparison analyses and where economic modelling 
occurred. The high returns found in modelled studies could be due to projecting the benefits 
further into the future. A negative ROI was found in studies with a RCT design. There was a 
shift in ROI upon weighting for stratifications of ‘measured costs’ and ‘valuation of indirect 
costs’ as well as multicomponent versus single-intervention programs. While 
multicomponent programs, by virtue of being more comprehensive, could be expected to 
have a wider impact, only in the unweighted results did it demonstrate a greater positive 
ROI. Therefore, single intervention programs offered higher financial return after accounting 
for the number exposed to the intervention and skew. Studies that measured indirect costs 
and those that valued wage costs at an individual level saw similar disagreement once data 
were weighted. This was due to a single study48 outlier with a large positive ROI and a 
participant sample of 1,264 employees. The heavy right skew was accounted for upon 
weighting. Removal of it from the analysis did not significantly alter the weighted results. 
After adjustment, our regression analyses showed that methodological quality was a 
significant predictor of ROI, with studies of higher methodological quality tending to have 
lower ROI. In so doing, we have highlighted the impact robust economic evaluations can 
have and emphasised the practical importance of good quality economic evaluations in 
limiting over-estimation of economic outcomes. 
Although our finding of an overall positive return on investment was congruent with 
previous literature reviews,6-9,11,87,88 and that RCT designs do not show positive financial 
returns supported by others,5,89 we demonstrated that the magnitude of positive return was 
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lower than previously reported. Much of the difference is because of the difference in the 
formula used to calculate ROI. If we had used ROI = Benefits/Costs, our overall weighted ROI 
would have been 2.38 instead of 1.38. 
Strengths of this review include the use of economic databases and economic search filters 
alongside biomedical standards, the inclusion of studies that only met the definition of a full 
economic evaluation and the assessment of methodological quality by multiple checklists. 
Our quality assessment scored economic elements, known to have important impacts on the 
validity of findings, for each study evaluation. Although the BMJ Checklist is 
recommended18,19 and considered most reliable,15 a valid scoring method to reflect the 
assessment of methodological quality remains elusive.15 Also relevant to this review, 
economic quality checklists, including the ones we used, have been developed largely for 
assessment of cost-effectiveness (cost-utility) studies rather than cost benefit analyses. The 
impact of this on our quality scores was viewed to be low. First, the identification, 
measurement and valuation of costs and benefits are fundamental across all evaluation 
methods and second, for items specific to cost-effectiveness (cost-utility) analysis, CBA 
studies received a NA, and scores were expressed as a percentage of the applicable items. 
High correlation of quality scores obtained during sensitivity analysis against the CHEC-List14 
and NICE study limitations checklist20 was an expected finding due to the similarity of 
components within them. We demonstrated that economic evaluations in WHP are of low to 
moderate methodological quality. Methodological strength in the analysis and interpretation 
of results was most lacking. Our findings reflect a similar quality score finding of 51 ± 34% 
(tallied from the CHEC-List) from a review of eighteen workplace health programs aimed at 
improving nutrition and/or increasing physical activity.5  
Our study offers a resource for stakeholders wishing to improve the methodology of 
evidence in WHP. High methodological-quality studies were a critically missing element 
found in a recent review by Lerner and colleagues4 who concluded no positive, negative or 
neutral ROI could be made in light of methodological limitations. We were able to reconcile 
this limitation and report an aggregate ROI by accounting for differences in methodological 
quality in regression analysis. Pelletier11 in the latest of a series of reviews spanning 20 years 
adopted cautious optimism about the cost-effectiveness of WHP, highlighting the increasing 
number of RCT studies in this field were having an effect on bold positive conclusions. Our 
negative ROI findings from RCT’s support this. Neither author investigated the association of 
economic methodological quality with financial outcome. 
Our methods resulted in fifty one empirical studies, twenty five not seen in previous 
reviews.4-7,9 Many previously reviewed were excluded from this review for failing to meet 
the economic inclusion criteria.28,90-120 The inclusion of single interventions played a major 
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role in this new body of evidence, accounting for nineteen new studies. Previous reviews 
have focussed on multicomponent programs,7,10 research conducted within the United 
States,4,11 included only studies solely targeted nutrition and/or physical activity5 or mental 
health interventions89 or, like Baicker et al,6 included studies with no reported program 
costs.  
At its time of publication, the Baicker et al review offered the most systematic treatment of 
research design and calculation of equivalent costs and benefits, and demonstrated a more 
modest ROI than previously seen (2.73 for programs measuring absenteeism and 3.27 when 
targeting healthcare costs). Although ten studies were also included in our 
review,36,37,44,45,48,50,62,74,77,79 due to methodological differences it is difficult to make direct 
comparisons. Our approach and subsequent results differ from Baicker et al in terms of the 
comprehensiveness of the search strategy, the economic rigor of included studies, and the 
method of data analysis. The primary contributor to the difference in ROI reported by 
Baicker et al was the method of ROI calculation. The ROI formula used by Baicker was 
ROI=Benefit/Costs. When we adopted this formula our overall mean weighted ROI was 2.38. 
The costing assumptions applied by Baicker et.al introduced uncertainty to their results. 
Their use of a price year (2009 US dollars) for which program costs and healthcare benefits 
were standardised, assumed a linear distribution of price over time and additionally 
assumed no change in service provision despite publications spanning three decades. 
Program costs were not reported in 32% of studies measuring healthcare cost savings and 
55% of studies measuring absenteeism, instead, these studies were assigned a program cost 
from an average cost (an average of those that did report program costs). The cost of 
absenteeism was derived from the number of absentee days (extracted) then monetised by 
assuming an 8 hour work day at a US uniform wage rate of $20.49 per hour.121 In addition, 
Baicker et al did not perform any sensitivity analysis against these cost assumptions, and 
aside from rough estimates across RCT or matched control groups, non-randomised or 
unmatched control groups and post-intervention only studies, there were no sensitivity 
analyses for other key study characteristics. We believe our method of incorporating 
economic evidence, the extraction of ROI ratios at the time point and locale of each study, 
our standardisation of the ROI calculation, the weighting for participant numbers, and the 
sensitivity analyses undertaken to test the robustness of conclusions, all add to the 
confidence that can be placed in our findings. Moreover, in contrast to Baicker et.al, our 
summary ROI values have been estimated using minimal cost assumptions. 
These findings offer employers and policy makers an empirically sound basis to scrutinise the 
financial outcomes of WHP and provide better evidence to assist more sustainable business 
justification. Ultimately, it reinforces that a positive return-on-investment is probable, 
although considerable scrutiny and critical appraisal of published return figures are needed 
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to be confident of the degree of magnitude; in particular, the quality of the economic 
evaluation, the study design, how the ROI was calculated and what method of valuation was 
used. The ROI may be inflated if the study reports only healthcare costs, does not report an 
incremental analysis (difference calculation between treatment and control) or reports ROI 
using the benefit/cost formula. Vaccination programs in the workplace were demonstrated 
to be most worthwhile. They showed higher returns than those programs targeting chronic 
disease or dental/screening, and in addition, studies evaluating vaccination programs were 
of moderate/high quality and some were of RCT design. 
The evaluation of vaccination interventions to our knowledge has never been incorporated 
in reviews of this kind. There are many health interventions to consider when implementing 
a workplace health program and in an attempt to identify and review the broadest program 
offerings available in the literature, vaccination was considered a relevant addition.  
Our assessment of methodological quality attempted to ascertain how near the ‘truth’ our 
findings were likely to be. A subgroup analysis revealed higher methodological quality 
studies were more likely to be recently published, often of RCT design, and evaluated single 
interventions. In contrast, low methodological quality studies offered a most favourable 
return. In the interest of business justification, higher return studies are enticing, yet 
economic findings derived from poorer method may be less robust and undermine 
generalisability due to their limited transparency, applicability and uncertainty of result, 
which the methodological quality score reflects.13,14,23  
Methodological quality has improved at a rate of 1.15% each year. The greatest 
improvements were seen in the reporting of perspective, methods for estimation of 
resource consumption, discount rates, and performance of appropriate sensitivity analysis, 
all of which improved by 30% or more in studies published after year 2000. Although this 
attests to an improved methodology, an urgent need still exists for reporting unit costs, 
discount rates, performing sensitivity analyses and addressing generalizability, which despite 
improvements over the time period continue to be the most poorly addressed aspects of 
included studies. Advances in reporting standards for economic evaluations have recently 
been published22 to assist evaluators in this endeavour. 
2.5.1 Limitations 
Although the majority of economic evaluations in healthcare literature are conducted by 
means of CEA followed by CUA,122 CBA is the predominant methodology in workplace health 
studies. Yet despite being a good fit, the concerns surrounding the application of CBA in 
health-related literature, as investigated almost two decades ago,123 continue to apply to 
economic evaluations in WHP. Although every effort was made in this review to capture 
studies that met the standard definition of a full economic evaluation, and in principle to be 
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of sound methodological quality, there was strong evidence of inconsistencies in both the 
calculation of the ROI metric and the valuation of benefits in these studies.  
Our efforts meant that we also captured a few studies that conducted CEA and CUA 
evaluations, and some that reported CBA as a net benefit (Benefit-Cost). In our attempt to 
calculate the ROI for studies that did not do so in their original form the authors recognise 
the implicit risks of miscalculation and they made every attempt to accurately attribute ROI 
figures from the original published data. 
Development of a CBA framework for workplace health evaluation to standardise method 
and offer the much sought-after return on investment figure is a research priority. Of 
particular note is the valuation of benefits. Coupled with the vast array of methods for how 
to place value on a unit measure of benefit, benefits were largely limited to direct medical 
care cost savings and indirect productivity loss savings as a result of absenteeism. 
Consequently, studies often offered only partial program evaluation and therefore 
conclusions about the overall profitability of WHP are not complete. 
In addition, there was a lack of reported “opportunity cost”. Few studies compared the 
intervention alongside a competing program option. Yet, the role of an economic evaluation 
is to assess the cost of a program considering the costs of an alternative program that has 
been foregone due to the commitment of resources to the former.23 Without consideration 
of opportunity costs alongside achieved benefits, calculating real program costs is elusive. 
Therefore, the basis on which we judge value for money in WHP is imperfect. 
Importantly, the economic quality checklists offered no specificity to key elements in WHP, 
such as the quality of the intervention, the appropriateness of its focus given the health 
needs of the population, or the appropriateness of the dose or duration. As such, the quality 
scores represent only the quality of the economic evaluation. 
There was a low representation of small to medium enterprises in this review, indicating 
limited published evaluations of WHP in the SME population. With 99.9% of workplaces in 
the United Kingdom124 and 99.7% workplaces in Australia125 defined as SME, the lack of 
evidence in small organisations limits generalisability and may reflect poor engagement, 
potential publication biases or a lack of resources or interest by SME operators or 
researchers to evaluate financial returns in this setting.126 
2.5.2 Conclusion 
This methodological quality-based review of single and multi-component WHP programs 
demonstrated that higher methodological quality studies provided evidence of smaller 
financial returns. The overall mean weighted ROI for workplace health promotion was 
positive but methodological quality and study type were important determinants of 
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economic outcome. We found that as methodological quality improved, return on 
investment decreased, and we found a negative ROI in randomised control trials. It is 
important for stakeholders who evaluate their investment in workplace health to use the 
highest possible methodological quality evaluation methods. 
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2.6  SO WHAT? Section 
What is already known on this topic? 
Economic evaluations of workplace health interventions are used to measure the financial 
impact of health-promoting initiatives. Traditionally, cost benefit analyses (CBA) have been 
undertaken, from an employer perspective, to assess allocation efficiency and determine 
whether or not the intervention is worthwhile. It is known that economic analytical 
techniques are variable in methodological quality, and decision makers must use extreme 
caution in the interpretation of economic outcomes. 
What does this article add? 
This review offers empirical evidence under methodological scrutiny of the financial impact 
of workplace health promotion. It applies economic quality checklists to a strong body of 
published economic evidence, and offers the most comprehensive summary estimate of 
return on investment (ROI). It identifies important determinants of ROI to be methodological 
quality, study design, how the ROI was calculated and what method of valuation was used in 
the economic evaluation. 
What are the implications for health promotion practice or research? 
These findings offer employers and policy makers better evidence to make more accurate 
and sustainable business justifications. Although a positive return-on-investment is 
probable, considerable critical appraisal of published return figures are needed to increase 
confidence in the degree of magnitude. For stakeholders who evaluate investment in 
workplace health, engaging the highest possible methodological quality evaluation methods 
will maximise efficient resource allocation. Researchers must ensure economic evaluations 
are based on comparative analyses of both program costs and health outcomes to limit over-
estimation of economic outcomes. 
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2.7  Summary 
Objective: To determine the relationship between return on investment (ROI) and quality of 
study methodology in workplace health promotion programs. 
Methods:  A systematic literature search of NHS EED, DARE, HTA, CEA registry, EconLit, 
PubMed, Embase, Wiley and Scopus. Articles written in English or German reporting cost(s) 
and benefit(s), single or multicomponent health promotion programs on working adults 
were included. Return-to-work and workplace injury prevention studies were excluded. 
Methodological quality was graded using British Medical Journal Economic Evaluation 
Working Party checklist. Economic outcomes were presented as return on investment (ROI). 
ROI was calculated as ROI= (Benefits – Costs of program)/Costs of program. Results were 
weighted by study size and combined using meta-analysis techniques. Sensitivity analysis 
was performed using two additional methodological quality checklists. The influences of 
quality score and important study characteristics on ROI were explored. 
Findings: Fifty one studies (61 intervention arms) published between 1984–2012 included 
261,901 participants and 122,242 controls from 9 industry types across 12 countries. 
Methodological quality scores were highly correlated between checklists (r=0.84–0.93). 
Methodological quality improved over time. Overall weighted ROI [mean ± SD (CI)] was 
1.38±1.97 (1.38–1.39) which indicated a 138% return-on-investment. When accounting for 
methodological quality, an inverse relationship to ROI was found. High quality studies (n=18) 
had a smaller mean ROI 0.26 ± 1.74 (0.23–0.30), compared to moderate (n=16) 0.90 ± 1.25 
(0.90–0.91) and low quality studies (n=27) 2.32 ± 2.14 (2.30–2.33). Randomised control trials 
(RCTs) (n=12) exhibited negative ROI -0.22 ± 2.41 (-0.27– -0.16). Financial returns become 
increasingly positive across quasi-experimental, non-experimental and modelled studies: 
1.12 ± 2.16 (1.11 - 1.14), 1.61 ± 0.91 (1.56 - 1.65), and 2.05 ± 0.88 (2.04 – 2.06) respectively. 
Conclusion: Overall mean weighted ROI in workplace health promotion demonstrated a 
positive ROI. Higher-methodological-quality studies provided evidence of smaller financial 
returns. Methodological quality and study design are important determinants. 
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2.8  Postscript 
This review was particularly well-received by the WHP research community and leaders in 
the field.127-130 It was acknowledged by the editor in chief of the American Journal of Health 
Promotion as “the most thorough and rigorous systematic review of the literature conducted 
to date on the return on investment (ROI) of workplace health promotion programs” p iv. 127 
Its findings have been cited in the American Heart Association Presidential Advisory.131 The 
results in this review provide strong support for the need to improve standards of economic 
evaluations in workplace health promotion.    
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Appendix 2B.  Criteria for quality checklists used in sensitivity 
analysis of British Medical Journal Economic Evaluation Working 
Party (BMJ checklist) 
 
 
Appendix 2B 1 Criteria found in Consensus on Health Economic Criteria: Chec-List 14 (CHEC-List) 
(2005) 
1. Is the study population clearly described? 
2. Are competing alternatives clearly described? 
3. Is a well-defined research question posed in answerable form? 
4. Is the economic study design appropriate to the stated objective? 
5. Is the chosen time horizon appropriate to include relevant costs and 
consequences? 
6. Is the actual perspective chosen appropriate?  
7. Are all important and relevant costs for each alternative identified? 
8. Are all costs measured appropriately in physical units? 
9. Are costs valued appropriately? 
10. Are all important and relevant outcomes for each alternative identified? 
11. Are all outcomes measured appropriately? 
12. Are outcomes valued appropriately? 
13. Is an incremental analysis of costs and outcomes of alternatives performed?  
14. Are all future costs and outcomes discounted appropriately? 
15. Are all important variables, whose values are uncertain, appropriately subjected 
to sensitivity analysis? 
16. Do the conclusions follow from the data reported? 
17. Does the study discuss the generalizability of the results to other settings and  
patient/client groups? 
18. Does the article indicate that there is no potential conflict of interest of study 
researcher(s) and funder(s)? 
19. Are ethical and distributional issues discussed appropriately?  
 
Evers, S., et al. (2005). "Criteria list for assessment of methodological quality of economic 
evaluations: Consensus on Health Economic Criteria." International Journal of Technology 
Assessment in Health Care 21(2): 240-245. 
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Appendix 2B 2 Criteria found in NICE Study Limitations (2010) 
1 Does the model structure adequately reflect the nature of the health conditon under 
evaluation? 
2 Is the time horizon sufficiently long to reflect all important differences in costs and 
outcomes? 
3 Are all important and relevant health outcomes included? 
4 Are the estimates of baseline health outcomes from the best available source? 
5 Are the estimates of relative treatment effects from the best available source? 
6 Are all important and relevant costs included? 
7 Are the estimates of resource use from the best available source? 
8 Are the unit costs of resources from the best available source? 
9 Is an appropriate incremental analysis presented or can it be calculated from the data? 
10 Are all important parameters whose values are uncertain subjected to appropriate 
sensitivity analysis? 
11 Is there no potential conflict of interest? 
12 Overall Assessment: Minor limitations/Potentially serious limitations/Very serious 
limitations 
 
Shemilt I, M. M., Vale L, Marsh K, Donaldson C (editors) (2010). Evidence-based decisions 
and economics : health care, social welfare, education and criminal justice. 2nd ed. 
Chichester, West Sussex, UK ; Hoboken, NJ, Wiley-Blackwell/BMJ Books. 
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Appendix 2C Supplementary Tables and Figures 
Below is a table of the search results broken down into the yield of studies from the long 
search and the MESH search. 
Appendix 2C 1 Combined summary of yield from search results (long and MESH search) 
Database Long Search MESH Search Total 
NHS EED  504 116 620 
DARE 107 13 120 
HTA 26 7 33 
PUBMED MEDLINE NP 79 79 
EconLit 439 79 518 
Scopus 1122 216 1338 
Embase 953 208 1161 
CEA Registry 4 NP 4 
Total 3188 718 3906 
Total studies  3906 
From economic 
databases 
1295 
From biomedical 
databases 
2611 
NP = Not performed, yield was too large for long search in PubMed and too small for MESH terms 
in CEA Registry.  
Economic databases include: NHS EED (National Health Service Economic Evaluation Database); 
DARE (Database of Abstracts of Reviews of Effects); HTA (Health Technology Assessment 
Database); Econlit (American Economic Association); CEA Registry (Cost Effectiveness Analysis 
Registry) 
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Bland Altman plots 86 were used to check systematic patterns in differences between the 
BMJ checklist and the CHEC –List and NICE Study Limitations quality scores 
 
Appendix 2C 2 Data from quality scores plotted to show the difference in scores between BMJ and 
CHEC-List against the average score 
 
 
Appendix 2C 3 Data from quality scores plotted to show the difference in scores between BMJ and 
NICE Study Limitations against the average score 
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Below is the mean number of ‘yes’ ‘no’ and ‘not applicable’ scores for all studies. 
Appendix 2C 4 Mean response per individual quality question of the 36-item BMJ checklist23 
 Mean number of 
answers 
Mean percentage mark for ‘yes’  
Quality Questions Yes No NA 
Overall 
Score 
Studies 
pre 2000 
(n=24) 
Studies 
post 2000 
(n=28) 
1. Was the research question stated? 
45 7 0 87% 83% 89% 
2. Was the economic importance of the research question 
stated? 
44 8 0 85% 75% 93% 
3. Was/were the viewpoint(s) of the analysis clearly stated 
and justified? 
21 31 0 40% 21% 57% 
4. Was a rationale reported for the choice of the alternative 
programmes or interventions compared? 
37 15 0 71% 58% 82% 
5. Were the alternatives being compared clearly described? 
35 17 0 67% 54% 79% 
6. Was the form of economic evaluation stated? 
38 14 0 73% 71% 75% 
7. Was the choice of form of economic evaluation justified in 
relation to the questions addressed? 
23 29 0 44% 29% 57% 
8. Was/were the source(s) of effectiveness estimates used 
stated?  
31 9 12 78% 68% 86% 
9. Were details of the design and results of the effectiveness 
study given (if based on a single study)? 
34 7 11 83% 80% 86% 
10. Were details of the methods of synthesis or meta-analysis 
of estimates given (if based on an overview of a number of 
effectiveness studies)? 
0 0 52 NA NA NA 
11. Were the primary outcome measure(s) for the economic 
evaluation clearly stated? 
39 13 0 75% 71% 79% 
12. Were the methods used to value health states and other 
benefits stated? Time tradeoff, standard gamble, contingent 
valuation(CEA) human capital WTP (CBA) 
27 24 0 53% 42% 63% 
13. Were the details of the subjects from whom valuations 
were obtained given? 
29 23 0 56% 38% 71% 
14. Were productivity changes (if included) reported 
separately? 
30 20 2 60% 48% 70% 
15. Was the relevance of productivity changes to the study 
question discussed? 
35 17 0 67% 54% 79% 
16. Were quantities of resources reported separately from 
their unit cost? 
16 36 0 31% 17% 43% 
17. Were the methods for the estimation of quantities and 
unit costs described? 
35 17 0 67% 50% 82% 
18. Were currency and price data recorded? 
49 3 0 94% 100% 89% 
19. Were details of price adjustments for inflation or currency 
conversion given? 
24 27 1 47% 46% 48% 
20. Were details of any model used given? 
7 2 43 78% 50% 86% 
21. Was there a justification for the choice of model used and 
the key parameters on which it was based? 
7 2 43 78% 50% 86% 
22. Was time horizon of cost and benefits stated? 
46 6 0 88% 92% 86% 
23. Was the discount rate stated?  
10 23 19 30% 17% 47% 
24. Was the choice of rate justified?  if Q23= NA Q24= NA, if 
Q23 = 0 Q24 =0  
5 28 19 15% 11% 20% 
25. Was an explanation given if cost or benefits were not 
discounted? 
2 40 10 5% 5% 5% 
26. Were the details of statistical test(s) and confidence 
intervals given for stochastic data? 
19 33 0 37% 13% 57% 
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27. Was the approach to sensitivity analysis described? 
(multivarate, univariate, threshold analysis)...NA if actual 
company/claims 
14 38 0 27% 8% 43% 
28. Was the choice of variables for sensitivity analysis 
justified? 
14 37 1 27% 9% 43% 
29. Were the ranges over which the parameters were varied 
stated? 
16 35 1 31% 17% 43% 
30. Were relevant alternatives compared? (i.e. Were 
appropriate comparisons made when conducting the 
incremental analysis?) 
43 9 0 83% 71% 93% 
31. Was an incremental analysis reported? Difference 
calculation 
33 18 0 65% 58% 70% 
32. Were major outcomes presented in a disaggregated as 
well as aggregated form? 
27 24 0 53% 38% 67% 
33. Was the answer to the study question given? 
39 13 0 75% 63% 86% 
34. Did conclusions follow from the data reported? 
26 26 0 50% 29% 68% 
35. Were conclusions accompanied by the appropriate 
caveats? 
34 18 0 65% 58% 71% 
36. Were generalisability issues addressed? 
14 38 0 27% 21% 32% 
TOTAL "YES"  948 356 592 
TOTAL "NO" 707 413 294 
TOTAL "NA" 214 95 119 
TOTAL OVERAL SCORE 57% 46% 67% 
NA = ‘Not applicable’ 
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Below is the BMJ quality scores for each paper, showing the breakdown for study design, 
data collection and analysis and interpretation. The overall score has been listed in order of 
highest to lowest 
Appendix 2C 5 BMJ scores for individual papers included in the review 
Author Year Origin 
Study 
Design 
Data 
Collection 
Analysis and 
Interpretation Overall score 
Groeneveld 66 2011 Netherlands 100% 100% 92% 97% 
Samad 54 2006 Maylasia 86% 100% 92% 94% 
Colombo 52 2006 Italy 100% 91% 92% 94% 
At'kov 42 2011 Russia 100% 92% 92% 94% 
Bridges 51 2001 USA 86% 100% 92% 94% 
Cohen 41 2003 Australia 100% 91% 85% 90% 
Proper 68 2004 Netherlands 100% 82% 92% 90% 
Meenan 67 2010 USA 100% 100% 71% 88% 
McEachan 39 2011 UK 100% 73% 92% 87% 
Morales 55 2004 Columbia 100% 91% 69% 84% 
Greene 65 2009 USA 86% 92% 71% 82% 
Naydeck 78 2008 USA 86% 73% 86% 81% 
Campbell 50 1997 USA 86% 82% 77% 81% 
Taimela 69 2008 Finland 86% 85% 69% 79% 
Shi 35 1993 USA 86% 90% 67% 78% 
Ichihashi 48 2007 Japan 86% 73% 64% 72% 
Schneider 57 2011 Germany 100% 70% 57% 71% 
Goetzel 63 2005 USA 86% 77% 57% 71% 
Ozminkowski 36 1999 USA 86% 44% 71% 67% 
Baker 38 2008 USA 86% 69% 54% 67% 
Dille 53 1999 USA 57% 91% 46% 65% 
Mills 61 2007 UK 57% 73% 54% 61% 
Bertera 49 1990 USA 57% 89% 40% 58% 
Schrammel 58 1998 USA 43% 77% 47% 57% 
Nyman 34 2012 USA 57% 67% 50% 57% 
Kumpulainen 57 1997 Finland 71% 82% 27% 55% 
Aldana 76 1993 USA 71% 80% 27% 53% 
Schwartz 33 2010 USA 57% 64% 38% 52% 
Golaszewski 64 1992 USA 57% 62% 36% 50% 
Foote 84 1991 USA 71% 36% 47% 48% 
Wood 44 1989 USA 57% 55% 40% 48% 
Aldana 47 2005 USA 43% 89% 27% 48% 
Henke 37 2011 USA 71% 62% 20% 46% 
Yen 75 2010 USA 57% 55% 33% 45% 
Gibbs 43 1985 USA 43% 50% 43% 45% 
Merrill 80 2011 USA 57% 22% 53% 45% 
Bowne 70 1984 USA 43% 55% 33% 42% 
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Bertera 81 1990 USA 71% 45% 20% 39% 
Milani 45 2009 USA 57% 55% 20% 39% 
AHA 62 1987 USA 57% 40% 23% 37% 
Gettman 77 1986 USA 43% 36% 33% 36% 
Leutzinger 72 1995 USA 43% 46% 20% 34% 
Windsor 74 1989 USA 57% 36% 20% 33% 
Shore 59 1989 Canada 57% 36% 15% 32% 
Shephard 60 1992 Canada 43% 36% 15% 29% 
Schultz 73 2002 USA 29% 33% 27% 29% 
Tao 46 2009 USA 57% 30% 13% 28% 
Harris 79 1986 USA 14% 36% 23% 26% 
Harvey 83 1993 USA 43% 22% 13% 23% 
Serxner 82 1993 USA 29% 36% 8% 23% 
Davis 71 2009 USA 0% 18% 7% 9% 
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3.1 Preface 
The preceding Chapter investigated the global evidence concerned primarily with the state 
of the methodological quality of economic evaluations in workplace health promotion. 
Further, an expected return on investment (ROI) and significant correlates of this economic 
outcome were calculated. 
The work in Chapter 3 was performed from a local Tasmanian perspective and represents an 
outcome from partneringHealthy@Work. It is the result of a research-policy student 
internship within the Tasmanian Government Department of Health and Human Services 
(November 2011-February 2012), and investigated a partner-directed research question: 
How to make sense of the evidence in order to develop appropriate resources for business 
engagement? Resource development was considered within the Healthy@Work project as 
demonstrating leadership in the state’s workplace health and wellbeing arena.1 The aim of 
the internship was to 1) write a business justification chapter for a government-published 
“Healthy Workplace Resource Toolkit” (the ‘Toolkit’), designed to support Tasmanian 
organisations (including the Tasmanian State Service) when they develop and implement 
WHP; and 2) develop a simple tool to calculate economic impact associated with WHP. 
Aim 1, the business justification chapter titled “How will a health and wellbeing program 
improve my bottom line?” is shown in Appendix 3A. The original paper-based version of the 
simple tool (Aim 2) titled “How can I calculate the financial benefit to my organization?” 
appears in Appendix 3B and Appendix 3C. The Toolkit was piloted by Tasmanian businesses 
to gauge its utility. A brief comment on its utility can be found in this Chapter’s postscript. 
The following Chapter describes the methods used to address aim 2 and the subsequent 
development of the Workplace Health Savings Calculator that was further accepted by the 
Australian government as a workplace health promotion resource. This work is an example 
of translational research through partnership. This manuscript is published in BMC Research 
Notes – Technical Note (Appendix 3D) and titled:  
Baxter S, Campbell S, Sanderson K, Cazaly C, Venn AJ, Owen C, Palmer AJ. 
“Development of the Workplace Health Savings Calculator: a Practical Tool to 
Measure Economic Impact from Reduced Absenteeism and Staff Turnover in 
Workplace Health Promotion.” BMC Research Notes – Technical Note (2015) 8:457 
3 Chapter three: Development of the Workplace Health Savings 
Calculator; a WHP business case resource 
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3.2 Background 
Improving the health and wellbeing of workers is firmly on the public health and business 
agenda. The World Health Organization (WHO) has identified the workplace as a target 
setting for health promotion,2 and formed a Global Plan of Action on Workers’ Health (2008-
2017)3 to protect and promote health at work and respond to the health needs of the 
working population. Endorsement of this action plan is evidenced in the emergent company 
and society-wide shift to include workplace health promotion as a key strategy. 
Consequently, workplace health has gained profile as a strategic asset to economies, as 
revealed in various international reports and policy guidelines.4-10 This stands, despite recent 
inconclusive reviews on whether health and economic outcomes are positive, negative or 
neutral,11-14 and an extensive review that demonstrated economic evidence, although 
improving over time, is low to moderate in methodological quality.15 Nonetheless, the 
evidence that healthy employees provide social and economic benefits to businesses and the 
community continues to be largely accepted. These include reductions in absenteeism from 
illness and injury, increased productivity, reduced staff turnover, reduction in health care 
costs and a more satisfied work force.15-18 
Health economics offers an analytical technique to measure the financial impact of health-
promoting initiatives in order to assess allocation efficiency and determine whether or not 
an intervention is worthwhile. Although it is important for government, organisations and 
businesses to accurately measure the rate of return on investments, the application of 
health economic theory in workplace health is steeped in methodological complexities.15 
Primarily, economic evaluations focus on indicators of business performance and health 
change targets. Although tools such as workplace health calculators are available for 
decision makers who wish to create a business case for workplace health, those that 
currently exist online have been developed from evidence arising out of the Unites States 
and the United Kingdom with financial estimates available in British pound19,20 and United 
States dollar,21 and the latter only suitable to businesses with greater than 1000 employees 
based in US, Europe, India and China. Little is available to assist other jurisdictions in the 
business case for workplace health, both in terms of currency output and simple translation, 
and as a result, the adoption of these existing online-calculators can be problematic. 
In 2009 the Australian Government established the National Partnership Agreement on 
Preventive Health initially promising an investment of $221.8 million over nine years (2009-
10 to 2017-18).9 This committment provided funding to all states and territories to support 
the Healthy Workers Initiative and enabled Australian health policy-makers to engage in a 
common mission to improve and maintain the health and wellbeing of workers. With this 
support, a Healthy Workers Initiative project team was developed within Population Health 
Services in the Tasmanian Department of Health and Human Services. One of the many 
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objectives of the project team was to develop an evidence-based, simple and easy-to-use 
resource (calculator) for Australian employers interested in workplace health investment 
figures, and make this available through the Healthy Workplace Resource Toolkit. 
This paper describes the development of the Workplace Health Savings Calculator, a toolkit 
output that is currently available online. 
3.3 Methods 
3.3.1 Data collection  
Data were collected in three phases (i) locate appropriate effectiveness measures, (ii) 
identify change estimates surrounding these measures and (iii) decide on an appropriate 
model. 
To satisfy the first phase, a literature review was being performed by SB, AP, KS and AV (the 
researchers) at the time the Healthy Worker Initiative project team members SC and CO 
approached with the question “What is the evidence-based business case for workplace 
health promotion?” A partnership agreement was established and researchers utilised their 
concurrent literature search for the purposes of providing economic evidence to assist the 
development of the Healthy Workplace Resource Toolkit. The search was conducted in 
relevant economic and biomedical databases between November 2011 and January 2012. In 
addition, a keyword search using Google Scholar and a manual search of citations from 
relevant papers was undertaken to locate published evidence on the financial impact of 
workplace health promotion. The search strategy has been published along with the 
review.15 Information gained from this review was utilised to ascertain measures of 
effectiveness which contextually provided transferability and generalisability to the 
Australian sector. Two measures of effectiveness were recognised as business metrics most 
readily captured in operations. These were worker ‘absenteeism’ and ‘staff turnover.’ Both 
were adopted as the key performance estimates for the calculator.  
The second requirement in the development phase was to establish the magnitude of 
possible change in absenteeism and staff turnover as a result of implementing a workplace 
health program. These estimates of change for absenteeism and staff turnover were sourced 
from a second review study22 which readers can refer to for additional information. This 
review, published in 2008, was commissioned by the Health Work Wellbeing Executive in 
England and undertaken by PriceWaterhouseCoopers LLP. Under the constraints identified in 
the first review, namely, that no Australian equivalent published data source existed, that 
volume of publications from the United States of America far exceeded that from 
jurisdictions operating under a national health care system, and that large variability in both 
estimates and methodological quality of studies prevail, the authors considered this 
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PriceWaterhouseCoopers’ review to be most appropriate for our needs and of sound 
evidence base. Moreover, the evidence from this review is cited and supports the Workplace 
Wellbeing Charter,7 a national award, whose “standards reflect best practice” and is 
endorsed by Public Health England. 
Finally, an internet search was conducted to locate workplace health calculators currently in 
existence. These were assessed for their ease of use and applicability to the Australian 
business context. As a result of this search, a model developed by the National Institute for 
Health and Clinical Excellence (NICE)20 was considered simple to use and adapted for our 
purposes. 
3.3.2 Assumptions used to develop the tool 
In developing the tool, the following assumptions were made. First, 'absenteeism’ (or ‘sick 
leave’) was defined as an employee’s unplanned leave from work, not including other leave 
such as carer’s leave or maternity leave. Examples of unplanned leave would be due to 
illnesses such as colds and flu. 
Second, a workplace health promotion program was considered ‘successful’ when it was 
designed to target the needs of employees, when participation rates were reasonable 
(greater than 25% participation), and the program was actively supported by senior 
management and leaders within the organisation.  
Third, different types of workplace health promotion interventions (health and safety, 
disease management, and health promotion – the modification of risk behaviours such as 
smoking, nutrition, physical activity and stress to improve overall employee wellbeing) 
contributed equally, and were linked to the improvement of the effectiveness estimates.  
Last, calculated savings were assumed to be a long-term benefit. It is evidenced in the 
literature that positive effects on absenteeism and staff turnover occur between two and 
five years post implementation of a successful workplace health program.23 
3.4 Results 
The PriceWaterhouseCoopers’ review,22 from which the magnitude of change for 
absenteeism and staff turnover was sourced, included 55 case studies from organisations in 
the United Kingdom that implemented a variety of workplace health promotion programs. 
The case studies were submitted to the Health Work Wellbeing Executive and 
PricewaterhouseCoopers LLP was commissioned to undertake a review including interviews 
with selected organisations. Overall, 45 case studies reported evidence on change related to 
absenteeism and 18 on staff turnover, with 28 (51%) providing evidence from behaviour 
modification or lifestyle programs such as smoking cessation, healthy diet and subsidised 
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exercise programmes. These interventions focussed on similar behavioural and lifestyle 
health risk change targets to those encouraged in Australia, which are commonly referred to 
as SNAPS (smoking, nutrition, alcohol, physical activity, stress) interventions.24 There were 
32 case studies (58%) focussed on occupational health and safety interventions. The data 
was collected from businesses within nine different industries; defined as manufacturing, 
finance, public service, utilities, business services, construction/engineering, retail, 
education, and others. Company size and intervention type by industry group for all case 
studies is provided in the source review.22 Their diversity represented a good range of 
industry types relevant to Australia, with national statistics identifying the vast majority of 
Australian businesses operate in the service sectors (construction, 
professional/scientific/technical, retail trade, education, accommodation, transport, and 
utilities), with the remaining in manufacturing, mining agriculture/forestry and fishing.25 
Further similarities between these two nations such as the proportion of small to medium 
businesses, population demographics and drivers for workplace health promotion are shown 
in Table 3.1.   
Global trends in employer wellbeing strategies and practices were reported in 2014.26 Data 
were collected from 37 countries (in 11 languages) that included 1041 employer-participants 
(8 million employees) across all industry categories. Although it documented similarities 
between Australia/New Zealand and Europe in terms of percentages of organisations 
offering health promotion, health risk drivers (namely stress, physical activity, nutrition), and 
types of program components, no evidence relating to differences in effect size between 
countries was obtained. There is paucity in the literature surrounding between-country 
magnitudes of effect in workplace health promotion. Consequently, within the calculator, 
functionality allows change estimates for absenteeism and staff turnover to be edited by the 
user, and the default figure represents the lowest effectiveness estimate from the range 
reported in the UK PricewaterhouseCoopers’ review. Refer to Table 3.2 for change estimates 
and ranges. This most conservative approach acknowledges that these benefits may not be 
fully transferable to the Australian context.  
When an average effectiveness estimate was reported, it was assumed the average was an 
average across the case studies that measured that particular effectiveness outcome. It was 
therefore presumed the average would apply for any business that measured these 
particular outcomes after implementation of a workplace health promotion program. 
In concluding the assumptions used to develop the Workplace Health Savings Calculator, this 
tool is considered by the authors to be most appropriate for use in Australia, on the 
following basis; 1) input estimates for absenteeism and staff turnover are generated by the 
Australian user company, 2) cost estimates are derived using Australian wage statistics, and 
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3) change estimates from the PriceWaterhouseCoopers’ review are a) most conservative and 
b) generalizable to the Australian business context. The Workplace Health Savings Calculator  
specifically does not attempt to measure or quantify in dollar value any additional health 
benefits that may be enjoyed by employees undertaking health promotion in their 
workplace; as such estimates remain elusive in the literature.15 
3.4.1 Description of user interface  
The calculator was adapted from a model developed by the National Institute for Health and 
Care Excellence (NICE),20 and consists of three tabs (Figure 3.1). The first allows the user to 
input relevant data on employee numbers and salary, the second to input data on staff 
turnover, and the third tab calculates the total potential annual savings that arise from the 
implementation of a successful workplace health promotion program. Below the savings 
output on this third and final tab is an organisational profile box which users have the option 
to complete and submit (Figure 3.2). The submitting user maintains anonymity of the 
company name yet provides the site administrator with base level information about the 
company, such as industry type, business size and locality. Lastly, for users who wish to 
identify themselves, there is an option at the bottom of the box to submit an email via a 
‘Contact us’ hyperlink.  
 
Figure 3.1 Workplace Health Savings Calculator as it appears on the Commonwealth Government’s 
Department of Health, Healthy Workers web portal 
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The example calculation presented in Figure 3.1 is for a company profile whose input would 
match the following scenario.  
In the last 12 months, Company ‘eX’ of 100 employees has experienced a sick leave rate of 4 
days per employee (total annual sick days 400) and has recruited 3 replacement staff. The 
average staff salary is $45,000. The company operates 8 hours a day and the average hourly 
wage is $25. The estimated potential savings to the company when implementing a 
successful workplace health and wellbeing program is set at the default effectiveness 
measures; a 30% reduction in sick leave and a 10% reduction in staff turnover. The cost of 
replacing an employee is defaulted at 75% of the annual salary.  
 
 
Figure 3.2  Screen that accompanies the Workplace Health Savings Calculator for purposes of data 
collection. The data is non-identifiable unless users wish to identify themselves by submitting an 
email via the ‘Contact us’ hyperlink option at the bottom of this organisational profile box. 
 
For companies whose staffing profile does not solely consist of full-time employees, an 
additional feature was added to account for part-time and casual positions. For these 
businesses, where total number of full-time equivalent hours may not be recorded, there is 
an option within the calculator that allows the user to input ‘total number of sick days in the 
last 12 months’ instead of ‘total number of employees’. This feature simplifies the data 
gathering process, and allows users to choose between two algorithms in order to estimate, 
with minimal burden, the total annual savings in sick leave achievable by implementing a 
successful workplace health and wellbeing program. 
Tabs one and two use effectiveness estimates to derive savings that arise from reduced 
absenteeism and staff turnover, which is defaulted to the most conservative estimates and 
can be overridden by the user. It was envisioned that the default estimates may be 
overridden by companies that are already implementing a program for which company-
specific evaluation data were available, and for whom an online-generated calculation of 
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annual savings offered some utility. 
The effectiveness estimates within the calculator are sourced from the 
PriceWaterhouseCoopers’ review22 and  Australian wage statistics.27 These were 
absenteeism rates, which reduce by an average of 30-40%;22 staff turnover rates, which 
decrease by 10-25%;22 and replacement cost due to staff turnover, which ranged from 75%-
150% of the worker’s wage.27 There were many and various costs associated with this 
measure, such as costs for recruitment, training, specialist knowledge and productivity28 
which could account for the large range that was reported. In line with agreed assumptions, 
the most conservative estimates were used in the model when a range of estimates were 
offered. Details of these change estimates used and generalisability are provided in Table 3.1 
and Table 3.2. 
Table 3.1  Generalisability of the source reviewa 
Parameters Australia United Kingdom (UK) Comments/Assumptions 
SME 
proportion 
99.7% 
29 
99.9% 
30,31
 UK effectiveness estimates in 
report derived from similarly 
high proportion of SMEs to 
Australia * 
Industry 
types  
85 per cent of SMEs operate in the 
service sectors (construction (14%), 
professional/scientific and 
technical (12%), retail trade (10%) 
and others including education, 
accommodation, transport, 
utilities), with the remaining in 
agriculture/forestry and fishing 
(8%), manufacturing (6%) and 
mining (1%) 
25
 
Data from 9 industries: 
manufacturing, finance, 
public service, utilities, 
business services, 
construction/engineering, 
retail, education, others
22
 
Good range of industry types 
relevant to Australian 
industry. Construction 
industry reported 
effectiveness for 
occupational health and 
safety (OH&S) interventions 
only. 
Aging 
population 
In 2005, median age 36.6 years 
32
 
By 2050, median age 45 
33
 
1 in 4 Australians aged 65 years or 
over by 2056 
34
 
In 2005 median age 39 
years
32
  
By 2050, median age 43
33
 
Between 1971-2006, 
those aged 65 years 
increased by 31% 
22
 
Similar population aging 
demographics 
Aging 
workforce 
By 2050, 26% over 65 years 
35
  By 2024, 50% over 50 
years 
36 
By 2050, 24% in UK over 
65 years 
35
  
Similar workforce 
demographics 
Drivers  Human capital**, government 
initiative, OH&S 
37
 
Government, social 
responsibility, rising cost 
of human capital
22
 
Similar implementation 
drivers 
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Intervention 
targets 
SNAPS (ie: smoking, nutrition, 
alcohol, physical activity, stress) 
behavioural and lifestyle health 
risks 
24
 
51% (28/55) lifestyle (i.e.: 
smoking cessation, 
healthy diet and 
subsidised exercise 
programmes) 58% 
(32/55) OH&S 
22
 
Lifestyle interventions focus 
on similar behaviour change 
targets to those encouraged 
in Australia and are also 
those most commonly seen 
in research of behaviour 
modification health 
interventions in the 
workplace.  
a PricewaterhouseCoopers LLP was commissioned by the Health Work Wellbeing Executive to 
undertake a review of the business case for workplace health, which included a review of 55 case 
studies from United Kingdom organisations22 
* There were seven SMEs (small-to-medium enterprise) of the 55 case studies in the source report; 
two measured absenteeism, one measured staff retention, three measured both absenteeism and 
staff retention, and one measured absenteeism (from OH&S interventions only). In their reported 
benefits, all SMEs saw decreased absenteeism and improved retention. 
** Human capital: drivers include talent attraction, retention and ideas of broader corporate social 
responsibility. This approach also seeks to improve productivity and reduce workforce 
absenteeism37 
Table 3.2 Change estimates used within the Workplace Health Savings Calculatorb 
Change estimate  Source Measurement Assumption  
Absenteeism                
(% decrease)  
PWC 2008 
22b
 
 
Average 30%-40% reduction, 
based on 45/55 case studies 
The other 10 studies did not 
measure the perceived benefits of 
AB, so average holds for all that 
do  
 
Staff Turnover 
(replacement cost) 
 
ABS 2008 
27
 75%-150% salary as 
replacement cost. 
Industry types: Engineering, 
Construction, Professional 
Services (e.g.: Finance, Admin), 
Public Service, Resources (e.g.: 
Agriculture, Mining) Retail and 
Entertainment  
75% a conservative assumption 
used in place of conclusive 
evidence 
Staff Turnover             
(% decrease) 
 
 
 
PWC 2008 
22
 
 
10-25% decrease in staff 
turnover, based on 18/55 case 
studies.  
On average this retention range 
was 20-25% (from 4 industry 
categories: finance, utilities, 
business service, and other) 
That 37 case studies did not 
report on turnover, average based 
on the 18 studies that did. 
Average holds as an average for 
all 
b These were extracted from the source review22 of 55 case studies that had varying durations of 
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implementation. It has been shown in the literature that benefits from reduced absenteeism and 
staff turnover may not be realised before two-five years after implementation of a successful 
workplace health promotion program.23 We wish to reiterate an assumption outlined in this study 
that the calculated potential annual savings is a long-term benefit.  
The calculator was initially published in print within the Healthy Workplace Resource Toolkit 
(Appendix 3B) with an accompanying page offering an example of the algorithm (Appendix 
3C). In 2013 a Microsoft Excel spreadsheet was developed and the calculator was published 
on the WorkSafe Tasmania website.38 
The algorithm was later adapted and reproduced by the Australian Government Department 
of Health and Aging for use on the Healthy Workers web portal, as part of its official toolbox 
for the economic assessment of workplace health promotion programs. Titled “The 
Workplace Health Savings Calculator,” it is available at: www.healthyworkers.gov.au  on the 
home screen in the ‘News’ link (or via direct link: 
http://www.healthyworkers.gov.au/internet/hwi/publishing.nsf/Content/roi-introduction). 
Since its national online publication, the tool has been endorsement by an Australian non-
government organisation and commercial providers of workplace health promotion and 
their respective networks. Further adaptions of the calculator can be viewed online.39,40 
Evidence regarding its usability and further application are being collected through the 
organisational profile box and ongoing collaborator consultations. Initial data from the first 
year demonstrate the calculator has been accessed by a variety of businesses within the 
industries of Agriculture, Forestry & Fishing;  Health and Community Services; Education; 
Government Administration and Defence; Retail; Electricity, Gas and Water; and Personal 
and Other Services. Data also indicate these businesses are located across every state and 
territory in Australia, and in both metropolitan and regional areas. Two international 
companies have also completed the organisational profile. The majority of organisations 
(88%) employed less than 200 workers of which 40% identified as small in size (1-19 
employees). These initial statistics are encouraging, and not only demonstrate an interest in 
workplace health promotion from the Australian small-to-medium enterprise (SME) 
community but also across the entire country.  
3.5 Discussion 
The Workplace Health Savings Calculator is an online tool for estimating the economic 
impact of improved productivity from the implementation of a successful workplace health 
promotion program. It utilises a conservative set of assumptions to generate an estimate of 
potential annual savings. It calculates financial benefits related to reduced absenteeism and 
staff turnover using input estimates (number of employees, sick leave rates, average hours 
worked, average wage, number of resignations) that are generated at the individual 
company level. Annual turnover and number of employees are tangible key performance 
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estimates most commonly measured in Australia.25 The estimate for cost to replace staff is 
an Australian statistic.27 Although commonly measured, there is a lack of Australian evidence 
on absenteeism and staff turnover in relation to workplace health promotion outcomes and 
the authors were required to carefully consider the vast and varying evidence on 
effectiveness and cost-effectiveness in the global literature. This was achieved in 
concurrence with a systematic review undertaken by the authors SB, AP, KS and AV.15 It was 
considered that these two metrics (absenteeism and staff turnover) provided 1) the ease of 
measurement needed, and 2) best attainable estimates to attribute a dollar value, and 
thereby met our primary objective to develop an evidence-based, simple and easy-to-use 
resource (calculator) for Australian employers interested in workplace health investment 
figures.  
Presenteeism, being present at work while suffering from a health problem that may limit 
job performance,41 is also linked with negative impacts to productivity and associated costs. 
Indeed, presenteeism accounts for greater aggregate productivity loss than absenteeism,42-44 
thus decreasing worker presenteeism rates will lead to greater savings. Although preliminary 
evidence has shown that workplace health promotion may be effective at decreasing 
presenteeism rates,45 there are critical issues surrounding the measurement, conversion and 
translation of value into economic outcomes.46-48 It is not the intention of this calculator to 
overestimate outcomes or in the interest of sustainability of engagement for users to receive 
an inflated savings figure which may not be realised. For this reason, only business estimates 
from absenteeism and staff turnover were considered and the most conservative estimates 
were utilised when average ranges were reported.  
The authors further acknowledge that estimating economic savings from productivity loss, 
even with the exclusion of a measure for presenteeism, remains debatable due to the wide 
variability, large influence on saving outputs, and issues surrounding use of indirect costs 
such as double counting and perspective.49  Therefore the computed savings estimate from 
the Workplace Health Savings Calculator should not be considered to have utility in a health 
economic evaluation of workplace health promotion program. It is not an assessment or 
evaluation tool, rather an engagement tool to support workplace health and wellbeing 
efforts. The intended design and application is to engage businesses who are seeking an 
instrument to develop commitment at a stakeholder level.  
Furthermore, the Workplace Health Savings Calculator is not a return on investment tool. It 
does not give the option to quantify program costs and therefore does not estimate net 
benefits or utilise cost benefit analysis techniques.  
The United Kingdom PriceWaterhouseCoopers’ review22 was considered to have a strong 
methodological approach for the reported business outcomes, with its published 
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effectiveness data also being used to support the Workplace Wellbeing Charter, National 
Award for England. The authors believe this review represented the best evidence base. In a 
field known to be lacking in robust quantifiable effectiveness and economic data, the 
authors recognise the lack of a more scientific approach compromises the validity of the 
calculator however consider the findings from the case studies to be real world 
representation and their use in this tool a pragmatic application.  
Moreover, the NICE model from where the Workplace Health Savings Calculator was 
adapted is available as a business case tool within the NICE guidelines [PH13]20 for 
promoting physical activity at work. In December 2014 the guidelines underwent a second 
three-yearly review and the concluding decision states “no new evidence was identified 
which appeared to contradict the existing recommendations” p 8.50 Reliability and validity 
are cornerstone principles to scientific method, and although a gross limitation to the 
calculator is the fact that neither has been tested, the continued and ongoing expert opinion 
accepts such limitations due in part to a lack of rigorous evaluation designs, and the 
complexities and heterogeneities surrounding this public health intervention.    
In terms of generalisability, the research evidence used for change estimates was generated 
from an international (UK) context not an Australian setting where the calculator is applied. 
It is therefore unknown whether the effect size is transferable to locally-implemented 
interventions. However, we demonstrated that business sector statistics, workplace health 
strategies and practices, and the overarching political agenda focused on promoting health 
in the workplace to address rising prevalence of chronic disease is similar between both 
countries. Baseline prevalence, characteristics of the target population and capacity to 
implement interventions are key attributes for transferability in evidence-based public 
health.51 
From the initial data on organisational profile collected by the online Workplace Health 
Savings Calculator there has been a large proportion of SME interest. Australia defines a SME 
as a business employing 0-199 workers (small represents 0-19 employees and medium 
represents 20-199 employees25), and SMEs make up 99.7% of the Australian business 
sector.29 This is comparable in both proportion and definition to United Kingdom, where 
SMEs are “businesses with zero to 249 employees, (which) account for 99.9 per cent of all 
enterprises” p9. 30 Interestingly, of the 55 case studies in the source review, only seven 
(13%) were SMEs, representing manufacturing, financial, business services and retail sectors. 
The approximate size for all other organisations ranged from 200-100,000+, the largest being 
the public sector service organisation. The low representation by small-to-medium business 
in the review could indicate a general lack of engagement or lack of resources. Nevertheless, 
in jurisdictions and regions where the business profile differs, for example in Tasmania, 
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Australia (where the vast majority of SMEs are small businesses (94.8%), with 58.8% being 
non-employing businesses and 36% employing 0-19 workers29,52), a declaration of company 
size from where estimates originated should be made within the calculator. 
Workplace health promotion is a modern corporate strategy, and for countries like Australia, 
it is a recognised public health initiative aimed at improving employee health and wellbeing. 
Calculators to assist in business justification are needed to develop stakeholder commitment 
and are seen as suitable to engage business in conversation for promoting health in the 
workplace. Other currently available online calculators lack generalisability to the Australian 
business market. Limitations surround country specificity, currency, complexity and 
appropriate evidence transferability. In contrast, the Workplace Health Savings Calculator is 
a practical easy-to-use business case tool that was developed in line with one of the core 
principles of the National Partnership Agreement on Preventive Health, and is to be used to 
support, engage and promote the implementation of healthy lifestyle programs in Australian 
workplaces. 
3.6 Availability and requirements  
Project name: Workplace Health Savings Calculator 
Project home page: www.healthyworkers.gov.au  and direct link available at: 
http://www.healthyworkers.gov.au/internet/hwi/publishing.nsf/Content/roi-introduction 
Operating system(s): Platform independent 
Programming language: HTML 
Other requirements: Nil 
Any restrictions to use by non-academics: None (free to access) 
3.6.1 Availability of supporting data 
The data supporting the results of this article are included within the article and its 
additional files. 
3.6.2 List of abbreviations 
SME  Small to medium enterprise 
WHO  World Health Organization 
UK   United Kingdom 
NICE  National Institute for Health and Clinical Excellence 
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evaluate a workplace health promotion program implemented for Tasmanian public service 
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3.11 Summary 
3.11.1 Background 
Workplace health promotion is focussed on improving the health and wellbeing of workers. 
Although quantifiable effectiveness and economic evidence is variable, workplace health 
promotion is recognised by both government and business stakeholders as potentially 
beneficial for worker health and economic advantage. Despite the current debate on 
whether conclusive positive outcomes exist, governments are investing, and business 
engagement is necessary for value to be realised. Practical tools are needed to assist 
decision makers in developing the business case for workplace health promotion programs. 
Our primary objective was to develop an evidence-based, simple and easy-to-use resource 
(calculator) for Australian employers interested in workplace health investment figures. 
3.11.2 Results 
Three phases were undertaken to develop the calculator. First, evidence from a literature 
review located appropriate effectiveness measures. Second, a review of employer-
facilitated programs aimed at improving the health and wellbeing of employees was utilised 
to identify change estimates surrounding these measures, and third, currently available 
online evaluation tools and models were investigated. We present a simple web-based 
calculator for use by employers who wish to estimate potential annual savings associated 
with implementing a successful workplace health promotion program. The calculator uses 
effectiveness measures (absenteeism and staff turnover rates) and change estimates 
sourced from 55 case studies to generate the annual savings an employer may potentially 
gain. Australian wage statistics were used to calculate replacement costs due to staff 
turnover. The calculator was named the Workplace Health Savings Calculator and adapted 
and reproduced on the Healthy Workers web portal by the Australian Commonwealth 
Government Department of Health and Aging. 
3.11.3 Conclusion 
The Workplace Health Savings Calculator is a simple online business tool that aims to 
engage employers and to assist participation, development and implementation of 
workplace health promotion programs.  
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3.12 Postscript 
This chapter describes the translational development of a WHP resource resulting from a 
research to policy internship within partneringHealthy@Work. The resource included a 
business justification chapter and a workplace health savings calculator.  
A subsequent review and closure report on the Healthy Workplace Resource Toolkit was 
carried out by the Tasmanian Department of Health and Human Services and other 
members of the partneringHealthy@Work team. The report included an evaluation of 
responses from Tasmanian employers who piloted the toolkit across public, private and 
non-government settings (n=20). Specific to the business justification section was their 
responses to one of the questions I provided: “How would you rate the importance of the 
following reasons for your workplace to support a WHP program (unimportant, not very, 
neutral, somewhat, very important)?” There were fifteen business reasons:    
Staff health, Workplace injuries, Employee job satisfaction (enjoyment), Worker 
Compensation, Absenteeism, Attendance regardless of illness/injury, Productivity, Staff 
morale, Business image, Recruitment and  retention, Job performance/efficiency, Team 
cohesiveness (work together), Staff engagement, Operational savings, and Increase 
profitability  
The percentage of ‘very important’ responses as valued by the pilot businesses and related 
to my thesis were: staff health (90%), absenteeism (60%), staff retention (50%), increase 
profitability (44%), and operational savings (40%).   
This Chapter has demonstrated that resources in WHP are needed and sought in both state 
and federal government arenas to promote acceptable, relevant and usable tools to engage 
WHP business interest. Taking into consideration the post-review and closure report, input 
estimates of absenteeism and staff turnover are appropriate measures that are valued by 
Tasmanian employers, although a greater importance for ‘staff health’ was indicated as a 
reason to support a WHP program.      
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Appendix 3A The Healthy Workplace Resource Toolkit: “How will a 
health and wellbeing program improve my bottom line?”  
 
This toolkit was published by the Tasmanian Government in February 2012 and updated in 
July 2015. It is still currently available in its updated form online on the Worksafe Tasmania 
website www.worksafe.tas.gov.au 
The full toolkit consists of 106 pages. In the interests of conservation, I have attached only 
the contents page and specific section (Section 03) that relates to my internship outcomes. 
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Appendix 3B Print version of the simple Workplace Health 
Savings Calculator as it appeared in the Healthy Workplace 
Resource Toolkit 
 
HOW CAN I CALCULATE THE FINANCIAL BENEFIT TO MY 
ORGANISATION? 
 
Two of the more tangible ways that employee health can have an immediate financial benefit to your organisation 
is through reducing: 
1. Absenteeism 
2. Staff turnover. 
The following exercise will help you calculate the impact a successful workplace health and wellbeing program can 
have on staff absenteeism and turnover rates. Where a percentage range is provided, the percentage that 
calculates the most conservative saving is used. 
 
1. Absenteeism 
Fill in the following spaces to estimate the cost of absenteeism to your organisation. 
 
Total number of employees        _______ (A) 
Sick leave rate per employee per year (in days)      _______ (B) 
OR 
Total number of sick days in last 12 months      _______ (C) 
Average hours worked per day       _______ (D) 
Average hourly wage ($)        _______ (E) 
Total annual cost of staff sick leave          $______ (F) (A x B x D x E 
   or (C x D x E) 
It is estimated that a successful workplace health and wellbeing program can decrease staff absenteeism by an 
average of 30-40%
22
 
 
Reduction in sick leave (%)        30%     (G) 
Total annual savings in sick leave achievable by 
implementing a workplace health and wellbeing program    $______  (H) (F x G) 
 
2. Staff turnover 
Fill in the following spaces to estimate the cost of staff turnover to your organisation. 
 
Total number of employees resigned in the last 12 months     _______ (I) 
Average annual gross wage ($)       _______ (J) 
 
It is estimated that the cost of replacing an employee is 75-150% of the employee’s salary
27
 
 
Cost of replacing an employee as a percent of annual salary    75%        (K) 
 
Annual cost of replacing employees as a result of resignation $    _______ (L) (I x J x K) 
 
It is estimated that a successful workplace health and wellbeing program can decrease staff turnover by an 
average of 10-25%.
22
 
Reduction in staff turnover (%)       10%       (M) 
Total annual savings in staff turnover achievable by implementing a workplace health and wellbeing program 
          $_______(N) (L x M) 
Total annual savings as a result of implementing a successful workplace health and wellbeing program   
          $_______(O) (H + N) 
Appendix 3C Example which accompanied the simple Workplace Health Savings Calculator 
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Appendix 3C Example which accompanied the simple 
Workplace Health Savings Calculator in the Healthy 
Workplace Resource Toolkit 
HOW CAN I CALCULATE THE FINANCIAL BENEFIT TO MY 
ORGANISATION? 
The following example illustrates these calculations. 
In the last 12 months, a company of 50 staff has experienced a sick leave rate of 8.5 days per employee and has 
recruited 3 replacement staff due to resignations. The average staff salary is $50,000. The company runs a shift 
roster of 8-hour days and the average hourly wage is $25. 
Total number of employees  50    (A) 
Sick leave rate per employee per year (in days) 8.5    (B) 
Total number of sick days in last 12 months  425    (C) 
Hours worked per day   8    (D) 
Average hourly wage ($)  25    (E) 
Total annual cost of staff sick leave  $85 000 (F) (A x B x D x E)
Reduction in sick leave due to a workplace health and wellbeing program (%)  30%    (G) 
Total annual savings in sick leave achievable by 
implementing a workplace health and wellbeing program $25 500     (H) (F x G) 
Total number of employees resigned in the last 12 months  3      (I) 
Average annual wage ($) 50 000      (J) 
Cost of replacing an employee as a percent of annual salary  75%      (K) 
Annual cost of replacing employees as a result of resignation $112 500   (L) (I x J x K) 
Reduction in staff turnover due to a workplace health and wellbeing program (%) 10%     (M) 
Total annual savings in staff turnover achievable by 
implementing a workplace health and wellbeing program $11 250     (N) (L x M) 
Combined annual savings for reduced sick leave and staff turnover, as a result of 
implementing a successful workplace health and wellbeing program $36 750     (O) (H + N) 
In this example, the organisation has potential annual savings of over $36 000 through minimising absenteeism 
and staff turnover. Other less tangible savings could be made through increased productivity, staff engagement 
and morale. 
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Health Savings Calculator; a Practical Tool to Measure 
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Baxter S, Campbell S, Sanderson K, Cazaly C. Venn AJ, Owen C, Palmer AJ. “Development of 
the Workplace Health Savings Calculator; a Practical Tool to Measure Economic Impact from 
Reduced Absenteeism and Staff Turnover in Workplace Health Promotion” BMC Research 
Notes – Technical Note (2015) 8:457 
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4 Chapter four: Validation of a preference-based measure of health in 
the employee population 
4.1 Preface 
Predominantly, the state of the global economic evidence in workplace health promotion (WHP) 
measure benefits through productivity savings (mostly from reduced absenteeism) and reduced 
healthcare costs (refer to Chapter 2 systematic review). The review demonstrates a lack of 
standardised methods to measure and value such outcomes, with the largest variation seen from 
the measurement and valuation of indirect costs. 
The preceding Chapter 3 concentrated on a partner-defined question to develop a local resource. 
Absenteeism (an employee’s unplanned leave from work, not including other leave such as carer’s 
leave or maternity leave) and staff turnover were used as the key performance estimates within a 
workplace health savings calculator. This work demonstrated a need for locally-relevant resources 
for business engagement, despite the lack of methodologically-validated measures in the economic 
evidence.   
Most appropriate and in line with a health economic imperative is the need for identification 
measurement and valuation of employee health. 
This chapter presents a construct validity study of the health state utility value SF-6D, a measure of 
health status that is amenable to economic evaluations. Validation is investigated using data from 
the Tasmanian public sector state service workforce Healthy@Work project in addition to 
Australian general employed and Australian public sector normative samples within the Household 
Income and Labour Dynamics of Australia survey. It is crucial to identify whether SF-6D values of the 
Tasmanian State Service (TSS) employees discriminate appropriately between health and 
socioeconomic factors and work characteristics. Evidence of appropriate discrimination will ensure 
the SF-6D is measuring what it is supposed to measure. Thus provide confidence in its application in 
the economic evaluation of Healthy@Work (Chapter 5). 
This analysis has been published in Quality of Life Research (Appendix 4A). 
Impact factor: 2.486 
Baxter S, Sanderson K, Venn AJ, Otahal P, Palmer AJ. “Construct validity of SF-6D health 
state utility values in an employed population” Quality of Life Research July 2015; 24(4): 851-
870 
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4.2 Introduction 
For robust health economic evaluations in workplace health promotion to occur, greater 
attempts are needed to value the health benefits of participating employees. One way for 
evaluators to achieve this is by incorporating multi-attribute utility instruments (MAUIs) to 
measure health utility, define benefits in terms of quality adjusted life years (QALYs), and 
incorporate tariffs (predefined unit prices) to ascertain monetary value. Health economics 
offers an analytical technique, known as cost utility analysis, to explicitly use health utility to 
estimate QALYs. Such analyses are rarely conducted in economic evaluations of workplace 
health promotion.1 Although the lack of utility data from working populations has likely led 
to this paucity, perceptions that health utility is not a useful measure within this population 
may play a part. What is certain is that evidence-based decisions in policy customarily follow 
economic guidelines,2 with incremental cost per QALY the gold standard measure of value 
for money.3 A greater emphasis to include and measure employee health utility will help 
inform decisions of resource allocation for workplace health promotion. 
Health utilities measure strength of preference for a particular health state and are 
represented as a number between 0 and 1, with zero equating to death and one equivalent 
to perfect health. One of several MAUIs, known as SF-6D, derives utility values using 
Brazier’s algorithm,4,5 from either the SF-126 or SF-367 health surveys. SF-6D has been 
subjected to reliability and validity tests in general8,9 and clinical10,11 populations with a 
research application primarily focused on arthritis, muscular skeletal disease, and 
population norms.12 Although it is recommended or accepted for use by the 
pharmacoeconomic guidelines of Ireland, Australia, Italy and Canada, it has not been utilised 
in occupational studies, whereas the EuroQol EQ-5D, the most widely used MAUI, has been 
used to quantify the impact of limb injuries in workers13 and evaluate a workplace physical 
activity intervention.14 Studies that have compared SF-6D to EQ-5D have found SF-6D to be 
more efficient at detecting differences in self-reported health status, more sensitive to 
change in healthy individuals, less prone to ceiling effects, and to have a normal scaling 
distribution but lower completion rates and patient acceptability.15-19 Such evidence 
suggests SF-6D may be better suited to evaluate respondents in generally healthy 
populations like the workforce, yet the underlying SF-12 and SF-36 measures are seldom 
administered to employees; and little is known about the validity of SF-6D in an employed 
population. 
Population norm studies have shown that SF-6D discriminates between gender, age, body 
mass index (BMI) and educational attainment. On average, females report lower health 
utility than males, and those with higher educational attainment, lower age and lower BMI 
have a higher health utility than their counterparts.8 Studies have also detected differences 
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in health utility in those with risk factors versus established disease.20 The SF-12 and SF-36 
health surveys alone (i.e. when Brazier’s algorithm is not applied to derive the SF-6D) 
measure health-related quality of life (HRQoL). Previous research in working populations 
using the SF-12 have demonstrated that psychosocial work characteristics such as effort-
reward imbalance were associated with perceptions of mental health in German workers21 
and financial workers in Brazil22 and showed strong association with absenteeism in a 
German manufacturing plant.23 A US national cross-sectional study that administered the 
SF-36 to workers demonstrated that job strain was a significant contributor to HRQoL and 
warranted consideration as an independent risk factor.24 The Whitehall II cohort study of 
British civil servants (men and women) has administered SF-36 five times since 1991. 
Researchers investigating health and the work environment have demonstrated a strong 
positive association between employment grade (salary) and HRQoL,25 and concluded job 
strain was a predictor for common mental disorders, chronic heart disease and 
absenteeism.26  
This study aimed to investigate the construct validity of SF-6D in a large, diverse Australian 
state service workforce. Employees included senior executives, front line workers, clerical 
workers, administrators, lawyers, teachers, police, health and emergency personnel, 
technicians, service providers, labourers, junior graduates and cadets. We examined 
whether the SF-6D differentiated between participants according to categories of health, 
socioeconomic and work factors by testing the hypothesis that negative associations would 
exist for age, BMI, Kessler 10 Psychological Distress Scale (K10), effort-reward imbalance 
(ERI) and comorbidities, and positive associations would be shown for education and salary. 
We also examined sex differences. Additionally, we aimed to demonstrate that SF-6D 
provided preference-based health utilities that reflect working population norms. In so 
doing we considered the relevance and suitability of SF-6D as a measure of employee health 
change for use in future economic evaluations of workplace health promotion.  
4.3 Methods 
4.3.1 Study Population 
Data were from the partneringHealthy@Work (pH@W) study, a 5-year evaluation of a 
workplace health promotion program delivered to an entire state government workforce in 
Tasmania, Australia. At baseline (March 2010), a cross-sectional pen and paper 
questionnaire was delivered by mail to a stratified random sample of adults (n=12,179) 
representing approximately 40% of the Tasmanian government workforce. The pH@W 
partnership, study population and eligible sample have previously been described.27 Refer 
to Chapter 1, 1.7 partneringHealthy@Work. 
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Responders completed the SF-12 by answering questions about their perceived limits due to 
physical health related to their ability to do moderate activities; to perform in a role at work 
or other activities; bodily pain; vitality; and their perceived limits due to mental health 
related to their ability to participate socially; accomplish role-emotional functioning; as well 
as their feelings of depression. Based on their responses, subjects were assigned an 
individual health state, of which there were 7500 possibilities within six dimensions; physical 
functioning, role limitations, social functioning, bodily pain, mental health and vitality. The 
SF-6D health utility was derived when the individual’s health state was subjected to a 
preference-based scoring algorithm using standard gamble from UK general population 
norms (Brazier’s algorithm).5 SF-6D yields values between 0.29 and 1, with 1 representing 
perfect health.28 There is currently no published SF-6D (SF-12) algorithm for Australia. 
Construct validity was tested by correlations and comparisons of mean SF-6D against health, 
socioeconomic and work characteristics, both internally (pH@W) and externally, from an 
Australian employed normative sample, the Household Income and Labour Dynamics of 
Australia (HILDA) survey. HILDA is a clustered stratified panel survey of persons residing in 
private dwellings in Australia which commenced in 2001 and this analysis used SF36 (version 
1) data from employed individuals from the 2010 administered self-completion
questionnaire which was either collected or returned by mail (n=11,234). SF36 was 
converted to SF-6D using Brazier’s algorithm (model 10).4 More detailed information on the 
HILDA survey, the sample and validity of SF-36 have been published previously.29-31 Evidence 
suggests both SF-12 and SF-36 generate comparable estimates for SF-6D.5 
4.3.2 Measures 
Age was analysed as a continuous variable for correlations and categorised as 30 or 
younger, 31-40, 41-50, 51-60, and > 60 to analyse mean SF-6D.  
Body mass index (BMI) was derived from self-reported height and weight measures and 
analysed as a continuous variable and categorised as 24.9, 25-29.9, 30-34.9, 35-39.9 and 
>40.
Psychological distress was measured using the Kessler Psychological Distress Scale (K10), 
which identified level of current and depressive symptoms. Ten non-specific psychological 
distress questions were summed to give a total score between 10 and 50.32 K10 was 
analysed as a continuous variable and respondents’ psychological distress categorised low 
(10-15), medium (16-21), high (22-29) or very high (30+). Like the SF-6D, K10 has a 4 week 
recall period.  
Co-morbidities were measured by self-report. Within the pH@W questionnaire respondents 
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were asked to report against 23 chronic conditions, including heart conditions, chronic back 
pain, urinary and gastrointestinal problems, allergies, diabetes, obesity, sleeping problems, 
fatigue, severe and frequent headaches, cancer, osteoporosis, arthritis and lung problems 
(including chronic obstructive pulmonary disease, bronchitis or emphysema).33 Correlations 
with the number of reported conditions were examined and a count variable was used to 
further analyse associations of co-morbidity and health utility. This followed guidelines from 
previous studies using this measure.34,35 Respondents received either a 0 (no condition 
reported), a 1 (one condition), 2 (two conditions) and 3+ (if 3 or more conditions were 
reported). The HILDA survey did not have a comparable measure.   
Education was measured in both surveys by respondents’ highest attained qualification, and 
categorised; school-level (primary, year 12 or below); advanced training (trade/apprentice, 
certificate/diploma); and university (degree, graduate certificate/diploma and post 
graduate, ie: Masters or PhD).  
Employment was categorised three ways; occupational type (blue collar, white collar, 
service, professional and manager) from the Australian and New Zealand Standard 
Classification of Occupations (ANZSCO);36 employment category (permanent or fixed 
term/casual); and employment condition (full-time or part-time). 
Job stress was assessed using the effort-reward imbalance (ERI) instrument, a two-part 
response consisting of 17 items; 6 items for effort and 11 items for reward.37 An 
effort/reward ratio was calculated for each respondent, and further categorised by tertile 
cut-points representing low, intermediate and high effort-reward imbalance. These were 
used as a marker of job stress. This measure was only available in the pH@W survey. 
Socio-economic status was assessed using annual salary and analysed both as a continuous 
variable and categorised; <$40,000; $40,000-<$60,000; $60,000 –< $80,000; $80,000 – 
<$100,000; $100,000 –< $120,000; and $120,000+.  
Absenteeism was measured using a 4 week recall measure. In the pH@W survey “How 
many days in the last 4 weeks have you stayed away from work for more than half a day 
because of health problems?” was asked. In HILDA, respondents were asked to record the 
number of days they had taken paid sick leave in the past 12 months. For comparability, this 
number was then divided by 12 to derive an average number of days in any 4 week period. 
Absenteeism was dichotomised; zero days absent in past four weeks (when no days were 
reported); any days absent in past four weeks (when any number above zero was reported). 
HILDA respondents reporting a fraction of one day were considered to have zero days 
absent in the past 4 weeks. 
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Health behaviour measures included smoking status (respondents were categorised as 
being a never smoker, ex-smoker or current smoker), physical activity and alcohol risk. 
Frequency of alcohol intake (typical quantity consumed on a day when drinking) and 
frequency of heavy drinking (five or more standard drinks on one occasion) were measured 
using the Alcohol Use Disorders Identification Test (Audit C),38 which generated scores 
between 0 and 12. Alcohol risk was coded low (0-6) or high (7 -12) as per the Royal 
Australian College of General Practitioners (RACGP) guidelines.39  
Minutes and intensity of physical activity (related to work time, active transport, leisure 
time, and domestic/gardening activities) undertaken in the past week were assessed using 
the International Physical Activity Questionnaire (IPAQ-Long) and coded as low, moderate 
and vigorous activity using standard protocol.40 Reliability and acceptable validity has been 
demonstrated.41,42 Comparable measures for alcohol risk and physical activity were 
unavailable in HILDA. 
4.3.3 Statistical Analysis 
The pH@W dataset was propensity weighted43 to account for non-response; the logistic 
regression model was constructed from employment category, employment condition, 
agency as well as age, sex and tenure [service length]. Descriptive statistics were presented 
as mean or percentage (%) (standard error [SE]). Ceiling effects for each of the six SF-6D 
dimensions were assessed by examination of the proportion of respondents reporting no 
limitations, and considered present if >15% of participants reported full health (an overall 
health utility of 1).18  
To demonstrate construct validity of SF-6D we used Pearson correlation to examine 
associations between characteristics and measures that theoretically should be convergent: 
age, BMI, K10, ERI, co-morbidities and salary grade, all stratified by gender. We anticipated 
high inverse associations, with the exception of salary grade. 
We further examined predictors of SF-6D by regressing SF-6D on external factors and health 
status;  age, BMI, co-morbidities, education level, occupational type, employment category, 
employment condition, salary range, ERI, K10, smoking status, alcohol risk, physical activity 
and absenteeism. In order to account for variables associated with SF-6D (as defined by 
their significance (p<0.05) in univariable analysis), we performed both unadjusted and 
adjusted analyses. In the pH@W sample we adjusted for age, BMI, comorbidities, education, 
employment condition, effort-reward imbalance, K10, smoking status, physical activity, 
alcohol risk, and absenteeism and for the HILDA samples, BMI, K10, age, occupation, 
employment condition, salary, smoking status, and absenteeism. We presented both 
unadjusted and adjusted models for pH@W and adjusted for HILDA. To obtain an Australian 
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nationally representative sample for comparison and population-level generalisation, the 
clustered stratified HILDA dataset was weighted for differential response. Weights were 
supplied alongside the 2010 data.  
All statistical analyses were conducted using STATA© version 12 software package 
(Statacorp LP, Texas, USA). We assumed statistical significance to be p<0.05. 
The study was approved by Tasmania Health & Medical Human Research Ethics Committee 
(EC00337): H0010501 
4.4 Results 
4.4.1 Characteristics of the study population 
Mean age (standard error) of pH@W respondents was 45.7 (0.35) for males and 44.5 (0.22) 
years for females. Most males and females (69%; 61%) were married, with university level 
education (53%; 55%) and the majority of males (89%) were employed full time. Of the 
sampling frame (n=27659), 66% were female and of those who returned the questionnaire 
(n=3408), 72% were female demonstrating that a higher proportion of women participated. 
Our weighting for non-response accounted for this. The pH@W survey had a 24.8% 
response rate and 98.8% of respondents completed the 7 items of SF-12v2 needed to derive 
SF-6D. The normative population (n=11234) with its subset sample of public service 
employees (n=1938) was younger overall (males: 39.7 (14.2), females: 39.2 (13.9)), with the 
public service marginally older (males: 42.5 (12.8), females: 42.6 (12.2)). Again, both males 
and females were more often married, in full time employment and public service 
employees had predominantly attained university level education. A distinction existed in 
occupational type between samples. While pH@W respondents were largely classified 
white collar or service workers, the Australian normative sample public service were 
principally classified professional, and there was an even spread for occupational type 
across the entire sample. Demographic characteristics weighted to population levels are 
presented in Table 4.1.  
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Table 4.1 Characteristics of the two study samples: a random sample of an Australian public sector workforce (partneringHealthy@Work) and panel 
sample of Australian employed from the Household Income and Labour Dynamics of Australia (HILDA) study 
  
partneringHealthy@Work (N=3408) 
 
Australian normative sample (HILDA) 
 
      
 All employed (N=11,234) Public service (N=1938) 
 
  
Females (n=2444) Males (n=964) 
 
Females (n=5371) Males (n=5863) 
 
Females(n=1210) Males (n=728) 
  n %(SE) n %(SE)  n %(SE) n %(SE)   n %(SE) n %(SE) 
a)Categorical variablesa 
              Age (years)                              30 or younger 266 14(0.8) 74 10(1.1) 
 
1759 32(0.5) 1886 31(0.9) 
 
254 20(2.3) 162 21(1.8) 
 
31-40 437 20(0.9) 178 21(1.4) 
 
1054 20(0.6) 1212 22(1.0) 
 
244 20(1.8) 157 22(1.8) 
 
41-50 820 33(1.0) 299 31(1.5) 
 
1268 23(0.6) 1288 22(0.6) 
 
352 29(1.8) 174 25(2.6) 
 
51-60 799 29(0.9) 342 32(1.5) 
 
957 18(0.7) 1011 17(0.5) 
 
278 24(2.5) 183 26(1.9) 
 
>60 122 4(0.4) 71 6(0.7) 
 
333 6(0.6) 466 8(0.3) 
 
82 6(2.1) 52 7(1.2) 
Marital status   Single 307 14(0.7) 86 10(1.0) 
 
1340 28(1.2) 1484 29(1.0) 
 
202 18(1.6) 125 20(2.2) 
 
Married 1463 61(1.0) 660 69(1.5) 
 
2458 49(2.7) 2949 52(3.0) 
 
650 57(3.1) 427 61(2.5) 
 
De facto 304 13(0.7) 114 13(1.1) 
 
966 13(2.6) 1070 13(3.0) 
 
212 13(2.0) 136 15(2.8) 
 
Separated 258 10(0.6) 73 7(0.8) 
 
527 9(1.5) 329 5(0.9) 
 
137 11(1.6) 36 4(0.8) 
 
Widowed  55 2(0.3) 6 1(0.2) 
 
75 1(0.3) 25 0(0.1) 
 
8 1(0.4) 3 0(0.3) 
Education  School level 537 22(0.8) 166 17(1.2) 
 
2051 38(1.7) 2098 35(1.0) 
 
264 22(1.7) 130 17(2.5) 
 
Advanced training 567 23(0.9) 291 30(1.5) 
 
1584 29(0.9) 2298 37(0.9) 
 
304 25(1.8) 256 35(2.8) 
 
University  1308 55(1.0) 495 53(1.6) 
 
1735 33(1.6) 1466 28(1.3) 
 
642 53(2.5) 342 48(4.0) 
Occupational type  Blue collar 425 18(0.8) 157 18(1.3) 
 
623 12(0.6) 2598 44(1.0) 
 
70 6(0.9) 142 20(3.6) 
 
White collar 634 27(0.9) 233 26(1.5) 
 
1936 36(0.7) 747 14(0.7) 
 
246 21(1.5) 82 13(2.1) 
 
Service 1036 44(1.0) 268 31(1.6) 
 
825 15(0.6) 341 5(0.5) 
 
194 17(1.7) 126 16(2.5) 
 
Professional 52 2(0.3) 57 7(0.8) 
 
1477 28(1.1) 1189 20(1.0) 
 
612 49(2.1) 291 40(2.2) 
 
Manager 219 9(0.6) 180 19(1.3) 
 
505 9(1.0) 979 16(0.9) 
 
86 7(1.0) 84 11(1.3) 
Employment category  Permanent 2256 92(0.6) 848 87(1.1) 
 
- - - - 
 
- - - - 
 
Fixed 188 8(0.6) 116 13(1.1) 
 
- - - - 
 
- - - - 
Employment condition  Full-time 1243 49(1.0) 814 83(1.3) 
 
2714 51(1.3) 4797 80(1.0) 
 
710 59(1.9) 643 87(3.1) 
 
Part-time/Casual 1201 51(1.0) 150 17(1.3) 
 
2657 49(1.3) 1066 20(1.0) 
 
500 41(1.9) 85 13(3.1) 
Annual salary ($AUD) <$40,000 155 6(0.5) 71 7(0.8) 
 
434 15(1.0) 684 16(1.2) 
 
20 3(0.7) 10 2(0.9) 
 
$40-<$60,000 886 37(1.0) 231 26(1.5) 
 
1164 40(1.2) 1210 27(1.2) 
 
312 36(1.7) 142 21(2.7) 
 
$60-<$80,000 1091 44(1.0) 411 42(1.6) 
 
646 23(1.5) 925 21(1.5) 
 
258 30(1.9) 186 30(3.8) 
 
$80-<$100,000 256 10(0.6) 172 17(1.2) 
 
344 13(1.0) 615 14(0.9) 
 
177 24(2.2) 165 26(2.6) 
 
$100-<$120,000 33 1(0.2) 25 2(0.5) 
 
95 4(0.6) 331 7(0.6) 
 
36 4(0.8) 68 11(3.2) 
 
$120+ 23 1(0.2) 54 6(0.7) 
 
133 4(0.5) 648 15(1.1) 
 
26 3(0.8) 74 11(1.9) 
Body mass index  
(BMI) (kg/m2) <25 1045 48(1.1) 336 37(1.6) 
 
2333 52(1.0) 1743 37(1.0) 
 
473 45(2.1) 197 29(2.0) 
 
25-29.9 661 30(1.0) 425 44(1.6) 
 
1218 27(0.9) 2080 42(1.1) 
 
319 31(2.3) 302 46(2.7) 
 
30-34.9 326 15(0.8) 130 14(1.1) 
 
599 13(0.9) 809 16(1.0) 
 
154 15(2.3) 115 18(2.3) 
 
35-39.9 118 5(0.5) 36 4(0.6) 
 
243 5(0.4) 193 4(0.4) 
 
68 6(1.0) 28 4(1.1) 
 
40+ 49 2(0.3) 13 1(0.4) 
 
138 3(0.5) 75 2(0.2) 
 
31 2(0.6) 13 2(0.7) 
Comorbidities  0 523 26(1.0) 268 33(1.6) 
 
- - - - 
 
- - - - 
 
1 528 25(1.0) 224 26(1.5) 
 
- - - - 
 
- - - - 
 
2 395 19(0.9) 156 18(1.3) 
 
- - - - 
 
- - - - 
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3+ 657 30(1.0) 202 23(1.4) 
 
- - - - 
 
- - - - 
Effort-Reward 
Imbalance (ERI)          Low 752 33(1.0) 317 34(1.6) 
 
- - - - 
 
- - - - 
 
Middle 787 33(1.0) 325 35(1.6) 
 
- - - - 
 
- - - - 
 
High 812 34(1.0) 291 31(1.5) 
 
- - - - 
 
- - - - 
Psychological distress 
(K10)       Low 1570 64(1.0) 673 70(1.5) 
 
3059 64(1.4) 3441 68(0.9) 
 
759 67(2.5) 487 72(3.1) 
 
Moderate 572 24(0.9) 183 20(1.3) 
 
1044 22(1.4) 1024 20(0.8) 
 
233 23(1.9) 129 21(3.0) 
 
High 194 8(0.6) 80 9(0.9) 
 
466 10(0.8) 405 8(0.5) 
 
86 8(1.7) 39 5(1.0) 
 
Very High 74 3(0.4) 16 2(0.4) 
 
170 3(0.6) 162 3(0.4) 
 
14 1(0.6) 12 2(0.5) 
Smoker Never 1598 66(1.0) 619 65(1.5) 
 
2769 60(2.4) 2602 54(1.7) 
 
657 62(3.1) 392 58(2.5) 
 
Ex-daily 614 25(0.9) 243 24(1.4) 
 
1170 24(0.8) 1337 25(0.8) 
 
297 26(1.8) 186 29(1.8) 
 
Current 223 9(0.6) 99 10(1.0) 
 
796 16(2.0) 1090 21(1.8) 
 
135 12(2.0) 89 13(1.3) 
PA (mins/week)c Low 145 6(0.5) 49 5(0.7) 
 
- - - - 
 
- - - - 
 
Moderate 1032 42(1.0) 365 38(1.6) 
 
- - - - 
 
- - - - 
 
High 1267 52(1.0) 549 57(1.6) 
 
- - - - 
 
- - - - 
Alcohol risk Low 1354 55(1.0) 471 49(1.6) 
 
- - - - 
 
- - - - 
 
High 1075 45(1.0) 488 51(1.6) 
 
- - - - 
 
- - - - 
Absenteeismd Zero days 1910 78(0.9) 775 80(1.3) 
 
4016 96(0.3) 4387 97(0.3) 
 
870 93(0.9) 547 93(1.2) 
 
Any day(s) 519 22(0.9) 185 20(1.3) 
 
163 4(0.3) 147 3(0.3) 
 
70 7(0.9) 40 7(1.2) 
b) Continuous variablesb                            
    n mean(SE) n mean(SE)   n mean(SE) n mean(SE)   n mean(SE) n mean(SE) 
Age (years)  2444 44.5(0.22) 964 45.7(0.35) 
 
5371 39.2(0.18) 5863 39.7(0.17) 
 
1210 42.9(1.16) 728 42.9(0.53) 
Annual salary ($AUD)  2444 62,765(403) 964 73,110(1,195) 
 
5371 39,843(815) 5863 58,926(1,343) 
 
1210 53,336(1,095) 728 74,719(1,608) 
BMI (kg/m2) 2199 26.4(0.12) 940 26.9(0.15) 
 
5371 20.7(0.57) 5863 21.3(0.39) 
 
1210 22.0(0.62) 728 24.1(0.87) 
Comorbidities (#)  2103 1.9(0.04) 850 1.6(0.06) 
 
- - - - 
 
- - - - 
ERI 2351 0.5(0.00) 933 0.4(0.01) 
 
- - - - 
 
- - - - 
K10 2410 15.4(0.11) 952 14.7(0.16)  5371 12.7(0.27) 5863 11.7(0.30)   1210 12.5(0.38) 728 12.2(0.58) 
a criteria used to test discriminate validity 
b criteria used to test construct validity 
c denotes Physical Activity, intensity and duration of physical activity during the previous seven days  
d number of days reported absent from work over a four week period 
"-" denotes variable is not available in HILDA 
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4.4.2 Health utility 
SF-6D ranged from 0.357 to 1 in pH@W and 0.392 to 1 in the Australian normative sample. 
Males had a higher mean health utility (0.792 (0.004), 0.792 (0.002), 0.801 (0.005)) than 
females (0.771 (0.003), 0.775 (0.003), 0.784 (0.004)) across pH@W, normative and 
normative subset samples respectively. Males recorded higher values than females across 
all categorical variables with the exception of females in pH@W whose salary was 
>$120,000 per annum. In our sample, higher health utility values were seen in employees 
with lower BMIs, low psychological distress (K10), low effort-reward imbalance, no 
comorbidities, who reported high physical activity, had the highest salary range, reported 
zero absenteeism days and were not current smokers. This was reflected in both genders. 
Health and socioeconomic variables in the normative samples followed trends for BMI, K10, 
salary range, smoking status and absenteeism (Table 4.2). 
Females in pH@W who attained a university-level education recorded a lower mean SF-6D 
(0.765 (0.003), n=1294) than females of school-level education (0.785 (0.006), n=525).The 
normative subset of public service was in agreement with this finding, 0.781 (0.010), n=585 
and 0.793 (0.010), n=224 respectively, for university-educated females and their school-
level counterparts. 
Older state service employees (age>60) in pH@W were found to have the highest health 
utility for all ages across all samples. The normative public service subset, in all other age 
categories, reported highest utility values. Age was inversely proportional to utility in the 
normative population samples; however this association was not seen in pH@W (Table 4.2). 
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Table 4.2 Mean SF-6D health utility by sample characteristics 
  
partneringHealthy@Work (N=3408) Australian normative sample (HILDA) 
        
All employed (N=11,234)   Public service (N=1938) 
  
Females(n=2444) Males (n=964) Females (n=5371) Males (n=5863)   Females (n=1210) Males (n=728) 
  n mean se n mean se n mean se n mean se   n mean se n mean se 
SF-6D health utility score 2409 0.771 0.003 944 0.792 0.004 4639 0.775 0.003 4955 0.792 0.002 
 
1073 0.784 0.004 657 0.801 0.005 
Age (years) 30 or younger 264 0.766 0.007 72 0.796 0.013 1456 0.786 0.005 1456 0.805 0.004 
 
213 0.796 0.011 135 0.826 0.019 
 
31-40 434 0.759 0.006 175 0.785 0.009 911 0.777 0.012 1008 0.793 0.005 
 
219 0.784 0.010 141 0.797 0.009 
 
41-50 813 0.773 0.004 296 0.792 0.007 1116 0.772 0.005 1122 0.785 0.006 
 
318 0.775 0.009 159 0.792 0.009 
 
51-60 780 0.776 0.005 334 0.787 0.007 843 0.763 0.008 920 0.784 0.004 
 
244 0.781 0.007 171 0.798 0.008 
 
>60 119 0.803 0.011 68 0.835 0.013 303 0.765 0.011 427 0.785 0.009 
 
76 0.794 0.014 49 0.789 0.027 
BMI (kg/m
2
) < 25 1035 0.782 0.004 330 0.806 0.006 2278 0.786 0.003 1710 0.797 0.004 
 
467 0.799 0.006 197 0.817 0.009 
 
25-29.9  653 0.776 0.005 417 0.792 0.006 1189 0.774 0.009 2036 0.797 0.004 
 
312 0.780 0.011 295 0.787 0.008 
 
30-34.9  323 0.753 0.007 127 0.769 0.012 579 0.764 0.006 788 0.785 0.005 
 
147 0.762 0.016 111 0.816 0.014 
 
35-39.9  116 0.739 0.011 36 0.742 0.018 236 0.740 0.012 183 0.750 0.013 
 
67 0.735 0.026 25 0.778 0.030 
 
40+  49 0.723 0.021 13 0.806 0.035 135 0.719 0.017 73 0.746 0.029 
 
31 0.772 0.030 13 0.783 0.029 
Comorbidities 0 519 0.819 0.005 264 0.825 0.006 - - - - - - 
 
- - - - - - 
 
1 526 0.800 0.005 219 0.817 0.008 - - - - - - 
 
- - - - - - 
 
2 393 0.775 0.006 153 0.782 0.010 - - - - - - 
 
- - - - - - 
 
3+ 647 0.715 0.005 197 0.735 0.009 - - - - - - 
 
- - - - - - 
Education School level 525 0.785 0.006 162 0.800 0.010 1756 0.778 0.003 1695 0.790 0.004 
 
224 0.793 0.01 111 0.802 0.012 
 
Advanced 
training 559 0.774 0.005 284 0.787 0.007 1350 0.768 0.009 1940 0.793 0.006 
 
261 0.781 0.02 226 0.805 0.013 
 
University 1294 0.765 0.003 487 0.792 0.005 1522 0.778 0.004 1297 0.795 0.005 
 
585 0.781 0.01 318 0.798 0.014 
Occupational type Blue collar 418 0.775 0.006 153 0.792 0.010 522 0.756 0.009 2113 0.789 0.003 
 
57 0.765 0.02 122 0.808 0.013 
 
White collar 626 0.767 0.005 227 0.786 0.008 1672 0.779 0.007 645 0.791 0.01 
 
214 0.776 0.02 77 0.786 0.018 
 
Service 1022 0.776 0.004 261 0.800 0.007 711 0.769 0.007 293 0.792 0.008 
 
163 0.786 0.01 113 0.809 0.011 
 
Professional 52 0.765 0.017 57 0.791 0.016 1289 0.781 0.003 1048 0.796 0.005 
 
552 0.788 0.01 266 0.792 0.012 
 
Manager 216 0.764 0.009 178 0.795 0.009 432 0.777 0.008 826 0.797 0.006 
 
82 0.788 0.01 74 0.833 0.01 
Employment category Permanent 2224 0.771 0.003 830 0.793 0.004 - - - - - - 
 
- - - - - - 
 
Fixed/casual 186 0.778 0.009 115 0.784 0.012 - - - - - - 
 
- - - - - - 
Employment condition Full time 1226 0.766 0.004 796 0.791 0.004 2319 0.778 0.004 4027 0.797 0.002 
 
623 0.781 0.01 582 0.804 0.005 
 
Part time 1184 0.777 0.004 149 0.794 0.011 2310 0.772 0.004 906 0.775 0.005 
 
447 0.787 0.01 73 0.778 0.018 
Salary range ($AUD) <$40,000 150 0.775 0.011 67 0.794 0.017 363 0.762 0.028 575 0.776 0.005 
 
17 0.812 0.05 9 0.755 0.066 
 
$40-<$60,000 873 0.775 0.004 226 0.794 0.008 1000 0.779 0.004 1016 0.785 0.006 
 
269 0.788 0.01 127 0.785 0.011 
 
$60-<$80,000 1078 0.768 0.004 403 0.788 0.006 566 0.779 0.007 791 0.794 0.006 
 
234 0.773 0.01 168 0.793 0.019 
 
$80-<$100,000 254 0.766 0.008 171 0.790 0.009 307 0.783 0.01 540 0.799 0.006 
 
160 0.779 0.01 150 0.813 0.012 
 
$100-<$120,000 33 0.782 0.019 25 0.810 0.018 81 0.770 0.021 296 0.821 0.009 
 
34 0.780 0.02 64 0.823 0.019 
 
$120+ 22 0.813 0.021 53 0.807 0.017 115 0.803 0.014 560 0.811 0.009 
 
24 0.810 0.02 69 0.802 0.023 
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Effort-reward Imbalance 
(ERI) Low 746 0.814 0.004 311 0.833 0.006 - - - - - - 
 
- - - - - - 
 
Middle 777 0.789 0.004 318 0.803 0.006 - - - - - - 
 
- - - - - - 
 
High 800 0.714 0.004 286 0.738 0.007 - - - - - - 
 
- - - - - - 
Psychological distress 
(K10) Low 1554 0.823 0.003 662 0.838 0.004 2984 0.819 0.002 3380 0.830 0.002 
 
747 0.820 0.01 480 0.827 0.007 
 
medium 562 0.704 0.004 178 0.716 0.007 1016 0.731 0.004 993 0.740 0.004 
 
227 0.734 0.01 126 0.758 0.017 
 
High 190 0.628 0.005 77 0.641 0.009 455 0.663 0.01 390 0.675 0.006 
 
82 0.654 0.02 37 0.660 0.028 
 
Very high 72 0.584 0.010 16 0.596 0.024 164 0.597 0.01 156 0.619 0.012 
 
14 0.582 0.03 11 0.606 0.031 
Smoker Never 1579 0.773 0.003 607 0.797 0.005 2704 0.782 0.003 2552 0.801 0.004 
 
649 0.792 0.01 384 0.809 0.006 
 
Ex-daily 604 0.776 0.005 237 0.789 0.008 1135 0.774 0.004 1304 0.787 0.005 
 
288 0.772 0.01 182 0.787 0.010 
 
Current 218 0.747 0.009 98 0.766 0.011 776 0.752 0.009 1057 0.780 0.005 
 
130 0.765 0.01 87 0.802 0.017 
PA (mins/week)
a
 Low 143 0.710 0.011 49 0.743 0.020 - - - - - - 
 
- - - - - - 
 
Moderate 1018 0.765 0.004 358 0.783 0.006 - - - - - - 
 
- - - - - - 
 
High 1249 0.784 0.003 538 0.802 0.005 - - - - - - 
 
- - - - - - 
Alcohol risk Low 1335 0.775 0.003 462 0.796 0.006 - - - - - - 
 
- - - - - - 
 
High 1060 0.767 0.004 478 0.788 0.005 - - - - - - 
 
- - - - - - 
Absenteeism
b
 Zero days 1885 0.788 0.003 761 0.804 0.004 3489 0.781 0.003 3714 0.795 0.002 
 
776 0.791 0 490 0.808 0.005 
  Any day(s) 510 0.713 0.006 180 0.742 0.009 146 0.727 0.015 127 0.748 0.012   62 0.743 0.02 39 0.75 0.023 
a
 denotes Physical Activity, intensity and duration of physical activity during the previous seven days  
b
 number of days reported absent from work over a four week period 
"-" denotes variable is not available in HILDA 
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4.4.3 Ceiling effect 
Within pH@W 56 respondents (1.76%) scored ‘perfect health’ (SF-6D value of 1). A 
proportion of employees reporting no limitations were seen in all six dimensions, with little 
gender difference. Ceiling effects occurred in Physical Functioning (84% female, 89% male), 
Social Functioning (62% female, 68% male), Bodily Pain (57% female, 59% male), and for 
males in Role Limitations (52%). Ceiling effects were also seen in the normative sample for 
Social Functioning (59% female, 67% male), Role Limitations (75% female, 81% males), and 
to a lesser extent in Physical Functioning (51% males) with similar proportions seen in the 
public service subset (Table 4.3). 
 
Table 4.3 Proportion of respondents (%) reporting no limitations in each of the six dimensions of 
the SF-6D, stratified by gender 
 
  partneringHealthy@Work (N=3,408)   Australian normative sample (HILDA) 
      
All employed (N=11,234) Public service (N=1,938) 
 
Females 
(n=2,444) 
Males 
(n=964) 
 
Females 
(n=5,371) 
Males 
(n=5,863) 
Females 
(n=1,210) 
Males 
(n=728) 
  n % n %   n % n % n % n % 
Physical 
functioning 2034 83.6 855 89.0 
 
2183 46.2 2573 51.1 444 40.8 332 49.9 
Role 
limitations 1120 46.2 493 51.5 
 
3527 74.6 4053 80.6 825 76.0 555 83.1 
Social 
functioning 1511 62.1 652 68.1 
 
2788 58.8 3346 66.5 670 61.4 479 71.9 
Bodily pain 1380 56.7 564 59.0   1404 29.6 1544 30.6 290 26.6 216 32.4 
Mental health 840 34.5 389 40.8 
 
863 18.4 1181 23.7 246 22.6 161 24.3 
Vitality 67 2.8 38 4.0 
 
143 4.2 264 7.2 29 3.7 19 3.9 
 
  
 
Chapter four: Validation of a preference-based measure of health in the employee 
population 
 
201 | P a g e  
 
4.4.4 Construct validity 
Pearson’s correlations demonstrated that SF-6D correlated inversely and most strongly with 
K10 across all survey samples. The strongest correlation with K10 was seen in pH@W (r= -
0.63, females; -0.66, males). ERI and comorbidity measures also showed inverse associations 
(ERI r= -0.37, r= -0.34 and comorbidity r= -0.40 and r= -0.33, females and males 
respectively). A negative association existed with BMI across all samples and strongest in 
females (r= -0.11). Age and salary were not correlated with health utility (Table 4.4). 
 
Table 4.4 Pearson’s rank correlations of SF-6D health utility with key factors attesting to construct 
validity 
 
partneringHealthy@Work  Australian normative sample (HILDA) 
 
(N=3408) 
 
All employed (N=11,234) Public service (N=1938) 
 
Females Males   Females Males Females Males  
n  1780 773 
 
4629 4933 1070 655 
SF-6D     1    1 
 
    1      1    1      1 
K10 -0.6332* -0.6585* 
 
-0.612* -0.598* -0.6141* -0.5836* 
Age (years) 0.0712* 0.0484 
 
-0.0674* -0.1065* -0.0575 -0.1254* 
BMI (kg/m
2
) -0.1105* -0.0918* 
 
-0.0703* -0.0508* -0.1096* -0.0683 
Annual salary 0.0045  0.0509 
 
0.0524* 0.1031* -0.0001 0.0674 
Comorbidities -0.3958* -0.3318* 
 
- - - - 
ERI -0.3695* -0.3427* 
 
- - - - 
Absenteeism
 a
 -0.2539* -0.2101*   -0.091* -0.0727* -0.1159* -0.1226* 
K10 refers to Kessler 10 Psychological Distress Scale 
BMI refers to Body Mass Index 
ERI refers to Effort-Reward Imbalance, used to assess job stress 
* p values are statistically significant (p<0.01) 
a
 Number of days reported absent from work over a four week period 
"-" Denotes variable is not available in HILDA 
 
Analysis showing how SF-6D differentiated between health, socioeconomic and work 
characteristics are presented in Table 4.5 (pH@W sample) and Table 4.6 (normative and 
subset sample). All results presented are adjusted findings. Common to all samples, higher 
health utility was associated with lower psychological distress (p<0.01) and lower 
absenteeism (p<0.05). As measured in pH@W, significant negative associations existed for 
comorbidities and ERI (p<0.01), and positive associations for physical activity (p<0.05). 
Females in pH@W who had higher educational attainment were more likely to report 
poorer health utility. An association between SF-6D and occupational type, employment 
condition, and salary was seen in the general employed, with higher occupational positions 
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(i.e. professionals and managers), full-time employment (in males), and higher salary (in 
both males and females) associated with higher SF-6D. Both males and females in the 
general normative sample showed a significant inverse association between SF-6D and age. 
Although higher BMI was associated with lower health utility, the association was significant 
only for females in the normative sample. Smoking status exhibited no significant 
association with SF-6D in any sample. 
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Table 4.5 Relationship of health, socioeconomic and work characteristics with health utility in partneringHealthy@Work Tasmanian public service 
employees (N=3,408) 
  
Unadjusted Adjusted
a
 
    Females Males Females Males 
Variable 
 
n β CI n β CI β CI β CI 
Age (years) 30 or younger 264 ref 
 
72 ref 
 
ref 
 
ref 
 
 
31-40 434 -0.008 ( -0.03, 0.01) 175 -0.010 ( -0.04, 0.02) 0.004 ( -0.01, 0.02) -0.021 ( -0.05, 0.01) 
 
41-50 813 0.007 ( -0.01, 0.02) 296 0.000 ( -0.03, 0.03) 0.001 ( -0.01, 0.02) -0.012 ( -0.04, 0.01) 
 
51-60 780 0.009 ( -0.01, 0.03) 334 -0.010 ( -0.04, 0.02) 0.002 ( -0.01, 0.02) -0.026 ( -0.05, 0.00) 
 
>60 119 0.037 ( 0.01, 0.06) 68 0.040 ( 0.00, 0.08) 0.009 ( -0.01, 0.03) -0.001 ( -0.03, 0.03) 
 
p 
 
p<0.05* 
  
0.305 
 
0.460 
 
0.960 
 
BMI (kg/m
2
) < 25 1035 ref 
 
330 ref 
 
ref 
 
ref 
 
 
25-29.9  653 -0.006 ( -0.02, 0.01) 417 -0.010 ( -0.03, 0.00) -0.003 ( -0.01, 0.01) 0.007 ( -0.01, 0.02) 
 
30-34.9  323 -0.030 ( -0.05, -0.01) 127 -0.040 ( -0.06, -0.01) -0.006 ( -0.02, 0.01) -0.004 ( -0.03, 0.02) 
 
35-39.9 116 -0.044 ( -0.07, -0.02) 36 -0.060 ( -0.10, -0.03) -0.011 ( -0.03, 0.01) -0.016 ( -0.05, 0.02) 
 
40+  49 -0.060 ( -0.10, -0.02) 13 0.000 ( -0.07, 0.07) 0.013 ( -0.02, 0.04) 0.022 ( -0.03, 0.07) 
 
p 
 
p<0.05* 
  
p<0.05* 
 
0.381 
 
0.392 
 
Comorbidities 0 519 ref 
 
264 ref 
 
ref 
 
ref 
 
 
1 526 -0.020 ( -0.03, -0.01) 219 -0.010 ( -0.03, 0.01) -0.011 ( -0.02, 0.00) -0.013 ( -0.03, 0.00) 
 
2 393 -0.045 ( -0.06, -0.03) 153 -0.040 ( -0.07, -0.02) -0.022 ( -0.03, -0.01) -0.012 ( -0.03, 0.01) 
 
3+ 647 -0.105 ( -0.12, -0.09) 197 -0.090 ( -0.11, -0.07) -0.052 ( -0.07, -0.04) -0.033 ( -0.05, -0.02) 
 
p 
 
p<0.05* 
  
p<0.05* 
 
p<0.05* 
 
p<0.05* 
 
Education School level 525 ref 
 
162 ref 
 
ref 
 
ref 
 
 
Advanced training 559 -0.012 ( -0.03, 0.00) 284 -0.010 ( -0.04, 0.01) -0.005 ( -0.02, 0.01) -0.008 ( -0.03, 0.01) 
 
University 1294 -0.020 ( -0.03, -0.01) 487 -0.010 ( -0.03, 0.02) -0.015 ( -0.03, 0.00) -0.004 ( -0.02, 0.01) 
 
p 
 
p<0.05* 
  
0.699 
 
p<0.05 
 
0.684 
 
Occupational type Blue collar 418 ref 
 
153 ref 
 
ref 
 
ref 
 
 
White collar 626 -0.007 ( -0.02, 0.01) 227 -0.010 ( -0.03, 0.02) -0.004 ( -0.02, 0.01) 0.001 ( -0.02, 0.02) 
 
Service 1022 0.002 ( -0.01, 0.02) 261 0.010 ( -0.02, 0.03) 0.013 ( 0.00, 0.03) 0.009 ( -0.01, 0.03) 
 
Professional 52 -0.010 ( -0.05, 0.03) 57 0.000 ( -0.04, 0.04) 0.023 ( -0.01, 0.06) 0.010 ( -0.02, 0.04) 
 
Manager 216 -0.011 ( -0.03, 0.01) 178 0.000 ( -0.02, 0.03) 0.005 ( -0.02, 0.03) -0.001 ( -0.03, 0.02) 
 
p 
 
0.691 
  
0.577 
 
0.225 
 
0.886 
 
Employment category Permanent 2224 ref 
 
830 ref 
 
ref 
 
ref 
 
 
Fixed/casual 186 0.007 ( -0.01, 0.03) 115 -0.009 ( -0.03, 0.02) 0.013 ( 0.00, 0.03) -0.001 ( -0.02, 0.02) 
 
p 
 
0.453 
  
0.454 
 
0.104 
 
0.908 
 
Employment condition Full time 1226 ref 
 
796 ref 
 
ref 
 
ref 
 
 
Part time 1184 0.011 ( 0.00, 0.02) 149 0.003 ( -0.02, 0.03) 0.000 ( -0.01, 0.01) 0.006 ( -0.01, 0.02) 
 
p 
 
p<0.05 
  
0.810 
 
0.910 
 
0.549 
 
Salary range <$40,000 150 ref 
 
67 ref 
 
ref 
 
ref 
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$40-<$60,000 873 0.000 ( -0.02, 0.02) 226 0.000 ( -0.04, 0.04) 0.006 ( -0.02, 0.03) 0.005 ( -0.02, 0.04) 
$60-<$80,000 1078 -0.007 ( -0.03, 0.02) 403 -0.006 ( -0.04, 0.03) 0.011 ( -0.01, 0.04) 0.000 ( -0.03, 0.03) 
$80-<$100,000 254 -0.008 ( -0.04, 0.02) 171 -0.005 ( -0.04, 0.03) 0.008 ( -0.02, 0.04) -0.007 ( -0.04, 0.03) 
$100-<$120,000 33 0.007 ( -0.04, 0.05) 25 0.015 ( -0.03, 0.06) 0.030 ( -0.02, 0.08) 0.000 ( -0.05, 0.05) 
$120+ 22 0.038 ( -0.01, 0.08) 53 0.013 ( -0.03, 0.06) 0.021 ( -0.03, 0.07) 0.020 ( -0.02, 0.06) 
p 0.714 0.651 0.298 0.671
Effort-Reward 
Imbalance (ERI) 
Low 746 ref 311 ref ref ref 
Middle 777 -0.025 ( -0.04, -0.01) 318 -0.030 ( -0.05, -0.01) -0.015 ( -0.03, -0.01) -0.016 ( -0.03, 0.00) 
High 800 -0.100 ( -0.11, -0.09) 286 -0.095 ( -0.11, -0.08) -0.038 ( -0.05, -0.03) -0.040 ( -0.06, -0.02) 
p p<0.05* p<0.05* p<0.05* p<0.05* 
Psychological distress 
(K10) 
Low 1554 ref 662 ref ref ref 
medium 562 -0.120 ( -0.13, -0.11) 178 -0.122 ( -0.14, -0.11) -0.098 ( -0.11, -0.09) -0.109 ( -0.13, -0.09) 
High 190 -0.196 ( -0.21, -0.19) 77 -0.196 ( -0.22, -0.18) -0.164 ( -0.18, -0.15) -0.175 ( -0.20, -0.15) 
Very high 72 -0.240 ( -0.26, -0.22) 16 -0.241 ( -0.29, -0.19) -0.192 ( -0.21, -0.17) -0.208 ( -0.28, -0.14) 
p p<0.05* p<0.05* p<0.05* p<0.05* 
Smoker Never 1579 ref 607 ref ref ref 
Ex-daily 604 0.002 ( -0.01, 0.01) 237 -0.008 ( -0.03, 0.01) 0.000 ( -0.01, 0.01) 0.010 ( -0.01, 0.03) 
Current 218 -0.026 ( -0.04, -0.01) 98 -0.031 ( -0.06, -0.01) -0.009 ( -0.02, 0.01) -0.017 ( -0.04, 0.01) 
 
p p<0.05 p<0.05 0.253 0.169
PA (mins/week)
b
Low 143 ref 49 ref ref ref
Moderate 1018 0.055 ( 0.03, 0.08) 358 0.039 ( 0.00, 0.08) 0.024 ( 0.00, 0.04) 0.025 ( -0.01, 0.06) 
High 1249 0.074 ( 0.05, 0.10) 538 0.059 ( 0.02, 0.10) 0.037 ( 0.02, 0.06) 0.031 ( 0.00, 0.06) 
p p<0.05* p<0.05* p<0.05* 0.062
Alcohol risk Low 1335 ref 462 ref ref ref
High 1060 -0.008 ( -0.02, 0.00) 478 -0.008 ( -0.02, 0.01) 0.006 ( 0.00, 0.01) -0.003 ( -0.02, 0.01) 
 
p 0.112 0.330 0.180 0.655
Absenteeism
c
Zero days 1885 ref 761 ref ref ref
Any day(s) 510 -0.075 ( -0.09, -0.06) 180 -0.063 ( -0.08, -0.04) -0.025 ( -0.04, -0.01) -0.027 ( -0.05, -0.01) 
p p<0.05* p<0.05* p<0.05* p<0.05* 
p denotes linear trend, bold p values are statistically significant (p<0.05) 
* p values are statistically significant (p<0.01)
a 
Adjusted for age, BMI, comorbidities, education, employment condition, ERI,  K10,  smoking status, physical activity, absenteeism
b
denotes Physical Activity, intensity and duration of physical activity during the previous seven days
c
number of days reported absent from work over a four week period
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Table 4.6 Relationship of health, socioeconomic and work characteristics with health utility in employees and the public service subset of the Household 
Income and Labour Dynamics of Australia survey (HILDA)a 
  
All employed (N=11,234) Public service (N=1,938) 
 
 Females Males Females Males 
    n β CI n β CI n β CI n β CI 
Age (years) *30 or younger 1759 Ref 
 
1886 Ref 
 
254 Ref 
 
162 Ref 
 
 
31-40 1054 -0.008 ( -0.02, 0.004) 1212 -0.020 ( -0.036, -0.004) 244 0.005 ( -0.019, 0.028) 157 -0.028 ( -0.062, 0.006)
 
41-50 1268 -0.015 ( -0.031, 0) 1288 -0.032 ( -0.046, -0.018) 352 -0.009 ( -0.034, 0.016) 174 -0.049 ( -0.08, -0.018) 
 
51-60 957 -0.030 ( -0.043, -0.017) 1011 -0.039 ( -0.053, -0.024) 278 -0.009 ( -0.033, 0.014) 183 -0.039 ( -0.072, -0.007) 
 
>60 333 -0.034 ( -0.055, -0.012) 466 -0.041 ( -0.058, -0.024) 82 -0.015 ( -0.038, 0.008) 52 -0.069 ( -0.116, -0.022) 
 
p 
 
p<0.05* 
  
p<0.05* 
  
0.202 
  
p<0.05* 
 BMI (kg/m
2
) < 25 2333 Ref 
 
1743 Ref 
 
473 Ref 
 
197 Ref 
 
 
25-29.9  1218 -0.009 ( -0.021, 0.003) 2080 -0.008 ( -0.017, 0) 319 -0.001 ( -0.021, 0.019) 302 -0.014 ( -0.037, 0.008)
 
30-34.9  599 -0.024 ( -0.038, -0.01) 809 -0.006 ( -0.015, 0.003) 154 -0.031 ( -0.056, -0.007) 115 0.002 ( -0.022, 0.026) 
 
35-39.9  243 -0.032 ( -0.056, -0.008) 193 -0.030 ( -0.05, -0.01) 68 -0.017 ( -0.049, 0.015) 28 -0.019 ( -0.066, 0.028) 
 
40+  138 -0.045 ( -0.074, -0.015) 75 -0.028 ( -0.058, 0.002) 31 0.003 ( -0.042, 0.048) 13 -0.029 ( -0.082, 0.025) 
 
p 
 
p<0.05* 
  
0.067 
  
0.887 
  
0.289 
 Education School level 2051 Ref 
 
2098 Ref 
 
264 Ref 
 
130 Ref 
 
 
Advanced training 1991 0.002 ( -0.012, 0.016) 2601 0.004 ( -0.005, 0.013) 472 0.011 ( -0.015, 0.036) 342 0.006 ( -0.019, 0.031)
 
University 1328 -0.005 ( -0.022, 0.011) 1163 0.005 ( -0.009, 0.018) 474 0.004 ( -0.026, 0.034) 256 0.000 ( -0.027, 0.028) 
 
p 
 
0.521 
  
0.445 
  
0.988 
  
0.928 
 Occupational type Blue collar 623 Ref 
 
2598 Ref 
 
70 Ref 
 
142 Ref 
 
 
White collar 1936 -0.002 ( -0.023, 0.018) 747 0.015 ( 0.003, 0.026) 246 -0.003 ( -0.054, 0.049) 82 -0.010 ( -0.044, 0.024)
 
Service 825 0.004 ( -0.02, 0.029) 341 0.007 ( -0.012, 0.026) 194 -0.007 ( -0.065, 0.052) 126 -0.009 ( -0.041, 0.024) 
 
Professional 1477 -0.004 ( -0.022, 0.014) 1189 0.002 ( -0.008, 0.013) 612 -0.011 ( -0.057, 0.036) 291 -0.016 ( -0.045, 0.012) 
 
Manager 505 -0.020 ( -0.044, 0.004) 979 0.015 ( 0.005, 0.024) 86 -0.022 ( -0.074, 0.03) 84 0.008 ( -0.023, 0.04) 
 
p 
 
0.096 
  
p<0.05* 
  
0.396 
  
0.597 
 Employment condition Full time 2714 Ref 
 
4797 Ref 
 
710 Ref 
 
643 Ref 
 
 
Part time 2657 -0.009 ( -0.019, 0.001) 1066 -0.020 ( -0.037, -0.003) 500 -0.003 ( -0.025, 0.018) 85 -0.024 ( -0.1, 0.053)
 
p 
 
0.067 
  
p<0.05 
  
0.754 
  
0.537 
 Salary range <$40,000 434 Ref 
 
684 Ref 
 
20 Ref 
 
10 Ref 
 
 
$40-<$60,000 1164 0.017 ( -0.003, 0.037) 1210 0.007 ( -0.006, 0.019) 312 -0.036 ( -0.091, 0.019) 142 -0.047 ( -0.179, 0.086)
 
$60-<$80,000 646 0.017 ( -0.006, 0.04) 925 0.009 ( -0.002, 0.019) 258 -0.037 ( -0.1, 0.026) 186 -0.034 ( -0.162, 0.094) 
 
$80-<$100,000 344 0.024 ( -0.005, 0.052) 615 0.008 ( -0.008, 0.024) 177 -0.029 ( -0.095, 0.036) 165 -0.025 ( -0.151, 0.101) 
 
$100-<$120,000 95 0.027 ( -0.011, 0.065) 331 0.023 ( 0.008, 0.039) 36 -0.046 ( -0.111, 0.02) 68 -0.036 ( -0.175, 0.103) 
 
$120+ 108 0.029 ( 0.004, 0.055) 564 0.022 ( 0.009, 0.035) 26 -0.025 ( -0.088, 0.039) 74 -0.024 ( -0.154, 0.106) 
 
p 
 
p<0.05 
  
p<0.05* 
  
0.442 
  
0.706 
 Psychological distress 
(K10) Low 3059 Ref 
 
3441 Ref 
 
759 Ref 
 
487 Ref 
 
  
 
2
0
6
 | P
a
g
e
 
 
Medium 1044 -0.088 ( -0.099, -0.076) 1024 -0.086 ( -0.098, -0.075) 233 -0.094 ( -0.116, -0.071) 129 -0.074 ( -0.102, -0.046) 
 
High 466 -0.145 ( -0.167, -0.124) 405 -0.161 ( -0.178, -0.144) 86 -0.140 ( -0.184, -0.097) 39 -0.164 ( -0.219, -0.109) 
 
Very high 170 -0.217 ( -0.259, -0.176) 162 -0.194 ( -0.228, -0.16) 14 -0.208 ( -0.238, -0.178) 12 -0.213 ( -0.282, -0.144) 
 
p 
 
p<0.05* 
  
p<0.05* 
  
p<0.05* 
  
p<0.05* 
 Smoking Never 2769 Ref 
 
2602 Ref 
 
657 Ref 
 
392 Ref 
 
 
Ex-daily 1170 0.000 ( -0.009, 0.01) 1337 -0.004 ( -0.013, 0.004) 297 -0.004 ( -0.022, 0.015) 186 -0.015 ( -0.037, 0.006)
 
Current 796 -0.005 ( -0.02, 0.009) 1090 -0.007 ( -0.018, 0.003) 135 0.000 ( -0.027, 0.028) 89 0.004 ( -0.024, 0.033) 
 
p 
 
0.466 
  
0.168 
  
0.992 
  
0.759 
 Absenteeism
b
 No days 4016 Ref 
 
4387 Ref 
 
870 Ref 
 
547 Ref 
 
 
Any days 163 -0.042 ( -0.067, -0.017) 147 -0.027 ( -0.048, -0.006) 70 -0.048 ( -0.078, -0.018) 40 -0.014 ( -0.051, 0.023)
 p   p<0.05*     p<0.05     p<0.05*     0.443   
p denotes linear trend, bold p values are statistically significant (p<0.05) 
* p values are statistically significant (p<0.01) 
a
Model presented is adjusted for age, BMI, employment condition, occupation type, K10, salary, smoking status, absenteeism 
b
Number of days reported absent from work over a four week period 
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4.5 Discussion 
The present study examined the construct validity of SF-6D in a population of state service 
employees (pH@W), and compared findings with an Australian normative employed sample 
and public service subset. For both males and females, psychological distress (K10), 
comorbidity and job stress (ERI) had the strongest negative association with health utility. 
The normative sample also demonstrated significant negative associations between SF-6D 
and K10 in addition to age and BMI (in female workers). Additionally, the normative general 
employed showed a significant positive association with salary, which was not reflected in 
state or public service employees. 
We found mean health utility differed by gender and was higher in males than females 
across all samples. The existence of gender difference is consistent with prior 
research.8,15,35,44 Overall mean health utility was higher than the equivalent Australian 
population norms derived from SF-36.8 Considerable evidence in the occupational literature 
demonstrates those in the workforce, more than the general population, experience higher 
health functionality by the very nature of being able to work, or indeed as a result of 
working, a phenomenon known as the healthy worker effect45,46 This effect could explain the 
lack of association with age in pH@W with workers over age 60 showing relatively 
favourable health utilities possibly due to early retirement for those in poorer health or 
study selection bias not replicated in the normative samples. Although our overall mean 
values are lower than another Australian population norm study35 where authors derived 
health utility using another MAUI known as Australian Quality of Life (AQoL), it has been 
shown that different instruments produce different utility values.47  
Results demonstrated that females who had a university level education experienced a 
significantly poorer health state than their school-level counterparts. This finding was not 
supported in the normative working sample or literature and could indicate either a real 
effect specific to this population, selection bias or confounding due to factors not measured 
in pH@W.  
Psychological distress, job stress and existing medical conditions more so than health factors 
(physical inactivity, high alcohol risk and smoking) negatively impacted employee health 
utility. The high correlation with psychological distress (-0.66; -0.63 males: females) may 
indicate there is significantly greater impairment due to employee mental health issues, 
which aligns with findings from a study of HRQoL that showed mental more than physical 
health has greater impact.48 In a recent Delphi–procedure undertaken to identify core 
domains of health utility scales, mental and social domains were considered more essential 
than physical domains.49 Previous studies investigating work stress using the ERI measure 
confirm high job stress has a negative relationship with employee health.21,50,51 Moreover, a 
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recent study of male automotive assembly workers found working conditions (job demand, 
job control and social support) increased self-perceived stress and decreased self-perceived 
quality of life.52 In summary, our findings suggest employee psychological distress and 
perception of job stress are important correlates of employee health utility, and 
occupational studies could include SF-6D as an outcome to investigate causality. 
Appropriateness of SF-6D use was considered by examining ceiling effects, first, by 
investigating respondent proportions clustered at “no limitations” within dimensions, and 
second, by overall percentage who reported a value of 1 (perfect health). Our evidence 
demonstrated high proportions in four of six dimensions, a finding congruent with the 
functioning productive nature of the employed, as opposed to SF-6D’s inability to detect 
health state variability. Overall, 1.76% of pH@W respondents scored “perfect health”. This 
indicated SF-6D does not over predict better health states nor suffer from a ceiling effect in 
this occupational sample. It is known that clustering at ‘no limitations” occurs in these types 
of measures; however, published articles focusing on other populations demonstrate that 
SF-6D suffers less from a ceiling effect than the EQ-5D.10,17,18 Therefore, although EQ-5D 
tends to dominate in economic evaluations (66% over other MAUIs12) SF-6D may play a 
more important role for evaluating respondents in generally healthy populations like the 
workforce.  
There are limitations to our study. First, the lack of an additional health utility measure 
alongside SF-6D in the pH@W questionnaire impeded further analyses of validity. Thus 
important questions concerning whether utility values for SF-6D would be lower or higher 
than AQoL values when measured in an employee population (as the normative AQoL study 
demonstrated higher values 35) cannot be answered. The extent to which this would add 
validity is questionable considering a recent finding relating to the comparison of utility 
values across MAUIs has indicated a dissimilar distribution and difference in mean scores 
between results.18,47 Second, the low response rate (24.8%) could have affected 
generalisability of the overall results and to other working populations. In the attempt to 
minimise this implication propensity weighting for non-response was utilised, the work 
undertaken across pH@W state sector was considered diverse, and we demonstrated our 
findings were translatable to other business sectors by external validation of a working 
population normative sample. Finally, no attempt was made to infer causation, missing data 
from survey participants was low (<3%), and every effort was made to use well-validated 
measures in the survey design to ensure highest possible data quality and accuracy of 
results. 
Strength was in our ability to accurately examine health utility against a comparable 4 week 
recall of absenteeism. The significant association found between SF-6D and absenteeism 
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across all samples warrants particular attention. The possible predictive nature of SF-6D on 
workplace performance indicators will be of paramount importance if in fact SF-6D is found 
to be a proxy measure for indirect costs of productivity loss in the workplace. 
Our study provides insight into the validity of SF-6D as a measure of health utility in the 
Tasmanian state service employees. We demonstrated that the derived preference-based 
SF-6D health utility offered a level of interpretation and discrimination through expected 
correlations with socioeconomic, work factors and health status in a population of 
employees, in addition to external validation from a normative working population sample.  
Due to its capability and in recognition that the SF-6D has shown sensitivity to change in 
clinical settings,53,54 and is more sensitive to detecting small changes in relatively healthy 
individuals,19,35 we suggest SF-6D is a valid instrument for measuring employee health 
changes resulting from workplace health promotion programs. Fundamentally, SF-6D offers 
capability to place value on employee health outcomes in economic evaluations of 
workplace health interventions. 
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4.7 Summary 
Health utility values permit cost utility analysis in workplace health promotion however 
utility measures of working populations have not been validated. 
Purpose: To investigate construct validity of SF-6D health utility in a public sector state 
service workforce. 
Methods: SF-12v2 Health Survey was administered to 3408 randomly selected public service 
employees in Australia in 2010. SF-12 scores were converted to SF-6D health utility values. 
Associations and correlates of SF-6D with health, socio-demographic and work 
characteristics [co-morbidities, body mass index (BMI), Kessler-10 psychological distress 
(K10), education, salary, effort-reward imbalance (ERI), and absenteeism] were explored. 
Ceiling effects were analysed. Nationally representative employee SF-6D values from the 
Household, Income and Labour Dynamics in Australia (HILDA) survey (n=11234) were 
compared. All analyses were stratified by sex.  
Results: Mean (SE) age was 45.7 (0.35) males; 44.5 (0.22) females. Females represented 72% 
of the sample. Mean (SE) health utility 0.792 (0.004); 0.771 (0.003) was higher in males. SF-
6D demonstrated both a significant inverse association (p<0.01) and negative correlations 
(female; male) with K10 (r= -0.63; r= -0.66), comorbidity count (r= -0.40; r= -0.33), ERI (r= -
0.37; r= -0.34) and absenteeism (p<0.005, r= -0.25; r= -0.21). Mean (SE) SF-6D in HILDA was 
0.792 (0.002); 0.775 (0.003) males; females. Correlates and associations in all samples were 
similar. The general employed demonstrated a significant inverse association with age and 
positive association with salary. SF-6D was independent of BMI. 
Conclusions:  Psychological distress, comorbidity, effort-reward imbalance and absenteeism 
are negatively associated with employee health. SF-6D is a valid measure of perceived health 
states in working populations. 
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4.8 Postscript 
This analysis met the identified need for broader measures of health to be available for 
economic evaluations in WHP. It demonstrated the construct validity of a measure of health 
utility (SF-6D) in the employee population. SF-6D health utility is a single index of health 
status. It reflects people’s preference for different health states using preference scores 
based on community-derived weights. The analysis found worker SF-6D health utility values 
appropriately measured across gender and appropriately discriminated between health 
factors (comorbidity, body mass index, psychological distress, age), socioeconomic factors 
(salary, in populations within private enterprise), and work characteristics (job stress, 
absenteeism, employment condition and occupational type). Furthermore SF-6D did not 
demonstrate a ceiling effect in the working population.  
This result can support better economic methodology in workplace health promotion 
through provision of a valid measure of health status that is sensitive in a generally healthy 
population and that is amenable to economic evaluations. Specifically, this analysis assists to 
define employee health so that impacts on health can be assessed, provides a measure that 
places value on health, and offers a valuation option for those who may wish to align 
workplace health promotion intervention evaluations with policy guidelines and the 
presentation of quality adjusted life years.  
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5 Chapter five: Evaluating the health and economic impact of a 
workplace health promotion program in the public sector state 
service: results from the Healthy@Work Project 
 
5.1 Preface 
Conducting the economic evaluation of Healthy@Work (H@W) represents a pivotal task in 
this thesis as well as for the partneringH@W partners, who wish to know whether H@W 
provided value for money. The following analysis takes into account lessons from the 
previous Chapters and provides a worked example addressing my thesis aim: to investigate 
the application of health economics to evaluate workplace health promotion. 
Thus, the investigation within Chapter 5 follows health economic methodological 
guidelines,1 and includes health utility alongside productivity outcomes to ensure health is 
identified, measured and valued in the economic evaluation. Furthermore, it takes into 
consideration the organisational approach of the H@W project and the value placed by 
H@W decision makers on improving organisational capacity for health promotion within the 
Tasmanian State Service. In so doing, this investigation aims to be at the evaluative forefront 
in WHP and the current literary vision: an evaluation that reflects the ecological nature of 
WHP by incorporating both individual-level and organisational measures simultaneously.2 
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5.2  Introduction 
There is little debate that workplace health promotion (WHP) has value, as it is increasingly 
recognised in health policies around the world as a strategy for disease prevention.3-9 Of 
greater contention is whether it provides value for money; whether the social, health and 
economic benefits arising from workplace health promotion exceed, equal, or are worth the 
costs. The state of the evidence that is available to inform such decisions has suffered from 
health economic methodological inconsistencies and measurement limitations.10,11 Refer to 
the Chapter 2 systematic review. 
In order to improve the evidence, it is important for economic evaluations to identify, 
measure and value outcomes that reflect the complexities and comprehensiveness of 
workplace health interventions. Defined as “the combined efforts of employers, employees 
and society to improve the health and well-being of people at work,” p 2 12 WHP intrinsically 
involves individual, social, cultural and political processes, as well as actions that “help build 
the capacity of individuals, communities, organizations and governments” p12. 13 
Incorporating an organisational approach to WHP epitomises the growing interest in this 
broader multi-layered focus.14 Indeed, in 2006 ‘capacity building’ was added to the WHO 
health promotion glossary,15 emphasising effective health promotion involved advancing 
knowledge and skills, expanding support and infrastructure and developing cohesiveness 
and partnerships. Building capacity means improving organisational capabilities; 
commitment, structures, systems, and leadership.15 Currently WHP best practice 
encourages building organisational capacity for health promotion in workforces.5,16-28 
However, no single set of characteristics or scientific evidence validating measurement of 
organisational supports exist. Despite this, interventions implementing an organisational 
approach are emergent and proposed “value” in WHP may originate from participatory, 
multidisciplinary or integrative initiatives. Consequently, economic evaluations should 
consider incorporating organisational capacity as a measure of efficiencies in resource use 
to better reflect WHP comprehensiveness.  
Decisions as to whose values to consider, what impacts to analyse and what form of 
economic analysis to use are central to economic enquiry.29 In WHP undertaking a cost-
benefit analysis and reporting a return on investment (ROI) has been the predominant 
form.10 However the ROI metric has come under recent scrutiny as the sole measure of 
value.16 Cited inadequacies include its implied certainty and the presumption that a 
program has failed if it doesn’t produce a positive ROI. Fundamentally, ‘value’ must be 
defined by the decision maker whose resources are given up and value for money 
conditional on a value threshold that may reflect budget constraints, best alternative use of 
funding or other decision maker considerations such as their specific goals and guidelines.30  
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An intervention would be considered cost-effective when it costs less than the chosen 
threshold value.30,31 Cost-effectiveness analysis (CEA) has long been considered the gold 
standard decision analytic tool for health technology assessment.30-34 It offers technical 
advantage when evaluating uncertainty and does not require outcomes to be monetized, 
rather pertains to the decision rule that an intervention is worthwhile if its cost-
effectiveness ratio is less than the maximum willingness to pay (the threshold value). 
Additionally, the recently developed Value on Investment (VOI) framework for employee 
health management incorporates CEA conventions.16  The overarching goal for evaluators is 
to offer a more complete picture of economic value; one that is transparent and one that 
captures unbiased evidence of importance to inform employer or policy maker decisions.  
We present a health economic evaluation of a four year WHP project guided by these 
principles and cognisant of the challenges. The project, Healthy@Work (H@W), was 
implemented to the public sector state service population of Tasmania, Australia. It was 
coordinated and policy driven by the Tasmanian State Service (TSS) Management Office 
(employer and decision maker). An Art of Hosting Action Conversation,35,36 a diverse 
discussion to develop and synthesise ideas, was convened between employer and 
evaluators in 2011 to inform the ‘value for money’ proposition which outlined the outcomes 
of value to the employer. These included measures of organisational change, worker 
impacts (productivity and employee health and wellbeing) and community reach, with an 
overarching H@W goal to instil health-promoting culture. To provide the decision maker 
with evidence to assess if their investment was good value for money our stated research 
question was: “What were the costs and benefits of the Healthy@Work Project (H@W) 
(2008-2012) on Tasmanian State Service employee productivity, health status, and 
healthcare utilisation for agencies of high organisational capacity (a strong capability to 
improve the health and wellbeing of their employees), compared to agencies with ‘low’ 
organisational capability, from the State Service Management Office (employer’s) 
perspective?”  
5.3 Methods 
The current standard for writing up an economic evaluation has been followed by using the   
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. 1 
CHEERS has been adopted in order to guide evaluation content, assist evidence reporting 
and improve transparency. 
5.4 Design 
This prospective health economic evaluation was conducted alongside an observational 
study of Healthy@Work (H@W). H@W was rolled out simultaneously across the entire 
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organisation with no staging or control group and represented a real world application of 
workplace health promotion. The H@W vision was: Well developed and effective workplace 
health and wellbeing programs integrated within each Tasmanian Government agency. 
H@W was based on a consistent model (Figure 5.1) with the purpose for Government ’to 
increase the efficiency and productivity throughout the Tasmanian State Service through a 
State Service culture that values, supports and improves the health and wellbeing of 
employees.’ Given the observational design and multiple measures of importance for the 
decision maker, a cost consequence analysis was presented, listing all costs and benefits 
that arose. Additionally, a cost-benefit and cost-effectiveness comparative analysis of costs 
and benefits between agencies of high versus low organisational capacity was performed to 
provide evidence on value for money in building organisational capacity for health 
promotion across all agencies, an outcome valued by the decision makers. Incremental net 
monetary benefit statistic was used to ascertain measure of uncertainty. The study was 
approved by the Tasmanian Health & Medical Human Research Ethics Committee: 
H0010501. 
5.4.1 Study perspective 
Costs of implementing H@W were derived from an employer perspective, represented by 
an Australian state government organisation. Costs included direct non-medical costs; 
program costs (resource development and implementation, infrastructure, operational 
expenditures, and staffing costs including salary, travel, supplies, and internal training); and 
cost-offsets (benefits) related to indirect/productivity loss costs (employee absenteeism and 
presenteeism), direct medical costs covered by the state government (employee hospital 
utilisation: admissions and overnight stays), and employee health utility. The state 
government as employer was a unique perspective that allowed for direct medical costs 
covered by the state government (not routinely borne by an Australian employer) to be 
incorporated. 
   
 
Healthy@Work model for the development of 
workplace health and wellbeing programs 
Key principles ‡ Implementation cycle* 
State Service Health and Wellbeing Policy and 
associated guidelines (Ministerial Direction 23) 
Healthy@Work Strategic Plan 
Vision - Each agency has a workplace health and wellbeing 
program. 
Networking and 
professional-
development 
opportunities for key 
agency staff. 
Healthy@Work 
coordinated activities 
Support for 
agency specific 
activities. 
Advocacy – leaders and 
employees 
Research and 
evaluation 
Figure 5.1 Healthy@Work Structureθ 
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The model developed and adopted by the central coordinator to consistently support the Healthy@Work project across all Agencies within the 
Tasmanian State Service. It allowed Agency-flexibility to develop programs specific to the employee needs of their organisation. 
Θ Reproduced with permission from the Healthy@Work Strategic Plan37  
‡Evidence based38-43 and used in policy guidelines (Ministerial Direction 23). For a list of the key principles see Table 5.1 
* Evidence-based38,42 and used as the foundation for development of Agency health and wellbeing programs. Implementation cycle included: Program 
initiation, Establishment of a coordination mechanism, Conduct a needs assessment, Develop an action plan, Implement the action plan, Monitor and 
evaluate, Revise and update the program.  
 
Chapter five: Evaluating the health and economic impact of a workplace health promotion 
program in the public sector state service: results from the Healthy@Work Project 
 
 243 | P a g e  
 
5.5  Sample  
The target population for H@W was all TSS employees representing between 28,000 and 
30,000 individuals working in any one year. They were located within fourteen agencies 
throughout the island state (68,401 square kilometres44), and delivered public service to the 
state’s 510,600 inhabitants.45 The employees were diverse and included senior executives, 
front line workers, clerical workers, administrators, lawyers, teachers, police, health and 
emergency personnel, technicians, service providers, labourers, junior graduates and 
cadets. A list of the agency names can be found in acknowledgements. Data were captured 
from a repeated cross-sectional partneringH@W (pH@W) survey of TSS employees selected 
by stratified random sampling (with oversampling for estimation in agencies with few 
employees).  
5.5.1 Comparators 
No comparators were required for the cost-consequence analysis and no intervention or 
comparator groups were originally assigned due to the ecological nature of the study 
design. However, in the attempt to provide evidence of greatest utility for the decision 
maker who valued building health promoting capacity within the TSS, an organisational 
capacity measure (‘capacity’) was developed that allowed for comparisons. At the 
conclusion of the study period employees were categorised according to their agency’s level 
of capacity; high, middle or low. Employees within agencies that received the intervention 
at the highest capacity level (the intervention group) were classified as being in a high 
capacity agency, while employees working in low capacity agencies were classified as having 
received the intervention at the lowest capacity level (the comparator group). Details on the 
capacity measure are provided below under ‘measurement of effectiveness.’ 
5.6  Measures 
Employee health status, lost productivity, and healthcare utilisation were available for the 
economic evaluation. The pH@W survey was developed in collaboration with the decision 
maker and included validated or well-tested common measures.  
Lost productivity from absenteeism (days absent due to health problems) and presenteeism 
(days at work while suffering from health problems multiplied by 1-[reported fraction of 
normal productive capacity when working while ill]) was measured using a 4 week recall and 
annualised (number of days per year) by linear extrapolation, an accepted convention.46,47 
Days due to absenteeism and presenteeism were combined to measure Total Lost 
Productive Time. An elasticity factor of 0.8 was applied to absentee days assuming 100% 
lost labour is proportional to 80% reduced productivity.48 Productivity loss was valued using 
individual annual salary rates in days i.e. annual salary divided by 240 working days per year 
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for full time (5 days x 4 weeks x 12 months), and 120 days for part-time/casual employees. 
Salary figures were sourced from a centralised TSS administrative database.  
Health care utilisation was measured by the number of hospital admissions and number of 
nights admitted in total over the last 12 months. Other less extreme health events such as 
GP (primary care) visits or pharmaceutical use were not asked within the pH@W survey due 
to costing difficulties. Hospital admissions were valued from the Tasmanian Major Hospital 
average cost per day for Australian Revised Diagnosis Related Group (AR-DRG). All units and 
costing are presented as average per employee per year. 
5.6.1 Choice of health outcomes 
Health outcomes were measured by preference-based health status (SF-6D health utility). 
Health utility is an internationally recognised gold standard measure of health outcome in 
cost-effectiveness analysis30-32 and cost-effectiveness analysis has been recently 
recommended in workplace health promotion in order to inform the value on investment.16 
5.6.2 Measurement of effectiveness 
Effectiveness was measured by organisational capacity. Capacity was identified by the 
degree an organisation (agency) developed, implemented and sustained a workplace health 
and wellbeing program. It was linked to the H@W vision. The vision was communicated 
broadly throughout the intervention years and supported by policy; ‘Ministerial Direction 23 
(MD23): Workplace Health and Wellbeing.’ The policy was accompanied by a set of 
guidelines.49 These documents were evidence-based38,41 and outlined key principles for 
implementing H@W. Both the MD23 and its guidelines were signed by the Tasmanian 
Premier (head of government) on June 7, 2010, providing administration powers under the 
State Service Act 2000. Updated versions of the policy were signed by the Premier on August 
21, 2012 and February 4, 2013.50  
Valuation of ‘capacity’ was linked to agency compliance to the MD23 key principles which 
were embedded within an agency Health and Wellbeing Audit. Audits were completed by 
agency-specific managers or workplace health coordinators for all agencies in 2010, 2011, 
and 2012. Capacity-related audit questions sought respondents’ level of agreement with 
twenty ‘MD23 key principle’ statements (see Table 5.1), and further included eleven open 
ended questions to enrich these data.  
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Table 5.1 Key principles captured within the Agency audit survey* used to assess organisational 
capacity 
How strongly do you agree with the following statements in relation to the agency 
health and wellbeing program? Our Program …. 
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Is cost effective 
      
Acknowledges and supports Occupational 
Health and Safety practices 
      
Is managed within the organisation 
      
Includes an assessment of the needs within 
the organisation 
      
Involves voluntary participation by 
employees 
      
Involves high levels of participation by staff 
      
Program coordinators have access to 
relevant professional development 
opportunities 
      
Coordinators have access to appropriate 
information and resources to support the 
development of the program 
      
Is sustainable because it is integrated within 
the organisations ongoing operations 
      
Is supported by a long-term commitment by 
the agency 
      
Involves access to the program for all staff 
irrespective of the current health status or 
role within the organisation 
      
Involves an evaluation process 
      
Involves strategies that address a range of 
individual, organisation and environmental 
issues 
      
Is strongly supported by senior 
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management 
Senior management participate in program 
activities 
      
Is promoted well internally to staff. 
      
Is promoted well to people outside of the 
organisation 
      
Staff are supported by their supervisors to 
take part 
      
The program is regularly reviewed and 
updated         
      
Staff are consulted in relation to program 
content 
      
*Key principles were developed by the H@W central coordinator from evidence,38-43 and 
documented in the policy guidelines49 and the Healthy@Work model (Figure 5.1). Reproduced 
with permission. 
 
An extensive effort to capture agency capacity was undertaken using an integrative mixed 
methods approach (a matrix).51,52 The matrix incorporated; (i) the quantitative and 
qualitative audit data, (ii) additional data from face-to-face semi-structured interviews with 
agency key personnel (collected for  a pH@W process evaluation), and (iii) a measure of 
program exposure identified through individual employee responses to questions within the 
pH@W survey and assessed using a checklist of 5 key elements in program 
comprehensiveness.53 Each agency received a score or comment against each feature within 
the matrix to indicate level of achievement. The matrix therefore facilitated integration of 
all available data for each agency. Two of the authors (SB and KJ) independently considered 
the matrix data to rank then categorise agencies into high, middle or low capacity levels. On 
two occasions and in order to meet consensus, two agency health and wellbeing plans (a 
completion requirement for all agencies at the inception of the MD23) were additionally 
examined.  
For the purposes of analysis high capacity agencies demonstrated greatest adherence to the 
MD23 key principles and employees within these agencies were considered to have 
received an ‘optimal’ intervention. Thus, in line with the H@W vision and in accordance 
with TSS policy these agencies most strengthened their capability to improve the health and 
wellbeing of their employees. In contrast, ‘low’-ranked agencies underperformed against 
these benchmark guidelines and their employees received an under-delivered program. The 
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capacity measure was tested for internal consistency using additional employee responses 
from the pH@W survey (refer to 5.9 Results).  
Refer to the pH@W 2013 survey Chapter 1 Appendix 1D, Section E Questions: 27, 28, 29, 30, 
31 and 35 for the questions used to test internal consistency. Reproduced in Appendix 5A 
This integrative valuation of capacity, that required ranking as a means to place value on an 
outcome, was considered more appropriate than an economic measure of capacity (i.e. 
measuring capacity by productivity efficiencies), as it reflected the inherent policy intention 
of H@W to establish a health-promoting culture. Moreover, difficulties in measuring 
productivity efficiencies in this public sector have been documented.54  
5.6.3 Measurement and valuation of preference based outcomes 
Overall health was assessed using the health-related quality of life (short form SF-12v255) 
questionnaire, and health utilities (SF-6D) were derived from this as the measure of health 
outcome amenable to economic evaluation. Health utility measures the strength of 
preference for a particular health state. Values are anchored between 0 and 1, where 1 
represents the equivalent of being alive for a certain proportion of a year in perfect health. 
SF-6D values were derived from Brazier’s algorithm56 using standard gamble from United 
Kingdom general population norms. Employee responses to the SF-12v2 questionnaire were 
converted by algorithm into employee SF-6D health utility at 2010 and 2013. Although there 
is currently no published SF-6D (SF-12) algorithm from Australian general population norms, 
the construct validity of SF-6D using Brazier’s algorithm in Australian employed populations 
has been demonstrated.57  
5.7  Intervention 
5.7.1 Setting  
The Tasmanian State Service (TSS) has advocated and supported public health initiatives for 
health and wellbeing of Tasmanian workers since 2001.39 Implementation of H@W is one 
way the TSS is responding to increasing uncertainty, including fiscal constraints, 
demographic change and an aging population. The employees of the TSS are pivotal to the 
success of the state for their provision of Government services, policies and programs to the 
whole community. However, they are aging and the future composition of the TSS is facing 
great challenge. “In the next five to ten years, more than 50 per cent of the State Service 
workforce will be at the minimum retirement age. In excess of 15,000 people may exit the 
workforce” p4. 58 In 2008 the TSS announced a four-year commitment of resources to 
support its own agencies. The allocated budget was $2,014,037 AUD. 
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5.7.2 Healthy@Work Project (2008-2012) 
Central coordination included developing and resourcing interventions across all agencies 
with a coordinated education and communication strategy, mental health and wellbeing 
training, consultancy service, a project website, grants and subsidies. Each agency (n=14) 
within the TSS was required to develop a workplace health program plan for preventive 
strategies. Identification of employee needs and preferences was conducted by the TSS in 
2009 using an online employee assessment tool, including automated personalised health-
promotion feedback for employees and agency summary data for managers. This identified 
any number of key health risk factors for appropriate program targeting. Programs included 
activities and health-promoting interventions for smoking, nutrition, physical activity, 
sedentary behaviour, alcohol consumption and psycho-social health. Examples included 
stress management, pedometer challenges, influenza vaccination, breaking-up sedentary 
time, healthy catering (cafeteria or vending machines), Employee Assistance Programs 
(EAP), smoke free policies and other activities encouraging an organisational change 
approach to improve culture, policies and resources in relation to health and wellbeing. A 
more detailed explanation of H@W including the study design has previously been 
published.59-61 
Number, type and duration of activities were agency-specific. Potentially, all employees in 
their working surrounds received varying levels of visible or active health promotion 
resource. Employee risk factor snapshots by agency were provided in 2011 and 2013 by 
researchers working in partnership with the central coordinators, and agencies had the 
opportunity to tailor or sustain programs in response. 
5.8  Analysis 
5.8.1 Forms of economic analysis  
The array of benefits was quantified separately alongside costs in a cost-consequence 
analysis. Additionally and by utilising the organisational capacity measure, we investigated 
cost-effectiveness of employee health utility and performed a cost-benefit analysis on 
reduced medical costs and lost productive time between high versus low capacity agencies.  
5.8.2 Estimating resource use and costs 
Data on resource use (program costs) were compiled by the central coordinator for 
operational costs (resource development, implementation, agency grant funding, 
infrastructure and incidentals) and salary and staffing costs associated with the 
coordination. Resources were allocated in 2008/2009 financial year and budgeted annually 
across the four intervention years. Costs and benefits were evaluated over the entire four 
year time horizon. Benefits were estimated alongside costs in 2010 and 2013 by the pH@W 
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survey. 
5.8.3 Currency, price date, and conversion 
Both costs and cost offsets were reported as price year 2009 Australian Dollars using 
Consumer Price Indexing.62 No discounting was performed due to the short time horizon of 
the study.63 However, sensitivity analysis incorporating a 5% discount rate 32 was performed 
for benefits relating to productivity loss as it has been shown that these can occur within 
two – five years. 74 
5.8.4 Analytical methods 
All analyses were reported on a “per employee” basis. Self-reported data from the 2010 and 
2013 pH@W survey were propensity weighted for non-response to present TSS population-
level summary statistics as means and standard errors. The propensity weighting model has 
been previously described.57 All statistical analyses for cost-consequence and cost-benefit 
tables were conducted using STATA© version 12 software package (Statacorp LP, Texas, 
USA). 
For the cost-effectiveness analysis the incremental net monetary benefit (INMB) statistic by 
way a confidence ellipse was used for analysis of uncertainty.64,65 The application of the 
INMB framework is encouraged when analysing occupational interventions when person-
level data is collected alongside the economic evaluation.66 Use of the INMB also mitigates 
the need to assign an arbitrary threshold value for an effectiveness measure of health, a 
standard practice in health technology assessment but one that has raised concern by 
occupational health leaders.67 
5.9  Results: 
At the conclusion of H@W after 4 years all agencies had programs in place and each agency 
had implemented, on average, 21 individual health and wellbeing activities.68 Ninety per 
cent of employees had access to activities and more than 75% accessed at least one of 
them.61 On average, the project website received 600 visits per month.  
Characteristics of the survey study populations stratified by year and organisational capacity 
are presented in Table 5.2. The weighted results by year represent the entire TSS employee 
sampling frame of 27,659 and 27,439 in 2010 and 2013 respectively. Weighting for non-
response accounted for the low response rate of sampled employees (28% of 12,179 
(n=3,410) respondents in 2010 and 27% of 12,007 (n=3221) respondents in 2013). The TSS 
population mean age (standard error) was 44.9 (0.2 years) in 2010 and 45.5 (0.2) in 2013 
and annual salary was $66,233 (489) and $72,541(430) respectively. Both age and salary 
increased expectedly with the longitudinal nature of data collection. In the TSS across both 
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years there was a majority of female (66%, 68%), married (63%, 64%), full time (61%, 56%) 
and permanently employed (90%, 88%) workers.  
Internal consistency of the organisational capacity measure using questions from the pH@W 
survey showed employees from high capacity agencies reported greater agreement with 
positive statements on culture, personal attachment and attitudes relating to both the 
H@W intervention and the TSS in comparison to employees of low capacity agencies 
(positive correlation p<0.01, see Appendix 5A).  
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Table 5.2 Characteristics of the whole of Tasmanian State Service (TSS) employee population, stratified by organisational capacity* 
 
TSS Agency Organisational Capacity (2013) 
  2010 2013 Higha Middleb Lowc 
  n mean(se) n mean(se) n mean(se) n mean(se) n mean(se) 
Age (years) 3408 44.9(0.2) 3221 45.5(0.2) 603 42.5(0.4) 1339 47.3(0.3) 1279 44.7(0.3) 
Annual salary ($) 3408 66,233(489) 3221 72,541(430) 603 74,035(898) 1339 72,591(535) 1279 71,914(824) 
Health utility β 3356 0.778(0.0) 3173 0.783(0.0) 598 0.787(0.01) 1328 0.782(0.00) 1247 0.782(0.00) 
 
n %(se) n %(se) n %(se) n %(se) n %(se) 
Proportional 
   
        
  Females 2444 66(0.01) 2307 68(0.01) 338 50(0.02) 981 70(0.01) 988 74(0.01) 
Married 2123 63(0.01) 2066 64(0.01) 383 63(0.02) 901 68(0.01) 782 61(0.01) 
University  1803 54(0.01) 1748 55(0.01) 306 49(0.02) 769 57(0.01) 673 55(0.01) 
Occupational type‡ 
   
        
  blue collar 582 18(0.01) 534 18(0.01) - - 80 6(0.01) 453 37(0.01) 
service 1304 40(0.01) 1308 44(0.01) 110 24(0.02) 555 44(0.01) 643 52(0.01) 
manager 399 12(0.01) 314 9(0.00) 101 14(0.01) 116 8(0.01) 97 8(0.01) 
Full time employed ᶲ 2057 61(0.01) 1871 56(0.01) 449 75(0.02) 758 55(0.01) 664 51(0.01) 
Permanent 
employment λ 3104 90(0.01) 2819 88(0.01) 517 87(0.01) 1179 88(0.01) 1123 88(0.01) 
$60,000-80K per 
annumψ 1502 43(0.01) 926 29(0.01) 209 37(0.02) 249 19(0.01) 468 37(0.01) 
‡ refers to Australian and New Zealand Standard Classification of Occupations (ANZSCO);69 blue collar, white collar, service, professional, manager   
*Propensity weighted for non-response (sampling frame N=27,659 in 2010 and 27,439 in 2013) 
  Ψ Refers to annual salary in 2009 Australian Dollars. 36% (0.02) had increased their annual wage over the 4 year project this range. 
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a Five agencies out of the total 14 agencies across the TSS were classified ‘high’  in organisational capacity, propensity weighted results representing 
4,128 State Service employees 
b Five agencies out of the total 14 agencies across the TSS were classified ‘middling’  in organisational capacity, propensity weighted results 
representing 11,348 State Service employees 
c Four agencies out of the total 14 agencies across the TSS were classified ‘low’  in organisational capacity, propensity weighted results representing 
11,683 State Service employees 
ᶲ Employees were categorised either full time or part-time/casual as employment condition 
   β Measured using SF-6D derived from SF-12v2 health-related quality of life survey56  
λ Employees were categorised either permanent or non-permanent/fixed as employment category 
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In 2013, upon completion of H@W, 4,128 employees were working within agencies of high 
organisational capacity (n=5) versus 11,683 employees in low capacity agencies (n=4). 
Employees working in high capacity agencies were more likely to be younger 42.5 (0.4) vs 
44.7 (0.3) years, male (50% vs 28%), working full time (75% vs 51%), with a higher 
proportion of managers (14% vs 8%) and a higher mean annual salary $74,037 (898) vs 
$71,914 (824).  
The cost-consequence analysis, mean overall costs from budget records and benefits over 
the four years for H@W expenditure, are presented in Table 5.3. A further breakdown of 
these costs and benefits by agency organisational capacity is presented in Table 5.4. 
Costs of the program: The H@W project required 2.5 full time equivalent positions. On top 
of staffing costs, the H@W model aimed to fund central coordination, individual agency-
specific programs and resource development. As a result, overall H@W costs were 
combined under four levels of operational expenditures, and salary and staffing costs. Unit 
costs were not presented as these were exhaustive, however examples of funding outlays 
within expenditure categories are provided. The budgeted cost of H@W was $2,044,324; 
$74 per employee over 4 years, $18 per employee per year.  
Consequences (benefits): There was no difference in estimated total lost productive time 
between years 2010 and 2013. Thus TSS employees (N=27,159) recorded mean (SE) 9.9 (0.3) 
days per annum (7.8 days absent, 3.7 days due to presenteeism) [overall 8.5 (0.5) days per 
annum 7.0 days absent, 3.1 days presenteeism with 5% discount] at an average cost (SE) of 
$3,968 (206) per employee per year [$3,402 (177) discounted]. Overall healthcare utilisation 
was low with mean number of hospital admissions 0.1 (0.00) and overnight stays 0.4 (0.03) 
across the project years [with no change upon discounting]. Totalled mean cost offsets for 
lost productive time and hospital utilisation were $4,002 (199) per employee per year for 
the H@W implementation period [$3,431 (171) at 5% discount rate]. 
Overall health utility (SE) was 0.780 (0.0); no significant change was seen between 2010 
(0.778 (0.0)) and 2013 (0.783 (0.0)). For this reason and due to the uncertainty of effect over 
time, QALYs were not estimated. 
  
2
5
4
 
| 
P
a
g
e
 
Table 5.3 Cost Consequence Analysis; costs and associated costs of productivity loss and hospital utilisation for the Tasmanian State Service (TSS) 
Healthy@Work (H@W) project, overall 
      
TSS Overall 
H@W project cost Source         Mean cost Total Cost 
Salary and associated staffing 
costs* Budget 
    
47,084(0) 659,178 
Centralised implementation ψ Budget 
    
197,780(1,775) 676,091 
Individual agency grants λ Budget 
    
8,453(228) 244,513 
Organisation/Community 
resource development ϕ Budget 
    
109,732(960) 387,272 
Infrastructure and incidentals Budget 
    
21,894(192) 77,270 
Total H@W cost 
      
2044324 
Cost per employeeᶲ 
      
74(1) 
Cost per employee per year 
      
18(0) 
    
2010 2013 TSS Overall 
H@W cost offsets (per year) 
Unit 
Cost 
Source‡ 
Unit of 
measurement 
Mean 
units 
Mean units Mean units Mean cost 
Health utility - - - 0.778(0.0) 0.783(0.0) 0.780(0.0) - 
Absenteeism Indiv a Days 7.5(0.5) 8.2(0.5) 7.8(0.3) 3,307(214) 
Presenteeism  Indiv a Days 3.9(0.2) 3.6(0.2) 3.7(0.2) - 
Total lost productive time θ Indiv a Days 9.9(0.5) 9.9(0.5) 9.9(0.3) 3,968(206) 
Hospital admission ≈ 846 b Admits 0.1(0.0) 0.1(0.0) 0.1(0.0) 84(5) 
Hospital overnight stay 1282 b Stays 0.4(0.0) 0.5(0.1) 0.4(0.0) 119(7) 
Total hospital cost - - - - - - 405(23) 
Overall total cost offsets β - - - - - - 4,002(199) 
NB: All costs reported in 2009 Australian Dollars (AUD) 
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*Example of associated staffing costs include: office supplies, travel, internal training, and superannuation. Costs were divided evenly among the 14 
agencies as each agency regardless of size received the same level of project coordination 
λ Examples of costs include: funding for facility improvements, mental health and wellbeing training, coaching programs for managers, sedentary break-
time software, health assessments and activities focussed on nutrition, alcohol consumption, education, and stress management. 
ψ Example of costs include: corporate physical activity challenges, centralised mental health and wellbeing training and subsidies. Centralised funds 
were divided evenly and proportionally to number of employees using average agency head count in order to ensure employees working within the 
largest of agencies had equity 
 ϕ Example of costs include: development and delivery of workplace coordinator professional development program, smoke-free workplace and healthy
workplace resource toolkits, healthy options for vending (HOVER) project,  public health initiatives for physical activity and health promotion conference 
ᶲaverage over the 4-year program implementation  
           Indiv refers to Individual. Unit costs sourced from an individual employee’s annualised salary 
     ‡ Sources of unit costs used in the analysis (a) individual employee salary from a centralised Tasmanian State Service administrative database, extracted
in 2010 and 2013, updated for inflation, (b) 2012-13 TAS Major Hospital average cost per day for Medical AR-DRG (Diagnosis Related Group) corrected to 
2009 AUD, average costs of admission equates two thirds cost of overnight stay. 
θ Days due to absenteeism and presenteeism were combined to measure Total Lost Productive Time. An elasticity of 0.8 was applied to absent days 
indicating 1 day absent was equivalent to 80% lost productive time.  
  ≈ Unit cost when admitted into hospital was $846 and any subsequent overnight(s) stay within the admission incurred an additional $1282, valued from
the Tasmanian Major Hospital average cost per day for Australian Revised Diagnosis Related Group (AR-DRG). 
β Costs of total lost productive time and total hospital costs 
          
   256 | P a g e  
 
2
5
6
 | 
P
a
g
e 
Table 5.4 Cost consequence analysis by organisational capacity 
    
Agency Organisational Capacity 
    
High N=4,128 Middle N=11,348 Low N=11,683 Difference (H-L) 
H@W project cost Source       Mean cost   Mean cost   Mean cost   
Incremental 
cost 
Salary and associated staffing 
costs* Budget 
   
47,084(0) 
 
47,084(0) 
 
47,084(0) 
 
0 
Centralised implementation ψ Budget 
   
30,402(502) 
 
198,197(2,389) 
 
261,513(1,190) 
 
-
231,111(1,291) 
Individual agency grants λ Budget 
   
29,486(365) 
 
6,375(331) 
 
2,678(47) 
 
26,808(368) 
Organisation/Community 
resource development ϕ Budget 
   
17,179(284) 
 
111,486(1,274) 
 
143,294(649) 
 
-126,115(709) 
Infrastructure and incidentals Budget 
   
3,428(57) 
 
22,244(254) 
 
28,591(130) 
 
-25,163(141) 
Total H@W cost 
    
527,027 
 
802,682 
 
714,615 
 
-187,588 
Cost per employeeᶲ 
    
129(2) 
 
69(2) 
 
58(1) 
 
70(3) 
Cost per employee per year 
    
32(1) 
 
17(0) 
 
15(0) 
 
18(1) 
        High  Middle Low  Difference (H-L) 
H@W cost offsets (per year) Unit Cost Source‡ Unit  
Mean 
units 
Mean cost 
Mean 
units 
Mean cost 
Mean 
units 
Mean cost Mean units Mean cost 
Health utility 
   
0.787(0.0) - 0.782(0.0) - 0.782(0.0) - 0.006(0.0) - 
Absenteeism Indiv a Days 6.3(0.8) 2,451(319) 7.8(0.8) 3,150(337) 9.4(0.8) 3,804(362) -3.1(1.2) -1,353(482) 
Presenteeism  Indiv a Days 3.9(0.5) - 3.2(0.3) - 3.8(0.5) - 0.1(0.7) 0 
Total lost productive time θ Indiv a Days 8.4(0.8) 3,270(353) 9.3(0.7) 3,715(301) 11.2(0.9) 4,511(365) -2.8(1.2) -1,240(507) 
Hospital admission ≈ 846 b Admits 0.1(0.0) 73(10) 0.2(0.0) 96(8) 0.1(0.0) 74(7) 0.01(0.0) -1(12) 
Hospital overnight stay 1282 b Stays 0.4(0.1) 104(15) 0.5(0.1) 133(11) 0.4(0.1) 108(10) 0.02(0.1) -4(18) 
Total hospital cost - - - - 355(48) - 458(37) - 365(34) - -10(59) 
Overall total cost offsets β - - - - 3,358(346) - 3,751(289) - 4,526(355) - -1,168(495) 
NB: All costs reported in 2009 Australian Dollars (AUD) 
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*Example of associated staffing costs include: office supplies, travel, internal training, and superannuation. Costs were divided evenly among the 14 
agencies as each agency regardless of size received the same level of project coordination 
λ Examples of costs include: funding for facility improvements, mental health and wellbeing training, coaching programs for managers, sedentary break-
time software, health assessments and activities focussed on nutrition, alcohol consumption, education, and stress management. 
ψ Example of costs include: corporate physical activity challenges, centralised mental health and wellbeing training and subsidies. Centralised funds were 
divided evenly and proportionally to number of employees using average agency head count in order to ensure employees working within the largest of 
agencies had equity 
ϕ Example of costs include: development and delivery of workplace coordinator professional development program, smoke-free workplace and healthy 
workplace resource toolkits, healthy options for vending (HOVER) project,  public health initiatives for physical activity and health promotion conference 
ᶲaverage over the 4-year program implementation  
           Indiv refers to Individual. Unit costs sourced from an individual employee’s 
annualised salary 
        ‡ Sources of unit costs used in the analysis (a) individual employee salary from a centralised Tasmanian State Service administrative database, extracted in 
2010 and 2013, updated for inflation, (b) 2012-13 TAS Major Hospital average cost per day for Medical AR-DRG (Diagnosis Related Group) corrected to 
2009 AUD, average costs of admission equates two thirds cost of overnight stay. 
θ Days due to absenteeism and presenteeism were combined to measure Total Lost Productive Time. An elasticity of 0.8 
was applied to absent days indicating 1 day absent was equivalent to 80% lost productive time.  
  ≈ Unit cost when admitted into hospital was $846 and any subsequent overnight(s) stay within the admission incurred an additional $1282, valued from 
the Tasmanian Major Hospital average cost per day for Australian Revised Diagnosis Related Group (AR-DRG). 
β Costs of total lost productive time and total hospital costs 
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5.9.1 Incremental cost-effectiveness analysis of high versus low organisational capacity  
On the basis of the cost-consequence analysis (Table 5.4), when agencies were stratified by 
high versus low organisational capacity, the cost of H@W per employee per year was $32 vs 
$15 respectively, a mean difference (95% CI) of $18 (16-19) ($129 vs $58 mean overall H@W 
cost per employee). High organisational capacity agencies had less total lost productive time 
(8.4 (0.8) days) compared to low (11.2 (0.9) days), a mean difference of 2.8 (1.2) days gained 
productivity per employee per year [7.2 (0.7) vs 9.6 (0.8) days, mean difference 2.4 days at a 
5% discount rate], representing a cost saving of $1,240 (507) with a 95% CI (246 to 2,234) 
per employee per year [$3,270(353) vs $4,511 (365)], that reduced to $1,063 (312) savings 
at 5% discounting. Combined with healthcare cost offsets, employees (N=4,128) within high 
organisational capacity agencies were on average saving the TSS $1,168 (495) with 95% CI 
(197 to 2,139) [$1,001 (304) discounted] per employee per year relative to employees 
within low organisational capacity agencies. 
From these monetized benefits, net benefits (NB = benefits-costs), benefit cost ratios 
(BCR=benefits/costs) and return on investment (ROI = (benefits-costs)/costs)19 were 
calculated. Overall, high capacity agencies spent $129 per employee and saved $1,168 in 
terms of productivity loss and healthcare utilisation. The cost-benefit estimates were; 
NB=$1,039, BCR=9.05, and mean (95% CI) ROI=8.05 (0.53 to 15.58), indicating TSS gained $8 
($0.5 to $16) per dollar invested, an increase of 805% on resources spent on high compared 
to low organisational capacity agencies. Under sensitivity analysis NB=$872, BCR=7.76 and 
mean (95% CI) ROI=6.76 (-0.68 to 14.20) (5% discount rate). 
A cost-effectiveness analysis of H@W to assess value for money in costs and health state 
utility (SF-6D) values of high versus low organisational capacity agencies was moot as there 
was no health effect, meaning there was no difference in health utility mean(SE) 0.006 (0.0) 
for the additional cost ($70). Furthermore we have estimated the minimally important 
difference of SF-6D in the Australian employed population to be 0.023 (refer to Appendix 
5B). This value is within range of other populations (0.010-0.048)70 and much higher than 
the 0.006 found in H@W.  In light of no health effect the incremental net monetary benefit 
(INMB) statistic was used only to demonstrate uncertainty using confidence ellipses on a 
cost-effectiveness plane around the point estimate (0.006, $70). Figure 5.2 highlighted 
comparatively that high organisational capacity agencies demonstrated negligible 
increments in employee health utility, that health utility crossed the y-axis into the north 
west quadrant for all probability distributions, and only at the upper 95% limit reached a 
minimally important difference.  
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Figure 5.2 Confidence ellipse for employee health status for high vs low organisational capacity 
Using the incremental net benefit statistic framework this confidence ellipse represents the 
distribution of cost and health effect at 50%, 75% and 95% confidence intervals, when difference 
between high versus low organisational capacity on employee health utility and costs is at the 
point estimate 0.006, $74. 
 
5.10 Discussion 
H@W (2008-2012) supported and developed health and wellbeing programs within each 
government agency of the Tasmanian state service (TSS). It was rolled out simultaneously 
across the entire organisation with no staging or comparator arm. The study was 
observational in design and represented a real world application of workplace health 
promotion. Our research was performed opportunistically, and started one year into the 
project. 
At the conclusion of the 4 year project the $2.04 million budget was fully expended or 
committed at a project cost of $74 per employee for the ≈28,000 employees involved. There 
were no differences in health and productivity measures between the two time points 2010 
and 2013.  
A cost-consequence analysis provided outcomes of interest for the decision maker alongside 
costs, a common and accepted method for presenting health economic results. Indeed, a 
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2009 review of public health interventions found 78% of economic evaluations conducted 
either a cost-effectiveness or cost-consequence analysis.71 Furthermore, and in light of 
measurement challenges, the National Institute for Health and Care Excellence (NICE) in the 
UK advocates cost-consequence analyses when it is not appropriate to conduct a cost-utility 
(cost-effectiveness) analysis.72 For the H@W decision maker, the Tasmanian Government, 
this form of economic evaluation displays results so it can decide on the relative importance 
of outcomes, conditional on its threshold value to further invest. 
The H@W project focussed on strengthening the capability of the TSS to improve the health 
and wellbeing of their employees. As such, the decision makers placed value on the 
processes initiated through H@W towards achieving outcomes and not only on the 
outcomes themselves. In terms of shifting organisational capacity, we determined the 
additional cost incurred by high capacity agencies offered some value. However, the ROI 
ratio denominator (program cost) was considerably small due to the large employee 
population. The inadequacy of the ROI ratio to account for small denominator costs has 
previously been published.73 As a result, the reported H@W return on investment figure is 
an imperfect judgement on value for money.  
Measuring employee health status was also valued by the decision maker. Embedded within 
the pH@W survey was a health-related quality of life measure that derived health utility (SF-
6D). A broader explanation on how health utility is derived and its applicability for economic 
evaluations in workplace health promotion is available within a separate study on this H@W 
employee population57 (refer to Chapter 4). It has previously been demonstrated that SF-6D 
health utility discriminates between employee job stress, psychological stress, comorbidity, 
body mass index and age within this TSS public sector. We considered conducting a cost-
effectiveness analysis of employee health utility using SF-6D however the cost-consequence 
analysis results that demonstrated no change. Figure 5.2 highlighted the large probability 
distributions surrounding the SF-6D values therefore in respect to health it indicates no 
value was achieved. This indicated there was no association between capacity and 
employee health status. A cost-effectiveness analysis is inappropriate when no effect is 
achieved.30,31 Further analysis using the INMB framework was unwarranted.   
Changes to health arising from workplace interventions are known to be a long-term 
benefit63,74 and no expectation to demonstrate change in health status over the four year 
H@W implementation period was made. It is reasonable to consider possible undetected 
value was achieved. An example of an unmeasured consequence in H@W was the wider 
community reach, accounting for $387,272 (19%) of funding for resource development 
(Table 5.3). Benefits from use of these resources could be long-lasting and wide-reaching, 
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and affect individuals not only employed at the TSS. This represents a multi-operational 
level of complexity with increasing evaluative challenge.75 Moreover it would require 
broadening the level of analysis to a societal perspective. Evidence of economic 
methodological techniques to assess multiplier impacts from investments in community 
health promotion activity is emerging.76  
There was an expectation that H@W could, by changing TSS culture, assist in ongoing 
sustained efforts and long-term adherence to behaviour change for improved employee 
health. The ability to measure sustained outcomes by linking short term evidence with long 
term benefits77 is a key priority for economic evaluations in WHP. Modelling past the 
intervention period was not undertaken here. 
5.10.1 Generalisability 
The current evaluation has a number of generalisability considerations. H@W was 
implemented in a large and diverse Australian public sector workforce, with employees in 
rural, urban and remote locations. Transferability of these results is possible for other target 
populations with similar characteristics and working locations, in workplaces with the 
capacity to implement central coordination and policy direction to deliver programs tailor-
made to suit employee needs. Results may be applicable in diverse organisational structures 
and within a political environment similar to Australia where implementing workplace 
health promotion is culturally accepted.  
5.10.2 Limitations 
No causal relationship between H@W and outcomes could be made due to the 
observational study design. The employer perspective does not account for employee out of 
pocket expenses that would increase the program costs nor community and other societal 
costs. The evaluative perspective was not broadened to include these costs due to large 
missing and heavily skewed out of pocket employee expenses data, and measuring 
challenges and constraints related to societal costs. Furthermore no opportunity costs (the 
best alternative use of the resources that funded H@W) were approximated. Although 
internal consistency of the organisational capacity measure was met, the measure has not 
been validated and a baseline measure of organisational capacity was unavailable. Five 
agencies reportedly offered health programs in some form prior to H@W. Prior 
implementation was captured in agency H@W program plans and upon review, and in 
considering process evaluation interviews and partner discussions, prior implementation did 
not show extensive activity or evaluation. Therefore all agencies were considered to start at 
the lowest organisational capacity level. 
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5.10.3 Conclusions 
This study provided an economic evaluation of a workplace health promotion project from a 
state government (employer) perspective. The centrally coordinated organisational 
approach permitted quantification of an ‘organisational capacity’ measure that was used to 
gauge effectiveness. Other measures of interest included worker impacts (productivity and 
employee health and wellbeing) and community reach. Taken as a whole, no employee 
health status change in the TSS was seen over the four year time horizon, however 
employees within high organisational capacity agencies had lower total lost productive time 
than employees within low capacity agencies. This demonstrated a net saving to the TSS. 
5.10.4 Source of funding 
Funding for the study was provided through a research grant from the National Health and 
Medical Research Council Partnership Projects (Australia), grant no. 544954. There are no 
further financial relationships between funder and authors. The publication of study results 
was not contingent on sponsor’s approval. 
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5.12 SO WHAT? Section 
What is already known on this topic? 
Economic evaluations can assist evidence-based decisions in WHP. Although traditionally 
economic evaluations identify measure and value outcomes arising from program activities, 
organisational culture plays a role in program success. In order to improve the breadth of 
evidence it is important for economic evaluations to consider outcomes of organisational 
capacity. 
What does this article add? 
This article presents an economic evaluation of an organisational approach to WHP in a 
public sector setting where improving culture was identified by decision makers as a valued 
intervention outcome. Agencies with higher organisational capacity demonstrated lower 
employee lost productive time. Value for money was evidenced from the organisational 
commitment to developing a healthier workplace.  
What are the implications for health promotion practice or research? 
Utilising a measure of organisational capacity to perform a comparative analysis better 
aligns economic evaluations with guidelines when the study design does not accommodate 
a comparator group. Furthermore, it integrates both individual and organisation-level 
measures simultaneously to broaden the evaluative scope and assessment of impact.  
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5.13 Summary 
Purpose: To conduct an economic evaluation of a workplace health promotion project 
(Healthy@Work) in an Australian state government workforce. 
Design: Prospective health economic cost-consequence analysis of an observational study 
from the employer (state government) perspective. Costs were reported in Australian 
Dollars (AUD), 2009 values (1AUD=0.89USD). Data sources: repeated cross-sectional 
surveys, audit surveys, administrative records.  
Setting: Public sector agencies (n=14), Tasmania. 
Subjects: 27,659 state service employees.  
Intervention: Healthy@Work was an organisational workplace health and wellbeing project. 
Each agency was required to develop a plan for preventive strategies. The number and type 
of strategies varied across agencies.  
Measures: Organisational capacity (workplace capability to support/encourage positive 
health choices); SF-6D health utility; absenteeism; presenteeism; lost productive time; 
healthcare utilisation. 
Analysis: Cost-consequence analysis. Additionally, cost-benefit and cost-effectiveness 
analyses were performed with incremental net monetary benefit statistic to ascertain 
measure of uncertainty.  
Results: The Tasmanian government invested $2.04 million, $74 per employee over 4 years 
(2008-2012). Upon project completion all agencies had developed and implemented 
workplace health promotion activities, one third reached high organisational capacity. 
Although no overall improvements in employee health was seen, decreased lost productive 
time in agencies of high organisational capacity saved $1001 per employee per year 
compared to low capacity agencies. 
Conclusion: Value for money was realised in improving organisational capacity, a necessary 
step on the path to improving employee health.   
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5.14 Postscript 
There were some unique characteristics to this analysis. First, the use of an integrated mixed 
methods approach51,52 pulled data together to form the measure of organisational capacity. 
The mixed methods ‘matrix’ allowed for the collection and utilisation of qualitative and 
quantitative data. Data were combined from both individual employee responses to the 
H@W program as well as agency personnel responses to the H@W processes. In so doing 
we showcased a method whereby disparate data sources could be combined. We 
recommend the use of mixed methods to evaluate the evidence, noting that new ways to 
measure value on investment is being sought and considered critical to success within the 
broader ‘values’ WHP paradigm.78   
Second, the INMB statistic, although not fully able to be utilised in the analysis, was 
introduced. It offers an exciting economic methodological technique appropriate for 
measurement and evaluation in WHP at an individual employee level and within the scope 
of the value on investment CEA convention. “As collaboration grows between workplaces 
and research partners to evaluate the cost-effectiveness of new interventions, it will be 
critical for researchers to be aware of the latest methods for person-level analysis of cost-
effectiveness data” p 441.66 
Third, measuring organisational capacity is high on the WHP research agenda.73 This analysis 
developed a measure that was specific to the organisation’s vision and embodied their 
H@W model and key principles (Figure 5.1, Table 5.1). Although the measure was used to 
assess effectiveness, it mainly provided a unique way to assign a comparator group for the 
economic evaluation. An interesting finding yet one that was beyond the scope of this 
analysis was the characteristics of the employees within high capacity agencies, as they 
differed to those in low. They were more likely to be younger, male, working full time, with 
a higher proportion of managers and a higher mean annual salary. These characteristics may 
be an indicator of what type of working environments are more conducive to WHP 
implementation and further work to validate and test hypotheses are needed. 
Expanding the scope of measurement and valuation in WHP has its evaluative challenges. 
Challenges that parallel those of complex public health interventions which similarly 
advanced from single to multifactorial, to whole of community, to inclusion and integration 
of environmental factors and policy.79 These challenges include: diverse, non-linear, 
widespread, and protracted effects (benefits), valuation of non-health-related benefits, 
difficulties in causal attribution, complex contextual interactions (interventions 
implemented within varied operations, structures and relations), multiplier effects, and 
combined micro and macro-level variables.75,76,80-83 It is thus essential for economic 
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evaluations to seek new methods to not only address the expanded scope and value of WHP 
measurement but also the challenges inherent in its public health presentation.  
This chapter assisted in this endeavour by acknowledging the emerging broader WHP value 
proposition, adopting the latest economic evaluative technique in WHP, and utilising a 
measure of organisational capacity to overcome the lack of a comparator in this 
observational study design. Moreover, our finding that higher organisational capacity 
demonstrated lower employee lost productive time, in combination with the finding in 
Chapter 4 (higher health utility was associated with lower absenteeism) indicates a probable 
connection could be explored between culture, productivity and health. As yet, a direct 
association between organisational culture and health is still to be determined. 
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Appendix 5A: Questions within the 2013 pH@W survey testing 
internal consistency of organisational capacity measure 
 
 
 
 
 
Mean number of questions employees responded with ‘agree’ or  ‘strongly 
agree’ for agencies of high, middle and low organisational capacity 
Capacity Mean Std. Err Lower 95% CI Upper 95% CI 
High 3.39 0.07 3.24 3.53 
Middle 3.39 0.05 3.29 3.49 
Low 2.98 0.05 2.88 3.09 
 
Linear regression analysis to show relationship between capacity and positive 
employee response 
Capacity β Std. Err. Lower 95% CI Upper 95% CI 
High ref 
   Middle 0.00 0.10 -0.18 0.18 
Low -0.41 0.10 -0.59 -0.23 
Linear trend p<0.01 
 
% response of employees agreeing or strongly agreeing to all 5 statements 
46%  High capacity Agencies 
37%  Low capacity Agencies 
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Mean number of questions employees responded with ‘agree’ or  ‘strongly 
agree’ for agencies of high, middle and low organisational capacity 
Capacity Mean Std. Err Lower 95% CI Upper 95% CI 
High 3.80 0.09 3.62 3.97 
Middle 3.16 0.06 3.05 3.28 
Low 2.99 0.06 2.88 3.10 
 
Linear regression analysis to show relationship between capacity and positive 
employee response 
Capacity β Std. Err. Lower 95% CI Upper 95% CI 
High ref 
   Middle -0.63 0.10 -0.84 -0.43 
Low -0.81 0.11 -1.01 -0.60 
Linear trend p<0.01 
 
% response of employees agreeing or strongly agreeing to all 7 statements 
18%  High capacity Agencies 
9%  Low capacity Agencies 
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Appendix 5B: Method for estimation of minimally important 
difference of the SF-6D in the Australian employee  
 
Objective: To determine the minimal important difference (MID) of the SF-6D health utility 
in an employed population using the SF-36(version 1). 
Methods: An anchor-based approach was utilised to investigate the MID and the difference 
in health utility values which corresponded to a small but important health change on a self-
reported global rating of change (GRoC) scale. Data was obtained from the Household, 
Income and Labour Dynamics in Australia (HILDA) longitudinal study of persons residing in 
private dwellings in Australia which commenced in 2001. Respondents were employed 
individuals who completed the SF-36v1 questionnaire for any one year period across Waves 
8 (n=), 9 (n=), 10 (n=), and 11 (n=) of HILDA. For further analysis, individuals were classified 
into Private Sector or Public Sector employment categories. The GRoC score was derived 
from question 2 of the SF-36v1 (which was not used to generate SF-6D utility values); 
compared to one year ago, how would you rate your health in general now 1) much better 
than a year ago 2) somewhat better now than a year ago 3) about the same as one year ago 
4) somewhat worse now than one year ago 5) much worse now than one year ago. 
Individuals who scored either a 2 or 4 GRoC score were considered to have experienced the 
equivalence of a MID health change. For individuals who scored either a 1 or 2 GRoC score 
(i.e. a worsening of health) their SF-6D health utility value sign was reversed (i.e. multiplied 
by minus one). Mean change in the SF-6D health utility values for individuals reporting 
health change (GRoC score of 2 or 4) represented the MID. Sensitivity analysis using the 
effect size (SRM) and half a standard deviation was also performed. 
The mean MID was calculated as: 0.02318028 
Global rating of health scale* n MID^ SE 95% CI 
Better than a year ago 762 0.028 0.003 0.02, 0.03 
Same as a year ago 4417 0.001 0.001 0.00, 0.00 
Worse than a year ago 590 0.048 0.005 0.04, 0.06 
* Global rating of health scale is question 2 of the SF-36 and is not part of the SF-6D.  
^ The minimally important difference, the difference between the quality of life scale corresponding 
to a self-reported small but important change on the global rating of health scale 
 
For further explanation for calculating MIDs refer to Walters et al. 70  
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6 Chapter six: Discussion 
6.1 Preface 
The aim of this thesis was to investigate the application of health economics to evaluate 
workplace health promotion. It began with an overview of workplace health promotion 
(WHP); its evolution linked to our understanding of the multi-determinants of health, its 
drive from a public health approach, its recognition within economic development on a 
macroeconomic scale and its importance for the business case at the organisation level. The 
research presented has focussed on the use of health economics to conduct microeconomic 
evaluations in WHP; a review of health economic evaluations (Chapter 2), a business case 
tool (Chapter 3), and validation of a multi-attribute utility instrument to measure employee 
health status (Chapter 4). The knowledge gained through these works on quality and 
measurement culminated in an economic evaluation of the Tasmanian state government 
Healthy@Work (H@W) project (Chapter 5).  
In this Discussion Chapter, implications of the economic evaluation of the four-year whole-
of-state service workforce WHP project, along with cumulative understandings from these 
other works are presented. It is written with reference to sustainability. The future direction 
of applied health economics in WHP will be contemplated, with appreciation of the relative 
infancy of economic evaluations in WHP, as well as considering the difficulties and 
methodological challenges that arise. The validity of “the bottom line” will also be 
addressed. This Chapter will provide some key conclusions drawn from the work presented 
and the literature, and offer recommendations to the research community, employers and 
public sector employers, including the Tasmanian Government, to optimize the chances of a 
sustainable future for WHP.  
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6.2 Sustainability of WHP – the need for research like this 
Sustainability of WHP is the likelihood that programs and projects will continue to function 
effectively after initial implementation ends.1 The need for sustainability of WHP is great.  
 Global mortality is being driven by non-communicable ‘chronic’ diseases like 
cardiovascular disease, diabetes, chronic respiratory disease and cancer.2  
 Tobacco use, poor diet, sedentary lifestyle and excessive alcohol consumption are 
the four underlying risk factors responsible for half of all chronic diseases.3 
 Adopting a healthy lifestyle is associated with reduced mortality risk4 and  
 WHP supports healthy lifestyle choices and has been shown to decrease chronic 
disease.5  
In Australia in 2012, chronic disease accounted for an estimated 10,017 years of life lost per 
100,000 people; 84% of all causes: communicable, non-communicable and injuries.2 Despite 
the high burden of chronic disease and the understanding that the workplace is a priority 
setting to address this burden, commitment to WHP is currently lacking within Australian 
federal government policy. In contrast, the UK includes improving healthier working 
environments in their action framework to reduce early retirement6 and grants are available 
in the Unites States for employers who provide access to “comprehensive workplace 
wellness programs” p2285 of HR 3590 EAS/PP, line 19. 7 Implementation and any 
subsequent sustainability of WHP in Australia is the role of the Australian employer.  
6.2.1 But it wasn’t always this way: When the Australian political tide turned towards 
WHP ….or not! 
During the life of my candidature a perplexing example of failure in federal government 
commitment occurred. The following example illustrates the insecurity of sustainability 
efforts and significance of health economic research in WHP. 
Historically, the Australian national public health effort in relation to the well-being of our 
workers has focussed on occupational health and safety rather than health promotion.8 Yet 
the tide turned in 2009 with the largest federal commitment of funding and resource for 
WHP within The National Partnership Agreement of Preventive Health (NPAPH) and the 
Australian National Preventive Health Agency (ANPHA) (detailed in Chapter 1). 
Disconcertingly, these prevention bodies and functions ceased operations in July 2014, four 
years earlier than planned. A change in federal government saw value placed on other 
health spending over prevention,9 despite the expected impacts from health promotion 
reflecting the highest long-term returns on investment (ROI).10,11 Shifting tides such as these 
reflect the limitation of finite public resources but also lacklustre and fickle health 
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promotion commitment. It is known that many factors can impact the decision-making 
process;12 one factor that relates to my work in Chapter 2 is the provision of quality 
economic evidence to empower and inform. 
6.2.2 Of concern to our partners 
At the local Tasmanian level, there were no ongoing plans or centralised funding for 
Healthy@Work (H@W) beyond its initial implementation period (2008-2012). The 
sustainability of H@W will rely on the built capacity for health promotion at the individual 
organisation (agency) level. WHP resources, expertise, and infrastructure will all remain 
within individual agencies. In order for H@W to be sustainable, agency heads will need to 
recognise the worth of maintaining and supporting their individual WHP programs. There is 
also evidence that partnerships can help build capacity13 and possibly the research 
conducted within partneringH@W (including this thesis work) may feature in the 
sustainability effort. 
6.3 Improving the evidence-base in WHP 
Chapter 2 provided economic evidence in WHP from a quality-based systematic review. 
Another factor that can be critical to sustainability, and advocated in evidence-based 
decisions for public policy and professional practice, is having economic evidence to inform 
decisions.14 The analysis responded to the caution expressed by the research community 
regarding the influence of the strength of evidence on financial outcomes in WHP, and the 
continual call for analyses to adequately consider economic methodological quality. The 
published review (Chapter 2 Appendix 2A) applied rigorous and systematic methods to 
search for economic evidence in WHP. It aimed to assess the economic methodological 
quality using quality checklists and determine the ROI when accounting for quality. In 
summary, economic evidence in WHP is generally low to moderate quality. Studies have not 
adopted optimal health economic methodologies for economic evaluations. Specifically in 
their 1) design (mostly retrospective) 2) reporting standards (especially poor with respect to 
analysis and interpretation) 3) measurement (mostly limited to absenteeism and medical 
care cost) and 4) valuation methods (non-standardised and non-validated). Additionally, 
many economic studies were excluded from the review as they did not include all the 
components of a full economic evaluation; costs and benefits of a WHP intervention 
alongside a comparator.  
As a result, economic evidence in WHP has previously tended to over-estimate economic 
benefits, lack transparency, not fully assess uncertainty and is rarely reproducible. This may 
minimise the value of analyses for decision makers. Additionally and equally as crucial, it 
decreases the presence of WHP research within Cochrane-endorsed public registries, 
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economic databases and online ‘evidence libraries.’15-19 This dearth of evidence does little to 
assist decision making and commitment to WHP. Yet the demise cannot solely be placed on 
economic methodological quality. There are inherent difficulties in performing experimental 
design in health promotion.11,20-22 This can account for some of the limitations in WHP 
economic evidence generation and availability. Furthermore, the definition of ‘health 
promotion evaluation’ itself “an assessment of the extent to which health promotion 
actions achieve a ‘valued’ outcome” p12 23 indicates how context-sensitive WHP 
interventions should be. This definition can thwart evidence generalisability and 
transferability as it highlights the need for varied evaluative designs within diverse 
populations and settings under both controlled (‘Can WHP work?’) and ‘real-world’ (‘Does 
WHP work?’) scenarios. Moreover, and in consideration that ‘health promotion outcomes’ 
represent “changes to personal characteristics and skills, and/or social norms and actions, 
and/or organizational practices and public policies which are attributable to a health 
promotion activity,” p12 23 outcomes are vast and variable, achieved over considerable time 
and by nature of design, difficult to attribute to the WHP intervention alone. WHP has a 
myriad of complexity within its evaluative scope. 
As a result of these complexities, economic analyses need to be transparently reported. 
Putting differences between health promotion and clinical interventions aside, the purpose 
of an economic evaluation should offer robust information to inform decisions. The review 
suggests adopting the Consolidated Health Economic Evaluation Reporting Standards 
(CHEERS)24 to guide evaluation content and assist WHP evidence reporting. CHEERS 
guidelines purports to be “neutral about the conduct of economic evaluation, allowing 
analysts the freedom to choose different methods” p246. 24 This view supports its 
appropriateness for WHP where conducting cost-effectiveness analyses have traditionally 
been a less-common pursuit. 
6.3.1 Improving the evidence quality for business decision making 
A lack of trustworthiness in the reported bottom line can create a lack of understanding of 
the benefit in WHP. A lack of understanding has been reported as one of the most common 
barriers to employer commitment.25 Seemingly unrealistic high returns and evidence 
contradictions has a knock on effect for whether WHP programs are adopted and/or 
sustained, for they generate evidence fatigue and scepticism.26 An Australian example: an 
Executive of a large Australian company when asked why he declined to offer employees a 
workplace mental health screening and early intervention program (no cash contribution by 
employers required) remarked as his reason to decline “If I instigated all the programs to 
increase productivity, we would be working at 1,000% above current capacity” p514. 26  
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Our review in Chapter 2 demonstrated overall mean weighted ROI of high quality evidence 
in WHP to be positive and provided the most comprehensive summary estimate of financial 
return to date. Although financial outcomes are only one of many domains of evaluation on 
WHP effectiveness, it will remain an important and inherent part for business justification 
into the future.27 Improving the methodology for how we conduct and report economic 
evaluations in WHP may help decrease evidence fatigue, increase utility of the financial 
outcomes for policy and business and work towards improved sustainability.  
Recommendations arising from Chapter 2: 
 A potential solution to overcoming evaluative complexities is to follow economic 
principles in health economic evaluations by naming convention and reporting 
standards.  
 Weaknesses in methodological quality can impede evidence that may be used to 
support funding decisions. Therefore progression in the state of economic evidence 
in WHP can occur if evaluators: 1) Collect economic data alongside health and other 
effectiveness data prospectively; 2) Collect data on both costs and benefits of the 
intervention and the comparator to ensure the evaluation has the components of a 
full economic evaluation; and 3) Perform an incremental analysis. 
 Broader measures for health and non-health costs and consequences wherein 
economic value can be placed need to be considered. Employer costs that consider 
community-level outcomes needs better representation in WHP evaluations. 
Identifying, measuring and valuing WHP from a societal perspective will produce a 
greater depth of impact of WHP beyond the individual employee/company level.  
 Create a WHP repository of high-quality evidence to assist greater availability of 
evidence for decision makers.  
 To truly meet the public health objective of WHP, studies should consider measuring 
health inequalities. The impact of WHP on health inequalities was not represented in 
the review. Equity outcomes further encompass adopting a broader health economic 
scope, yet arguably are inherently important for optimizing the health of workers.  
6.4 Improving the measurement of health in WHP 
The research in Chapter 4 met the identified need for broader measures of health to be 
available for economic evaluations in WHP. It investigated the construct validity of a 
measure of health utility (SF-6D) in the employee population. 
When considering the significance of this analysis it is important to consider some 
assumptions that underlie the measurement of worker health. First, worker health 
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behaviour is voluntary and requires a participatory process involving individuals 
stakeholders and partnerships.28 Second, worker health is influenced by multi-
determinants29,30 (individual, environmental, social, political, organisational including work 
styles, practices, work groups, culture, and physical and working conditions). Third, health is 
multidimensional and a major component of quality of life. 
Figure 6.1 offers a pictorial representation of the significance of quality of life in health 
promotion. Published evidence suggests employer wellbeing programs can improve quality 
of life.31 
 
Figure 6.1 Quality of life: the ultimate health outcome, as depicted by part of the precede-proceed 
public health model of health promotion32 
Health-related quality of life instruments are multi-item scales that measure domains of 
health, from where multi-attribute utility instruments (MAUIs) like SF-6D derive health 
utility.33 The analysis in Chapter 4 validated the SF-6D measure of health utility in the 
employee population. Health utility is a single index of health status. It reflects people’s 
preference for different health states using preference scores based on community-derived 
weights. The analysis found worker SF-6D health utility values appropriately measured 
across gender and appropriately discriminated between health factors (comorbidity, body 
mass index, psychological distress, age), socioeconomic factors (salary, in populations within 
private enterprise), and work characteristics (job stress, absenteeism, employment 
condition and occupational type). Furthermore SF-6D did not demonstrate a ceiling effect in 
the working population.  
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There are many important implications for this work.  
1. Improving employee health is an inexorable mission of WHP and the ability to validly 
measure health status is of utmost relevance to the field.  
2. A health utility derived from a health-related quality of life measure is advantageous 
as it innately places value on health. Therefore this work not only provides a valid 
measure to assess health status of employees, it provides evaluators with a measure 
that fulfils the identification, measurement and valuation principle of health 
economic evaluation. Placing value on measures in WHP was found in the review (in 
Chapter 2) to be most lacking.  
3. A valid measure of health that has the ability to be valued through monetization will 
allow a clear articulation of health in the business case. The advantage that health 
utility can be woven into the dialogue of a company’s bottom line assists sustainable 
business discussions in WHP. This will meet the need for common definitions and a 
set of metrics for the measurement of health relevant for business, the need to 
define health beyond medical care, and the importance to have outcomes that can 
“speak the language of profit” p 9. 25 
4. The measure of health status using health-related quality of life helps to better align 
economic evaluations of WHP with the health economic discipline. For without 
defining “what is health?” it is methodologically flawed to attempt to analyse 
impacts on health, demands for health and so on. The disciplinary importance was 
represented in the schematic presentation of health economic elements in the 
introduction.34  
5. Evaluators (with policy stakeholders) have the ability to utilise health utility 
alongside another health outcome measure, life expectancy, to achieve a combined 
single index measure known as quality adjusted life years (QALYs). Although 
economic guidelines endorse QALYs as the gold standard measure of health,35 it is 
not yet known whether the valuation of employee health by QALY measurement 
offers utility for employers. Nonetheless, the inclusion of health utility in the WHP 
economic evaluation toolkit permits comparative cost-utility (cost-effectiveness) 
analysis to report incremental cost per QALY. This health outcome measurement is 
in line with policy standards14 and allows the potential for WHP interventions to 
compete for healthcare resources. 
Recommendations arising from Chapter 4 are: 
 Adopting a common metric for health that is valid in employee populations and that 
is amenable for use in economic evaluations and financial analysis is needed. Health 
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utility SF-6D is proposed as the appropriate measure.  
 Measuring health status follows economic principles in health economic evaluations 
and as health is an integral outcome in health promotion, health should be 
considered as a prerequisite measure in all health economic evaluations in WHP. 
 It has become clear in my work, my conference attendances and reading for this 
thesis that health is an important consideration for employers. Workplaces 
interested in WHP do look beyond just workplace productivity. As such, and beyond 
economic principles themselves, identifying, measuring and valuing health provides 
evaluative diligence. 
 For application in policy: Worker health utility and employee life expectancy can 
combine to produce a QALY. WHP economic evaluations that can produce QALY-
based incremental cost effectiveness ratios (ICERs) will allow for WHP interventions 
to be ranked accordingly within QALY league tables. In so doing WHP can better 
compete for funding in resource allocation decisions. It should be noted that QALYs 
are most utilised in health sector decision making within league tables for health 
economic decision rules. Again, it is unknown if this measure offers utility for 
employers.  
6.5 Informing decisions on the Healthy@Work (H@W) project  
The research in Chapter 5, a partner-driven economic evaluation of H@W, builds from these 
previous works on economic evidence development (can WHP provide value for money?) 
and on valuation of health (what measures better define employee health that can have 
assigned value?). The analysis was an economic evaluation conducted in collaboration with 
the Tasmanian State Service decision makers to answer the question “Was H@W good value 
for money?” 
H@W was a four-year commitment by the Tasmanian Government to implement WHP over 
their entire public service workforce. It was developed to support the health and wellbeing 
of public sector public service workers working within healthier workplaces, using evidence-
based WHP best practices, and implemented through a co-ordinated organisational 
approach. Economic forms considered within the analysis were cost-benefit analysis, cost-
utility analysis and cost-consequence analysis. Cost consequence analysis was considered 
the only appropriate form given there was no change in health status across the 
intervention years and comparator groups. The demonstrated large ROI ratio from the cost-
benefit analysis was an inadequate measure of value for money; in part due to concerns 
that large intervention populations produce consequentially small program costs (ensuring a 
very small denominator within the ratio).36 Moreover, total lost productive time was the 
only measured benefit that produced the ROI, and therefore the ratio represented value for 
 Chapter six: Discussion 
 
285 | P a g e  
 
money solely from a productivity outcome. This  is against Australian economic evaluation 
guidance37 which suggests reporting results with and without production consequences to 
minimise labour market biases.  
 
Implications for this work will be more fully known into the future when decisions regarding 
H@W are discussed by the decisions makers after the economic evaluation is presented. At 
this time the H@W project has ceased as originally planned and sustainability will be driven 
primarily by individual agencies. 
Following health economic principles for a comparator population did present difficulties as 
no control group existed. This was overcome to some extent by considering the value of 
organisational capacity and stratifying the Tasmanian State Service employee population 
into those working within high versus low capacity agencies. Measuring and utilising 
organisational capacity in this way was novel yet posed design issues, as no baseline 
measure and no change over time attributable to H@W was possible. The cross-sectional 
analysis however, demonstrated differences in the employee absenteeism and 
presenteeism outcomes. Furthermore, efforts to provide internal consistency of the 
measure showed that employee perceptions of culture, personal attachment and attitudes 
to their organisation were higher in high capacity workplaces and these were statistically 
significant. Although still in its infancy, measuring organisational capacity is recognised in 
the literature as a crucial step towards improving worker health.38 By improving the 
organisation we may improve factors contributing to the multi-determinants of worker 
health, create environments with better accessibility to healthy living, and enhance 
individual worker efforts to choose healthy behaviours. 
The analysis in Chapter 5 presents a practical use of a measure of organisational capacity in 
an economic evaluation. In so doing it attempted to measure health promotion outcomes 
that can occur in a shorter time frame compared to health outcomes and therefore may 
demonstrate an early impact. It also helped address the multi-focus complexity of improving 
workplaces beyond the conventional individualistic lifestyle-approach. Moreover it 
attempted to create a comparator within a study design without a control group in order to 
maintain a fundamental health economics principle to provide an incremental analysis. 
Recommendations arising from Chapter 5 are: 
 Implementation of workplace health promotion should consider adopting a Stepped 
Wedge Trial Design Approach.39,40 This approach would help to address some 
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complexities inherent in WHP and its economic evaluations. By implementing a 
(randomised) sequencing approach to WHP intervention roll out, a stepped wedge 
design trial can i) provide comparisons in organisation-wide delivery when no natural 
comparator exists, and  ii) allow the observational design suited to WHP to gain 
improved experimental evidence. Furthermore as expected effectiveness occurs 
over a considerable length of time in WHP, effect of time on outcomes can be 
modelled.41 So too, this approach could assist in detecting points of success or failure 
by distinguishing between the fidelity of the evaluation process and the intervention 
itself. Such evidence in public health interventions is lacking.21 A stepped wedge 
approach has been endorsed in the Medical Research Council guidance for use in 
complex interventions.42  
 Use the Consolidated Health Economic Evaluation Reporting Standards (CHEERS). 
Although concerns exist that they are better suited to pharmacoeconomic 
evaluations it was found that the guidelines offered a blueprint for inclusion of all 
important components of an economic evaluation. Adoption of this guidance will 
improve the transparency of reporting.  
 The incremental net monetary benefit framework is appropriate for use in economic 
evaluations of WHP for analysis of uncertainty where the cost-effectiveness 
threshold value is unknown.43,44 
 Employee health status is a final long term outcome and requires lengthy follow-up 
periods to assess impact. Evaluating health status requires sustainable commitment 
to the intervention in order to assess future changes that may be realised. 
Intermediate outcomes of health must also be considered for interim evaluations. 
Consideration should be given to the modelling of health status in order to evaluate 
effect and translate final outcomes when intervention durations are short. 
 As WHP impacts multiple levels (individual, organisation, community) outcomes 
from each level should be included in evaluations. Capturing outcomes at the 
broader levels including changes in structures, policies, built environment, capacity 
requires novel methods to be considered. Integrating both quantitative and 
qualitative data is required and using a mixed methods analysis approach is one 
possible direction.  
The partneringHealthy@Work project provided insights into the processes and evaluation 
needs when implementing an organisational WHP initiative. It also allowed for strength in 
partnership between policy and research to be developed. At the time of the economic 
analysis there was no definitive evidence to show the investment was financially 
worthwhile. Not an unexpected result, considering the short-term length of the project and 
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the long-term outcome measure of health status. 
Recommendations specific to partners 
 It is recommended that the TSS internal agency audit be continued and collected 
annually so that ongoing organisational capacity and sustainability efforts are 
measured and available for possible future monitoring of impacts.   
 Consulting with researchers/health economists before implementation will 
undoubtedly strengthen evaluative efforts by ensuring an improved study design and 
the use of most appropriate and valid measures.  
 Policy-research partnerships should be encouraged as they provide multidisciplinary 
strength that suits the integrative needs of economic evaluations in WHP. 
 It is recommended that the Tasmanian Government develop guidelines for 
incorporating economic evidence into policy. Guidelines make provisions for a 
broader scope of scientific evidence appropriate to public health evaluations. 
Infrastructure to support better systematic use of evidence will assist the allocation 
of funding in accord with best evidence-based knowledge. Evidence of opportunities 
and obstacles in facilitating such a process are available.45  
6.6 A resource to assist in sustainability efforts 
Non-lasting commitment to WHP delivery threatens sustainability and any gained benefits 
towards improved population health. So far the analyses have recommended for economic 
evaluations in WHP to address areas that jeopardise measurement, methodology and 
transparent reporting. Many of these threats are the direct result of challenges inherent in 
public health interventions. Yet it is also prudent to consider factors such as the healthy 
worker effect that directly influences studies on workers in relation to study design and 
evidence generation comparative to the general population. Epidemiological studies must 
account for the healthy worker effect considering “workers tend to be healthier as a group, 
and hence less susceptible to morbidity and premature mortality, than the general 
population” p 276. 46  
6.6.1 Challenges facing economic evaluations in WHP 
1. Diverse, non-linear, widespread, and protracted effects (benefits) 
2. Difficulties in assigning causality and attribution to WHP due to study design and benefit 
latency 
3. Difficulties in identifying, measuring and valuing the interdisciplinary multi-focus and 
complex contextual interactions that result in a broad number of outcomes and 
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consequences that are non-health related and beyond the targeted individuals  
4. Difficulties in generalisation due to contextual nature of evaluations 
5. Methodological difficulties and lack of reporting standards 
6. Whole-of-organisational approach decreases opportunity for comparator populations 
Despite these challenges affecting the evidence base in WHP, resources are needed and 
continue to be developed to help engage business interest. The analysis in Chapter 3 is an 
example of a business tool. Resource development was undertaken through an internship 
within the Tasmanian Department of Health and Human Services, an outcome of the unique 
research-policy partnership partneringHealthy@Work. The resource known as the 
‘Workplace Health Savings Calculator’ has been available online within the Australian 
federal government workplace health toolkit since 2013 and has been adapted and 
reproduced in other Australian states by non-government and state government bodies. 
Interest in the calculator to assist engagement of business in WHP has been demonstrated. 
There are some implications from this work. 
 The methodology considers the business case relating to absenteeism and staff turnover as 
the only outcome measures. Benefits are quantified in dollar terms and expected savings 
presented. There was no capability within the algorithm to produce a return on investment 
figure. These considerations were made and defended due to the short time frame the 
resource needed to be developed in, the state of the evidence at the time, the measures 
routinely captured by Australian businesses (a high proportion of organisations from the 
small-to-medium sector), and the utility of the tool to engage rather than evaluate program 
delivery. 
Recommendations arising from Chapter 3 are: 
 Policy-research partnerships are a great breeding ground for innovation and 
opportunity for translating research into policy. 
 Researchers must be prepared to work under the constraints of policy deadlines 
which may not always provide enough time for thorough investigation. These 
limitations must be considered and acknowledged within the outcomes developed. 
6.7 A look into the future  
Change in how economic evaluations will be conducted in WHP over the coming years has 
already begun. The following discussion is a comment on an emerging economic framework 
in WHP. It has been developed in the Unites States of America (USA) in response to a policy-
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directive. It is highlighted so as to demonstrate with greater clarity and broader 
understanding the value that WHP can produce.  
In Australia, the development of WHP as a priority setting has been driven by public health 
and etched from the work of Australian researchers within World Health Organization 
Collaborating Centres and Schools of Public Health.1,28,47,48 There are many Australian 
researchers performing health economic evaluations of health promotion interventions12,49-
55 and investigating health economic applications suitable for the workplace setting.22,56-70 
However, most of the financial evidence in WHP is conducted in the USA (see Chapter 2). 
American scholars have been focussed on the WHP research for decades 71 with financial 
analysis of WHP interventions spurred on by increasing business costs within the provider-
pay health care system. Today in the USA the Patient Protection and Affordable Care Act7 
encourages businesses to implement “comprehensive workplace wellness programs.” 
Comprehensiveness is “based on and consistent with evidence-based research and best 
practices, including research and practices as provided in the Guide to Community 
Preventive Services and the National Registry for Effective Programs.” (Section 10408 p 
2285-867) This criterion has impelled WHP scholars to consider ways to measure 
effectiveness so as to better align the WHP initiative of America with public health goals of 
sustainable community development and public (evidence-based) policy.  
Therefore the WHP paradigm is shifting in search of higher quality, more relevant evidence 
that can capture its integrative processes. This window of opportunity has been embraced. 
The Health Enhancement Research Organisation (HERO) and Population Health Alliance 
(PHA) have collaborated to develop a set of core (and consistent) measures so that WHP 
programs transition to data-driven health improvement processes. These include: Financial 
outcomes, Health impact, Participation, Satisfaction, Organizational support, Productivity 
and performance.27 The evidence generated from the USA from approaches like these will 
most assuredly inform Australian WHP efforts into the future.  
6.7.1 An emerging economic framework within WHP 
Sitting within the HERO-PHA model is a seventh essential measurement for program 
success: Value on investment (VOI). This framework is being operationalised by the 
following72: 
1. Calculation of input costs – direct and indirect 
2. Consider and review the full range of possible outcomes. Are they salient? 
Measureable? Of importance to company values and culture? 
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3. Determine measurement rigor for potentially monetized outcomes  
4. Compile the outcome measures, integrating appropriate coefficients for precision 
and priority 
5. Create appropriate Cost Effectiveness Analysis  (CEA) ratios – total program costs per 
outcome unit 
This framework holds promise, offering a unified approach to financial analysis. It aims to 
identify and measure costs and consequences. It has some essential components of an 
economic evaluation. However, what it lacks could hinder the methodological quality of 
economic evidence that arise from it. It lacks the inclusion of a comparator, and the 
integration of how value is placed on the measurements. Furthermore, the creation of a 
simple CEA ratio with recommendation that “simply by reversing the numerator and 
denominator (for monetized outcomes) a conventional ROI ratio will be created” p67 72 runs 
deeply against the main methodological developments in health economic evaluation that 
relate to the quantification of uncertainty in decision making.35 Decisions on incremental 
cost-effectiveness require estimations of uncertainty, e.g. confidence intervals around 
incremental cost-effectiveness ratios or measures of net benefit to give an indication of the 
level of uncertainty. So too, when decisions are based on threshold values, cost-
effectiveness acceptability curves are recommended in order to present the probability the 
intervention is more cost-effective than the alternative.35,73 This cannot be achieved by 
reporting simple cost effectiveness ratios. Such ratios have disconcerting measurement and 
interpretational difficulties.  
It is my recommendation that the operationalisation of the VOI framework in WHP should 
more closely be aligned with standard research-driven principles of health economics.  
Ultimately WHP scholars should decide what the best economic form to use is if a 
prescriptive framework is taken as best practice. There are clear distinctions between cost-
effectiveness (cost-utility) and cost-benefit analysis (CBA). A CBA can assess whether a 
program is worthwhile, without external reference. It can answer questions regarding 
allocative efficiency, whether to expand the budget to accommodate a new program, which 
goals are worth achieving, and was it worthwhile.74 In contrast cost effectiveness analysis 
(cost-utility analysis) is concerned with marginal gains in consideration of threshold cost-
effectiveness values or budget constraint. This form of analysis looks at the additional cost 
of producing an extra X, Y, Z, and therefore informs questions on production efficiency (for 
which the conventional outcome is health benefit). 
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Yet WHP outcomes go beyond health. They have multi-level employee, environment, social, 
political, and organisational foci. Thus, possibly the more relevant form to take is cost-
benefit analysis which is routinely performed in policy reform, economics of safety and 
physical risk, the environment, behavioural economics,  transportation, drugs and alcohol, 
exhaustible resources, social welfare, justice, infrastructure and of course health. 
6.8 Thesis recommendations in summary 
 Use terminology and convention that already exist in health economics and commit 
to a common economic language in economic research.  
 To be of high quality, economic evaluations in WHP must report financial outcomes 
through identification, measurement and valuation of the costs and benefits of the 
intervention alongside a comparator.  
 It is advisable that reporting of economic evaluations follow the Consolidated Health 
Economic Evaluation Reporting Standards (CHEERS) guidelines.  
 Health is a positive, multi-dimensional concept with multiple determinants. 
Economic evaluations of WHP can better evaluate outcomes by measuring beyond 
healthy lifestyles and health risks and towards employee wellbeing and quality of 
life. Health utility is a responsive measure for this purpose. 
 Monitoring and evaluation and stakeholder partnership help to support projects that 
assist sustainable actions in WHP. 
 Simple tools to engage business have utility for governments and health promotion 
advocates and assist in developing the business resource toolbox. 
 Continue the academic debate. “Economists are usually accused of three sins: an 
inability to agree among themselves, stating the obvious and giving bad advice”p1.75 
Conducting economic evaluations in WHP is a complex undertaking and complexities 
necessitate academic debate. This shouldn’t undermine confidence in the science of 
health economics in its application to evaluate WHP interventions rather highlight 
the importance of robust and transparent analysis and the evaluator’s unflinching 
determination to report and communicate within the current accepted guidelines 
and standards. 
6.9 Research priorities and further work 
6.9.1.1 Note 1 
It has been demonstrated that another conventional measure of health utility (EQ-5D) only 
captured health promotion outcomes partially (from the participants’ perspective in a 
lifestyle behaviour change study76). This discovery gives confirmatory evidence that health 
promotion has unmeasured impacts (benefits) beyond health-related quality of life. 
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Conceivably beyond what is captured by SF-6D (see Chapter 4). An even broader 
measurement in the wellbeing domain is missing in public health programs, one that can 
capture outcomes such as improvements in knowledge, opportunities, skills, accessibility.76 
A promising development possibly helping to address the complexity and breadth of 
potential impacts arising from health promotion interventions is the exploration of Sen’s 
capability approach.59,77 This approach is shifting from theoretical suitability to applicability 
in economic evaluations of public health interventions.78  It measures capabilities (a 
person’s ability to achieve) rather than “functionings” (what they manage to do); for 
‘functioning’ depends on a range of personal and social factors.59,79 The latest development 
is the ICECAP-A, a brief self-report ‘capability wellbeing measure’ for adults. It incorporates 
five domains: stability, attachment, achievement, autonomy and enjoyment.80 ICECAP-A has 
been used in studies in the UK, USA, Australia and New Zealand81 and most recently has 
been scored using  UK population level weights (tariff) for each of the domains to elicit value 
anchored between zero [a state of ‘no capability’] and one [‘full capability’]. This tariff 
enables its use in economic evaluations within health and public policy.81 In the current 
WHP community where guidance and criteria are being developed to better measure 
healthy culture and organisational capacity, these even broader measures of wellbeing may 
rival health-related quality of life wellbeing measures. Further investigation is a priority for 
WHP researchers. 
6.9.1.2 Note 2 
Health is not the only outcome in WHP. Indeed non-health measures of outcome, both 
quantifiable and non-quantifiable, exist. So as not to ignore them in health economic 
evaluations, adoption of other valuation methods should be considered, for example, 
contingent valuation (CV). CV is a stated preference approach eliciting willingness-to-pay (or 
willingness-to-accept) measures that represent an individual’s perceived value for the 
specified contingency. It offers a method for measuring benefits within CBA studies that can 
place monetary value on non-market goods.74 CV has been explored as a potential solution 
to capture broader benefits in the public health arena.82,83 Although found to be a feasible 
method, currently CV is not recommended as the sole valuation method to support 
decision-making in public health.83 There is need for further testing within other public 
health interventions such as WHP. Nevertheless, economic evaluations of WHP can gain 
greater understandings through investigation into other methodological applications within 
health economics. This will invariably take a more significant and in-depth account of 
applied methods of cost-benefit analysis in WHP.   
6.9.1.3 Note 3 
Comprehensive and thoughtful models already exist in WHP or are being utilised to increase 
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the knowledge in the field, such as the recent HERO-PHA collaboration project and the 
Precede-proceed model for community health and development. Developing an economic 
model alongside a best-practice guideline in WHP is an ambitious undertaking but an 
important next step.   
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6.10 Thesis Conclusion 
Health economics is a framework that helps evaluations in workplace health promotion to 
be explicit about relevant costs and benefits. It also provides a set of techniques to assist 
decision making towards effectiveness objectives. To be truly informative, economic 
evaluations should be comparative analyses accounting for both costs and benefits. 
Conducting economic evaluations in WHP is a complex undertaking in a complex system of 
health promotion and workplace dynamics. Frustratingly, there is still no complete answer 
as to the best method to improve the science of workplace health promotion. The analyses 
and works herein are a fractal of the greater research efforts across the globe to better align 
economic evaluation in WHP with robust standards. The use of health economic theory as a 
way to guide this pursuit has been discussed. It is my hope that through this work the reader 
has a sense of the significance that workplace health promotion adds to the fabric of public 
health, economic development, and population health research. The workplace contains a 
large ‘captive’ audience where WHP initiatives that improve employee health can minimise 
the global burden of chronic disease. It is my sincere hope that the recommendations 
arising from my work into the microeconomic application of health economics in workplace 
health promotion will indeed assist the sustainability of WHP.  
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